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Topic 1. PREOPERATIV PREPARATION 
 
The main aim: to be able to prepare the patient for surgery, 
to assess the risk of anesthesia, choose the appropriate type of 
anesthesia, premedication appoint, prepare equipment and 
instruments for anesthesia. 
 
The student must know:  
-The components of modern anesthesia.  
-Features of anesthesia preoperative history and physical. 
- The risk assessment. 
-Classification of modern anesthesia. 
-Principles of choice оf anesthesia technique.  
-Pharmacokinetics of drugs for premedication. 
-Mein components of the anaesthetic machine. 
-Preparation of the anaesthetic machine. 
- Mein components and preparation of monitors. 
 
The student must be able: 
-Collect anamnesis and examine of the patient in 
anestesiological aspect. 
-Prognosticate the difficult intubation. 
-Evaluate risk of anesthesia according ASA Physical Status 
Classification.  
- Select the appropriate for patient anesthesia technique. 
- Prepare the anestesiological equipment to operation. 
 
Short methodical instructions for practical study. 
The initial level of students knowledge-abilities 
performed at the beginning of the study, using the test tasks. 
Students examine patients which operative intervention 
coming, see the results of patients laboratory and instrumental 
investigations, study hospital charts, determine the degree of 
surgical risk and choose the optimal type of anaesthesia. If it 
possible they are in an operating-room, if not they decide 
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situational tasks. All students independent work and their 
answers controlled by a teacher.  
In an educational room students together with a 
teacher discuss the results of examination, produce the general 
tactic/pl of conduct of patients in a предоперационном 
period, optimal type of anaesthesia, general tactic/pl of 
conduct of patients and послеоперационном period. Students 
discuss with a teacher by them sufferet errors. After it 
students pass test control. In the end worked out the totals of 
work, and students get the estimations of the work on 
employment. 
 
Mein material 
Terminology 
Anesthesiology is the science of managing the life 
functions of the patients organism in connection with surgery 
or aggressive diagnostic procedure. 
Anesthesia, or anaesthesia (from Greek αν-, an-, 
"without"; and αἴσθησις, aisthēsis, "sensation". 
On October 16, 1846, in Boston,  William T.G. 
Morton conducted the first publicized demonstration of 
general anesthesia using ether. 
The pre-existing word anesthesia was suggested by 
Oliver Wendell Holmes, Sr. in 1846 as a word to use to 
describe this state.  
Anesthesia is reversible, drug-induced condition of: 
Amnesia & unconsciousness – inhibition of psychic perception 
(narcosis, sleep); 
Analgesia – blockade of pain impulses; 
Neurovegetative blockade; 
Immobility (myorelaxation); 
Maintenance of adequate gas exchange; 
Maintenance of adequate blood circulation; 
Maintenance of normal metabolism. 
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The main aim of anesthesiology is to protect the 
organism from the operative injury. According to Rene Lerish, 
"the operation saves the patient by ways which may kill him". 
General Anesthesia  consist from 3 main parts: 
– preoperative evaluation; 
– intraoperative management; 
– postoperative management  
 
Preoperative Evaluation 
Unlike the standard internal medicine H&P, ours is 
much more focused, with specific attention being paid to the 
airway and to organ systems at potential risk for anesthetic 
complications.  The type of operation, and the type of 
anesthetic will also help to focus the evaluation.  
The overall goal of the preoperative evaluation is to 
reduce perioperative morbidity and mortality and alleviate 
patient anxiety. 
The preoperative visit should include the following steps: 
I. Problem Identification 
II. Risk Assessment 
III. Plan of Anaesthetic Technique  
IV. Preoperative Preparation. 
 
         Problem Identification 
Anesthesia preoperative history and physical 
A. Note the date and time of the interview, the planned 
procedure, and a description of any extraordinary 
circumstances regarding the anesthesia. 
B. Current medications and allergies: history of steroids, 
chemotherapy and herb and dietary supplements . 
C. Cigarette, alcohol, and illicit drug history, including most 
recent use. 
D. Anesthetic history, including specific details of any 
problems. 
E. Prior surgical procedures and hospitalizations. 
F. Family history, especially anesthetic problems. 
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Birth and development history (pediatric cases). 
G. Obstetrical history: last menstrual period (females). 
H. Medical history; evaluation, current treatment, and degree 
of control. 
I. Review of systems, including general, cardiac, pulmonary, 
neurologic, liver, renal, gastrointestinal, endocrine, 
hematologic, psychiatric. 
J. History of airway problems (difficult intubation or airway 
disease, symptoms of temporomandibular joint disease, loose 
teeth, etc). 
K. Last oral intake. 
L. Physical exam, including airway evaluation (see below), 
current vital signs, height and body weight, baseline mental 
status, evaluation of heart and lungs, vascular access. 
M.Overall impression of the complexity of the patient’s 
medical condition, with assignment of ASA Physical Status 
Class (see below). 
N. Anesthetic plan (general anesthesia, regional, spinal, 
MAC). The anesthetic plan is based on the patient's medical 
status, the planned operation, 
and the patient’s wishes. 
O. Documentation that risks and benefits were explained to 
the patient. 
 
3. Preoperative laboratory evaluation 
A. Hemoglobin: menstruating females, children less than 6 
months or with suspected sickle cell disease, history of 
anemia, blood dyscrasia or malignancy, congenital heart 
disease, chronic disease states, age greater than 50 years (65 
years for males), patients likely to experience large blood loss. 
B. WBC count: suspected infection or immunosuppression. 
C. Platelet count: history of abnormal bleeding or bruising, 
liver disease, blood dyscrasias, chemotherapy, hypersplenism. 
D. Coagulation studies: history of abnormal bleeding, 
anticoagulant drug therapy, liver disease, malabsorption, poor 
nutrition, vascular procedure. 
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E. Electrolytes, blood glucose, BUN/creatinine: renal disease, 
adrenal or thyroid disorders, diabetes mellitus, diuretic 
therapy, chemotherapy. 
F. Liver function tests: patients with liver disease, history of 
or exposure to hepatitis, history of alcohol or drug abuse, drug 
therapy with agents that may affect liver function. 
G. Pregnancy test: patients for whom pregnancy might 
complicate the surgery, patients of uncertain status by history 
and/or examination. 
H. Electrocardiogram: age 50 or older, hypertension, current 
or past significant cardiac disease or circulatory disease, 
diabetes mellitus in a person age 40 or older. An EKG 
showing normal results that was performed within 6 months 
of surgery can be used if there has been no intervening 
clinical event. 
I. Chest x–ray: asthma or chronic obstructive pulmonary 
disease with change of symptoms or acute episode within the 
past 6 months, cardiothoracic procedures. 
J. Urinalysis: genito–urologic procedures; surgeon may 
request to rule out infection before certain surgical 
procedures. 
K. Cervical spine flexion/extension x–rays: patients with 
rheumatoid arthritis or Down’s syndrome. Routine screening 
in asymptomatic patients is generally not required. 
L. Preoperative pulmonary function tests (PFTs). There is no 
evidence to suggest that pulmonary function tests are useful 
for purposes of risk assessment or modification in patients 
with cigarette smoking or adequately treated brochospastic 
disease. 
Identification of the problems a patient brings to the 
operating room is one of the most vital, yet easily neglected, 
components of the perioperative management of the surgical 
patient. A system–oriented approach to the patient is helpful 
in completing a thorough preoperative assessment. As is the 
case elsewhere in medicine, the preoperative evaluation 
should progress through history (including a review of the 
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patient's chart), physical examination, and laboratory 
investigation. 
Anaesthetic drugs and techniques have profound 
effects on human physiology. Hence, a focused review of all 
major organ systems should be completed prior to surgery. 
The anaesthetist pays special attention to symptoms and 
disease related to the cardiovascular, respiratory, and 
neuromuscular systems as they will directly manipulate these 
systems during surgery. Because one of the goals of the 
preoperative evaluation is to ensure that the patient is in the 
best (or optimal) condition, it is important not only to identify 
symptoms, but also to document their severity and to 
determine their stability or progress. Patients with unstable 
symptoms should be postponed for optimization prior to 
elective surgery. 
 
Cardiovascular system 
Symptoms of the following problems must be sought 
in all patients: 
• ischaemic heart disease; 
• heart failure; 
• hypertension; 
• conduction defects, arrhythmias; 
• peripheral vascular disease. 
Patients with a proven history of myocardial infarction 
(MI) are at a greater risk of perioperative reinfarction, the 
incidence of which is related to the time interval between 
infarct and surgery. This time is variable. In a patient with an 
uncomplicated MI and a normal exercise test elective surgery 
may only need to be delayed by 6–8 weeks. 
Heart failure is one of the most significant indicators  
of perioperative complications, associated with increased risk 
of perioperative cardiac morbidity and mortality. Its severity 
is best described using a recognized scale, for example the 
New York Heart Association classification. 
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New York Heart Association classification 
Class I: Cardiac disease without limitation of physical 
activity.  
Class II: Slight limitation of physical activity. 
Ordinary physical activity results in angina or fatigue.  
Class III: Marked limitation of physical activity.  
Class IV: Angina at rest, increased with activity. 
 
Untreated or poorly controlled hypertension may lead 
to exaggerated cardiovascular responses during anaesthesia. 
Both hypertension and hypotension can be precipitated, which 
increase the risk of myocardial and cerebral ischaemia. The 
severity of hypertension will determine the action required: 
• Mild (SBP 140–159 mmHg, DBP 90–99 mmHg) No 
evidence that delaying surgery for treatment affects outcome. 
• Moderate (SBP 160–179 mmHg, DBP 100–109 mmHg) 
Consider review of treatment. If unchanged, requires close 
monitoring to avoid swings during anaesthesia and surgery. 
• Severe (SBP > 180 mmHg, DBP > 109 mmHg) At this level, 
elective surgery should be postponed due to the significant 
risk of myocardial ischaemia, arrhythmias and intracerebral 
haemorrhage.  In an emergency, will require acute control 
with invasive monitoring. 
 
Respiratory system 
Enquire specifically about symptoms of: 
• chronic obstructive lung disease; 
• emphysema; 
• asthma; 
• infection; 
• restrictive lung disease. 
Patients with pre–existing lung disease are more prone 
to postoperative chest infections, particularly if they are also 
obese, or undergoing upper abdominal or thoracic surgery. If 
an acute upper respiratory tract infection is present, 
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anaesthesia and surgery should be postponed unless it is for a 
life–threatening condition. 
 
Assessment of exercise tolerance 
An indication of cardiac and respiratory reserves can 
be obtained by asking the patient about their ability to 
perform everyday physical activities before having to stop 
because of symptoms of chest pain, shortness of breath, etc. 
For example: 
• How far can you walk on the flat? 
• How far can you walk uphill? 
• How many stairs can you climb before stopping? 
• Could you run for a bus? 
• Are you able to do the shopping? 
• Are you able to do housework? 
• Are you able to care for yourself? 
The problem with such questions is that they are very 
subjective and patients often tend to overestimate their 
abilities! 
 
Other conditions which are important if identified in 
the medical history: 
• Indigestion, heartburn and reflux Possibility of a 
hiatus hernia. If exacerbated on bending forward or lying flat, 
this increases the risk of regurgitation and aspiration. 
• Rheumatoid disease Limited movement of joints 
makes positioning for surgery difficult. Cervical spine and 
tempero–mandibular joint involvement may complicate 
airway management. There is often a chronic anaemia. 
• Diabetes An increased incidence of ischaemic heart 
disease, renal dysfunction, and autonomic and peripheral 
neuropathy. Increased risk of intra and postoperative 
complications, particularly hypotension and infections. 
• Neuromuscular disorders Coexisting heart disease 
may be worsened by anaesthesia and restrictive pulmonary 
disease (forced vital capacity  predisposes to chest infection 
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and the possibility of the need for ventilatory support 
postoperatively. Care when using muscle relaxants. 
• Chronic renal failure Anaemia and electrolyte 
abnormalities. Altered drug excretion restricts the choice of 
anaesthetic drugs. Surgery and dialysis treatments need to be 
coordinated. 
• Jaundice Altered drug metabolism, coagulopathy. 
Care with opioid administration. 
• Epilepsy Well–controlled epilepsy is not a major 
problem. Avoid anaesthetic drugs that are potentially 
epileptogenic. 
 
Previous anaesthetics and operations 
These may have occurred in hospitals or, less 
commonly, dental surgeries. Enquire about any difficulties, 
for example: nausea, vomiting, dreams, awareness, 
postoperative jaundice. Check the records of previous 
anaesthetics to rule out or clarify problems such as difficulties 
with intubation, allergy to drugs given, or adverse reactions 
(e.g. malignant hyperpyrexia, see below). 
Details of previous surgery may reveal potential 
anaesthetic problems, for example cardiac, pulmonary or 
cervical spine surgery. 
 
Family history 
All patients should be asked whether there are any 
known inherited conditions in the family (e.g. sickle–cell 
disease, porphyria). Have any family members experienced 
problems with anaesthesia; a history of prolonged apnoea 
suggests pseudocholinesterase deficiency and an unexplained 
death malignant hyperpyrexia  
Elective surgery should be postponed if any conditions 
are identified, and the patient investigated appropriately. In 
the emergency situation, anaesthesia must be adjusted 
accordingly, for example by avoidance of triggering drugs in 
a patient with a family history of malignant hyperpyrexia. 
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Drug history and allergies 
Identify all medications, both prescribed and 
selfadministered, including herbal preparations. Patients will 
often forget about the oral contraceptive pill (OCP) and 
hormone replacement therapy (HRT) unless specifically 
asked. The incidence of use of medications rises with age and 
many of these drugs have important interactions with 
anaesthetics.Allergies to drugs, topical preparations (e.g. 
iodine), adhesive dressings and foodstuffs should be noted. 
 
Social history 
• Smoking Ascertain the number of cigarettes or the 
amount of tobacco smoked per day. Oxygen carriage  is 
reduced by carboxyhaemoglobin, and nicotine stimulates the 
sympathetic nervous system, causing tachycardia, 
hypertension and coronary artery narrowing. Apart from the 
risks of chronic lung disease and carcinoma, smokers have a 
significantly increased risk of postoperative chest infections. 
Stopping smoking for 8 weeks improves the airways; for 2 
weeks reduces their irritability; and for as little as 24 h before 
anaesthesia decreases carboxyhaemoglobin levels. Help and 
advice should be available at the preoperative assessment 
clinic. 
• Alcohol This is measured as units consumed per 
week; >50 units/week causes induction of liver enzymes and 
tolerance to anaesthetic drugs. The risk of alcohol withdrawal 
syndrome postoperatively must be considered. 
• Drugs Ask specifically about the use of drugs for 
recreational purposes, including type, frequency and route of 
administration. This group of patients is at risk of infection 
with hepatitis B and human immunodeficiency virus (HIV). 
There can be difficulty with venous access following IV drug 
abuse due to widespread thrombosis of veins. Withdrawal 
syndromes can occur postoperatively. 
• Pregnancy The date of the last menstrual period 
should be noted in all women of childbearing age. The 
14 
anaesthetist may be the only person in theatre able to give this 
information if  X–rays are required. Anaesthesia increases the 
risk of inducing a spontaneous abortion in early pregnancy. 
There is an increased risk of regurgitation and aspiration in 
late pregnancy. Elective surgery is best postponed until after 
delivery. 
 
The examination 
As with the history, this concentrates on the 
cardiovascular and respiratory systems; the remaining systems 
are examined if problems relevant to anaesthesia have been 
identified in the history. At the end of the examination, the 
patient’s airway is assessed to try and identify any potential 
problems. If a regional anaesthetic is planned, the 
appropriateanatomy (e.g. lumbar spine for central neural 
block) is examined. 
 
Cardiovascular system 
Look specifically for signs of: 
• arrhythmias; 
• heart failure; 
• hypertension; 
• valvular heart disease; 
• peripheral vascular disease. 
Don’t forget to inspect the peripheral veins to identify 
any potential problems with IV access. 
 
Respiratory system 
Look specifically for signs of: 
• respiratory failure; 
• impaired ventilation; 
• collapse, consolidation, pleural effusion; 
• additional or absent breath sounds. 
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Nervous system 
Chronic disease of the peripheral and central nervous 
systems should be identified and any evidence of motor or 
sensory impairment recorded. It must be remembered that 
some disorders will affect the cardiovascular and respiratory 
systems, for example dystrophia myotonica and multiple 
sclerosis. 
 
Musculoskeletal system 
Patients with connective tissue disorders should have 
any restriction of movement and deformities noted. Patients 
suffering from chronic rheumatoid disease frequently have a 
reduced muscle mass, peripheral neuropathies and pulmonary 
involvement. Particular attention should be paid to the 
patient’s cervical spine and temperomandibularjoints. 
 
The airway 
All patients must have an assessment made of their 
airway, the aim being to try and predict those patients who 
may be difficult to intubate. 
 
Observation of the patient’s anatomy 
Look for: 
• limitation of mouth opening; 
• a receding mandible; 
• position, number and health of teeth; 
• size of the tongue; 
• soft tissue swelling at the front of the neck; 
• deviation of the larynx or trachea; 
• limitations in flexion and extension of the cervical 
spine. 
Finding any of these suggests that intubation may be 
more difficult. However, it must be remembered that all of 
these are subjective. 
Simple bedside tests 
16 
• Mallampati criteria The patient, sitting upright, is 
asked to open their mouth and maximally protrude their 
tongue. The view of the pharyngeal structures is noted and 
graded I–IV. 
 
 
Class 1: Soft palate, fauces, uvula, anterior and posterior 
faucial pilars can be seen.  
Class 2: Soft palate, fauces, uvula can be seen. The tongue 
masks anterior and posterior faucial pillars.  
Class 3: Soft palate and the base of uvula can be seen only.  
Class 4: Only hard palate is visible. 
Grades III and IV suggest difficult intubation. 
• Thyromental distance With the head fully 
extendedon the neck, the distance between the bony point of 
the chin and the prominence of the thyroid cartilage is 
measured .A distance of less than 7 cm suggests difficult 
intubation. 
 
          Investigations 
          There is little evidence to support the performance of 
‘routine’ investigations, and these should only be ordered if 
the result would affect the patient’s management. In patients 
with no evidence of concurrent disease (ASA 1, see below), 
preoperative investigations will depend on the extent of 
surgery and the age of the patient.  For each age group and 
grade of surgery, the upper entry, shows ‘tests recommended’ 
and the lower entry ‘tests to be considered’ (depending on 
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patient characteristics). Dipstick urinalysis need only be 
performed in symptomatic individuals. 
 
Additional investigations 
The following is a guide to those commonly requested. 
Again these will also be dependent on the grade of surgery 
and the age of the patient.  
• Urea and electrolytes: patients taking digoxin, 
diuretics, steroids, and those with diabetes, renal disease, 
vomiting, diarrhoea. 
• Liver function tests: known hepatic disease, a history 
of a high alcohol intake (>50 units/week), metastatic disease 
or evidence of malnutrition. 
• Blood sugar: diabetics, severe peripheral arterial 
disease or taking long–term steroids. 
• Electrocardiogram (ECG): hypertensive, with 
symptoms or signs of ischaemic heart disease, a cardiac 
arrhythmia or diabetics >40 years of age. 
• Chest X–ray: symptoms or signs of cardiac or 
respiratory disease, or suspected or known  malignancy, 
where thoracic surgery is planned, or in those from areas of 
endemic tuberculosis who have not had a chest X–ray in the 
last year. 
•  Pulmonary function tests: dyspnoea on mild 
exertion, chronic obstructive pulmonary disease COPD) or 
asthma. Measure peak expiratory flow rate (PEFR), forced 
expiratory volume in 1 s (FEV1) and FVC. Patients who are 
dyspnoeic or cyanosed at rest, found to have an FEV1 <60% 
predicted, or are to have thoracic surgery, should also have 
arterial blood gas analysed while breathing air. 
• Coagulation screen: anticoagulation, a history of a 
bleeding diatheses or a history of liver disease or jaundice. 
• Sickle–cell screen (Sickledex): a family history of 
sickle–cell disease or where ethnicity increases the risk of 
sickle–cell disease. If positive, electrophoresis for definitive 
diagnosis. 
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• Cervical spine X–ray: rheumatoid arthritis, a history 
of major trauma or surgery to the neck or when difficult 
intubation is predicted. 
 
Risk Assessment 
There are three components that must be considered 
when evaluating perioperative risk: the patient's medical 
condition preoperatively, the extent of the surgical procedure, 
and the risk from the anaesthetic. In general, the major 
contribution to increased risk is that of the patient's health 
prior to the procedure and the magnitude of the 
surgery.However, patients presenting for surgery often have 
more fear about their anaesthetic than the surgery itself. 
Fortunately, anaesthesia–related morbidity and mortality is 
rare, but unfortunately, not absent. This does, however, create 
its own problems. The combination of infrequent but serious 
events has led one author to state that "Perhaps the most 
insidious hazard of anaesthesia is its relative safety". 
 
Perioperatlve rlsk assessment: 
           The wide variety of surgical procedures and 
anaesthetic techniques, combined with the diversity of a 
patient's coexisting surgical and medical illnesses, produce a 
number of risk factors that contribute to overall outcome, and 
make generalized statements about risk difficult. Specific 
predictions for a single patient's outcome is virtually 
impossible, and the complexity of this issue has made 
research studies addressing outcome very difficult.  
The oldest and simplest method for risk assessment is 
the American Society of Anesthesiology (ASA) physical 
status. 
ASA Physical Status Classification 
Class 1: A normal healthy patient.  
Class 2: A patient with mild systemic disease that results in no 
functional limitation.  
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Class 3: A patient with severe systemic disease that results in 
functional limitation.  
Class 4: A patient with severe systemic disease that is a 
constant threat to life.  
Class 5: A moribund patient that is not expected to survive for 
24 hours with or without the operation.  
Class 6: A declared brain–dead patient whose organs are 
being removed for donor purposes.  
The modification E is added to the ASA physical 
status classification to indicate that the case is done 
emergently. 
As this system is simple, easy to use and requires no 
laboratory investigations, it has now been widely accepted as 
the standard means of preoperative patient classification. 
 
Plan of Anaesthetic Technique 
Classification of anestrsia 
          I. Local anesthesia 
1. Medicamentous: 
            terminal; 
            infiltration; 
            conduction: truncal, plexal, paravertebral; 
            regional: epidural, spinal. 
2. Nonmedicamentous: 
            acupuncture; 
            electro– and pharmaco–acupuncture; 
            refrigeration. 
          II. General anesthesia 
1.  Medicamentous: 
      1) mononarcosis: 
           a) inhalation: 
             – mask (including oro– and nasopharyngeal, with      
laryngomask); 
             –  intubation; 
            b) noninhalation: 
20 
           – intravenous; 
           – peroral; 
           – rectal; 
           – intramuscular; 
           – subcutaneous; 
           – intraosteal; 
           – intracavitary; 
       2) combained: 
           – two and more inhalation anesthetics; 
           – two and more noninhalation anesthetics; 
           – inhalation and noninhalation anesthetics; 
           –anesthetics and other neurotropic substances    
(analgetics, ataractics, myorelaxants et al.); 
           – neurotropic agents without anesthetics. 
2.  Nonmedicamentous: 
    1) electroanesthesia; 
    2) hypnonarcosis. 
 
Classification of operation 
Traditionally, surgery was classified as being either 
elective or emergency. Recognizing that this was too 
imprecise, the National Confidential Enquiry into 
Perioperative Deaths (NCEPOD) devised four categories: 
• Elective: operation at a time to suit both patient and surgeon; 
for example hip replacement, varicose veins. 
• Scheduled: an early operation but not immediately life 
saving; operation usually within 3 weeks; for example surgery 
for malignancy. 
• Urgent: operation as soon as possible after resuscitation and 
within 24 h; for example intestinal obstruction, major 
fractures. 
• Emergency: immediate life–saving operation, resuscitation 
simultaneous with surgical treatment; operation usually within 
1h; for example major trauma with uncontrolled haemorrhage, 
extradural haematoma. 
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All elective and the majority of scheduled cases can be 
assessed as described above. However, with urgent cases this 
will not always be possible; as much information as possible 
should be obtained about any concurrent medical problems 
and their treatment, and allergies and previous anaesthetics. 
The cardiovascular and respiratory systems should be 
examined and an assessment made of any potential difficulty 
with intubation. Investigations should only be ordered if they 
would directly affect the conduct of anaesthesia. With true 
emergency cases there will be even less or no time for 
assessment. Where possible an attempt should be madeto 
establish the patient’s medical history, drugs taken regularly 
and allergies. In the trauma patient enquire about the 
mechanism of injury. All emergency patients should be 
assumed to have a full stomach. Details may only be available 
from relatives and/or the ambulance crew. 
 A good anesthetic begins with a good plan. There is no 
rigid format for planning anesthesia. Rather, each plan is 
adapted to each case. The fundamental goal of anesthetic 
management is to provide safety, comfort and convenience, 
first for the patient and second for those caring for the patient.  
After a good plan, a good preparation is required for a good 
anesthetic.  
Before every anesthetic, every anesthesiologist should 
go through a checklist of necessary items including, 
anesthesia machine, ventilator, oxygen and nitrous supply 
check, suction device, monitors and anesthesia cart.  
Before bringing the patient to the operating room, the 
proper verification of patient's identity, the planned procedure 
and the site of the procedure should be carried out by the 
anesthesiologist. All the preparations should be completed 
before the patient enters the room including the placement of 
a working peripheral intravenous line.  
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Preoperative Preparation 
Premedication 
Nowadays, premedication refers to the administration 
of any drugs in the period before induction of anaesthesia. 
Consequently, a wide variety of drugs are used with a variety 
of aims. 
The 6 As of premedication: 
• Anxiolysis. 
• Amnesia. 
• Anti–emetic. 
• Antacid. 
• Anti–autonomic. 
• Analgesia. 
 
 
Anxiolysis 
The most commonly prescribed drugs are the 
benzodiazepines. They produce a degree of sedation and 
amnesia, are well absorbed from the gastrointestinal tract and 
are usually given orally, 45– 90mins preoperatively. Those 
most commonly used include temazepam 20–30mg, diazepam 
10–20mg and lorazepam 2–4mg. In patients who suffer from 
excessive somatic manifestations of anxiety, for example 
tachycardia, beta blockers may be given. A preoperative visit 
and explanation is often as effective as drugs at alleviating 
anxiety, and sedation does not always mean lack of anxiety. 
 
Amnesia 
Some patients specifically request that they not have 
any recall of the events leading up to anaesthesia and surgery. 
This may be accomplished bythe administration of lorazepam 
(as above) to provide anterograde amnesia. 
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Anti–emetic (reduction of nauseaand vomiting) 
Nausea and vomiting may follow the administration of 
opioids, either pre– or intraoperatively. Certain types of 
surgery are associated with a higher incidence of 
postoperative nausea and vomiting (PONV), for example 
gynaecology. Unfortunately, none of the currently used drugs 
can be relied on to prevent or treat established PONV. 
Drugs with anti–emetic properties  
Dopamine antagonists – Metoclopramide  – 10mg 
orally or IV 5–hydroxytryptamine antagonists – Ondansetron  
–  4–8mg orally or IV Antihistamines – Cyclizine – 50 mg IM 
or IV. Anticholinergics – Hyoscine –1 mg transdermal patch 
Antacid (modify pH and volume of gastric contents). 
Patients are starved preoperatively to reduce the risk of 
regurgitation and aspiration of gastric acid at the induction of 
anaesthesia (see below). This may not be possible or effective 
in some patients: 
• those who require emergency surgery; 
• those who have received opiates or are in pain will show a 
significant delay in gastric emptying; 
• those with a hiatus hernia, who are at an increased risk of 
regurgitation. 
A variety of drug combinations are used to try and 
increase the pH and reduce the volume. 
• Oral sodium citrate (0.3M): 30mL orally immediately 
preinduction, to chemically neutralize residual acid. 
• Ranitidine (H2 antagonist): 150mg orally 12 hourly and 2 
hourly preoperatively. 
• Metoclopramide: 10mg orally preoperatively. Increases both 
gastric emptying and lower oesophageal sphincter tone. Often 
given in conjunction with ranitidine. 
• Omeprazole (proton pump inhibitor): 40mg 3–4 hourly 
preoperatively. 
If a naso– or orogastric tube is in place, this can be 
used to aspirate gastric contents. 
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Anti–autonomic effects 
           Anticholinergic effects. 
(a) Reduce salivation (antisialogogue), for example 
during fibreoptic intubation, surgery or instrumentation of the 
oral cavity or ketamine anaesthesia. 
(b) Reduce the vagolytic effects on the heart, for 
example before the use of suxamethonium (particularly in 
children), during surgery on the extra ocular muscles (squint 
correction), or during elevation of a fractured zygoma. 
 Atropine and hyoscine have now largely been replaced 
preoperativelyby glycopyrrolate, 0.2–0.4mg intramuscularly 
(IM). Many anaesthetists would consider an IV dose given at 
induction more effective. 
           Antisympathomimetic effects. 
Increased sympathetic activity can be seen at 
intubation, causing tachycardia and hypertension. This is 
undesirable in certain patients, for example those with 
ischaemic heart disease or raised intracranial pressure. These 
responses can be attenuated by the use of beta blockers given 
preoperatively (e.g. atenolol, 25–50 mg orally) or 
intravenously at induction (e.g. esmolol). Perioperative beta 
blockade may also decrease the incidence of adverse coronary 
events in high risk patients having major surgery. An 
alternative is togive a potent analgesic at induction of 
anaesthesia, for example fentanyl, alfentanil or remifentanil. 
 
Analgesia 
Although the oldest form of premedication, analgesic 
drugs are now generally reserved for patients who are in pain 
preoperatively. The most commonly used are morphine, 
pethidine and fentanyl. Morphine was widely used for its 
sedative effects but is relatively poor as an anxiolytic and has 
largely been replaced by the benzodiazepines. Opiates have a 
range of unwanted side–effects, including nausea, vomiting, 
respiratory depression and delayed gastric emptying. 
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Preoperative Fasting Guidelines 
1. Recommendations (applies to all ages) 
Ingested Material Minimum Fasting Period (hrs) 
Clear liquids 2 
Breast milk 4 
Infant formula 6 
Non–human milk 6 
Light solid foods 6 
2. Recommendations apply to healthy patients exclusive of 
parturients undergoing elective surgery; following these 
recommendations does not guarantee gastric emptying has 
occurred. 
3. Clear liquids include water, sugar–water, apple juice, non–
carbonated soda, pulp–free juices, clear tea,black coffee. 
4. Medications can be taken with up to 150 mL of water in the 
hour preceding induction of anesthesia. 
 
 
 
The preparation of equipment and instruments 
The delivery of gases to theoperating theatre 
Most hospitals use a piped medical gas and vacuum system 
(PMGV) to distribute oxygen, nitrous oxide, medical air and 
vacuum. The pipelines’ outlets act as self–closing sockets, 
each specifically configured, coloured and labelled for one 
gas. Oxygen, nitrous oxide and air are delivered to the 
anaesthetic room at a pressure of 400 kilopascals (kPa) (4bar, 
60 pounds per square inch (psi)). The gases (and vacuum) 
reach the anaesthetic machine via flexible reinforced hoses, 
colour coded throughout their length (oxygen white, nitrous 
oxide blue, vacuum yellow). 
These attach to the wall outlet via a gas–specific probe 
(Figure 1.1) and to the anaesthetic machine via a gas–specific 
nut and union. Cylinders, the traditional method of supplying 
gases to the anaesthetic machine, are now mainly used as 
reserves in case of pipeline failure.  
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Oxygen 
Piped oxygen is supplied from a liquid oxygen reserve, 
where it is stored under pressure (10–12 bar, 1200kPa) at 
approximately – 180°C in a vacuuminsulated evaporator 
(VIE), effectively a thermos flask. Gaseous oxygen is 
removed from above the liquid, or at times of increased 
demand, by vaporizing liquid oxygen using heat from the 
environment. The gas is warmed to ambient air temperature 
en route from the VIE to the pipeline system. A reserve bank 
of cylinders of compressed oxygen is kept adjacent in case of 
failure of the main system. A smaller cylinder is attached 
directly to the anaesthetic machine as an emergency reserve. 
The pressure in a full cylinder is 12000kPa (120 bar, 1980 
psi) and this falls in direct proportion to the cylinder contents. 
 
Nitrous oxide 
Piped nitrous oxide is supplied from large cylinders, 
several of which are joined together to form a bank, attached 
to a common manifold. There are usually two banks, one 
running with all cylinders turned on (duty bank), and a 
reserve. In addition, there is a small emergency supply. 
Smaller cylinders are attached directly to the anaesthetic 
machine. At room temperature, nitrous oxide is a liquid within 
the cylinder, and while any liquid remains the pressure within 
the cylinder remains constant (440 kPa, 640 psi). When all the 
liquid has evaporated, the cylinder contains only gas and as it 
empties, the pressure falls to zero. 
 
 
 
Figure 1.1 – Wall–mounted outlets and gas–specific probes 
for (left to right) oxygen, nitrous oxide, air 
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The anaesthetic machine 
Its main functions are to allow: 
• the accurate delivery of varying flows of gases to an 
anaesthetic system; 
• an accurate concentration of an anaesthetic vapour to be 
added to the gas stream. 
In addition to these functions, many modern 
anaesthetic machines contain integral monitoring equipment 
and ventilators. 
 
Measurement of flow 
This is achieved on most anaesthetic machines by the 
use of flowmeters (‘rotameters’;  Figure 1.2  ): 
 • A specific, calibrated flowmeter is used for each gas. 
• A needle valve controls the flow of gas through the 
flowmeter. 
• A rotating bobbin floats in the gas stream, its upper edge 
indicating the rate of gas flow. 
• Several flowmeters are mounted adjacent with oxygen to the 
left; the control for oxygen has a different knurled finish and 
is usually more prominent. 
• Flowmeters do not regulate pressure. 
 
  
 
Figure 1.2 –  Flowmeter     Figure 1.3 –  Vaporizers  
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               The addition of anaesthetic vapours 
               Vapour–specific devices are used to produce an 
accurate concentration of each inhalational anaesthetic: 
• Vaporizers produce a saturated vapour from a reservoir of 
liquid anaesthetic ( Figure 1.3).  
• The final concentration of anaesthetic is controlled by 
varying the proportion of gas passing into the vapour 
chamber. 
• The vaporizers are temperature compensated (hence –tec 
suffix, e.g. Sevotec) to account for the loss of latent heat that 
causes cooling and reduces vaporization of the anaesthetic. 
The resultant mixture of gases and vapour is finally 
delivered to a common outlet on the anaesthetic machine. 
From this point, specialized breathing systems are used to 
transfer the gases and vapours to the patient. 
 
  Anaesthetic breathing systems 
The mixture of anaesthetic gas and vapour travels 
from the anaesthetic machine to the patient via an anaesthetic 
circuit, or more correctly an anaesthetic breathing system. 
Delivery to the patient is via a facemask, laryngeal mask or 
tracheal tube 
As several patients in succession may breathe through 
the same system, a low–resistance, disposable bacterial filter 
is placed at the patient end of the system, and changed 
between each patient to reduce the risk of cross–infection. 
Alternatively, disposable systems are used, and changed for 
each patient. 
 
Components of a breathing system 
All systems consist of the following: 
• A connection for fresh gas input Usually the common gas 
outlet on the anaesthetic machine. 
• A reservoir bag Usually of 2 L capacity to allow the 
patient’s peak inspiratory demands (30– 40L/min) to be met 
with a lower constant flow from the anaesthetic machine. Its 
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excursion gives an indication of ventilation and allows 
manual ventilation of the patient. It also acts as a further 
safety device, being easily distended at low pressure if 
obstruction occurs. 
• An adjustable expiratory valve To vent expired gas, helping 
to eliminate carbon dioxide. During spontaneous ventilation, 
resistance to opening is minimal so as not to impede 
expiration. Closing the valve allows manual ventilation by 
squeezing the reservoir bag. 
An example of a commonly used system is shownin  at 
Figure 1.5. 
 
The circle system 
The traditional breathing systems relied on the 
positioning of the components and the gas flow from the 
anaesthetic machine to eliminate carbon dioxide in expired 
gas, thereby preventing rebreathing and hypercapnia. Even the 
most efficient system is still wasteful; a gas flow of 4–6 L/min 
is required and the expired gas contains oxygen and 
anaesthetic vapour in addition to carbon dioxide. The circle 
system (Figure 1.4) overcomes theseinefficiencies: 
• The expired gases, instead of being vented to the 
atmosphere, are passed through a container of soda lime (the 
absorber), a mixture of calcium, sodium and potassium 
hydroxide, to chemically remove carbon dioxide. 
• Supplementary oxygen and anaesthetic vapour are added to 
maintain the desired concentrations, and the mixture 
rebreathed by the patient. Gas flows from the anaesthetic 
machine to achieve this can be as low as 0.5L/min. The circle 
system is therefore the only true ‘anaesthetic circuit’. 
• The gases are warmed and humidified as they pass through 
the absorber (by–products of the reaction removing carbon 
dioxide). There are several points to note when using a circle 
system. 
• As the inspired gas is a mixture of expired and fresh gas, the 
concentration of oxygen within the circle is not known 
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accurately. The inspired oxygen concentration must be 
monitored to ensure that the patient is not rendered hypoxic  
• The inspired anaesthetic concentration must be monitored, 
particularly when a patient is being ventilated through a 
circle, to prevent awareness. 
• When unable to absorb any more carbon dioxide, a change 
in the colour of the granules occurs as a result of the 
incorporation of an indicator. One of the commonly used 
preparations changes from pink to white. 
 
   
 
Figure 1.5 – The component parts of a breathing system 
 
 
 
Figure 1.4 – The circle system 
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Checking the anaesthetic machine 
It is the responsibility of each anaesthetist to check 
that the apparatus used will function in the manner expected 
at the beginning of each operating session. The main danger is 
that the anaesthetic machine appears to perform normally, but 
in fact is delivering a hypoxic mixture to the patient. In order 
to minimize the risk of this, the Association of Anaesthetists 
of Great Britain and Ireland (AAGBI) has published a 
Checklist for Anaesthetic Machines. Its main aim is to ensure 
that oxygen flows through the oxygen delivery system and is 
unaffected by the use of any additional gas or vapour. Most 
modern anaesthetic machines now 
have built–in oxygen analysers that monitor the inspired 
oxygen concentration to minimize this risk. 
 
Minimizing theatre pollution 
Unless special measures are taken, the atmosphere in 
the operating theatre will become polluted with anaesthetic 
gases. The breathing systems described and mechanical 
ventilators vent varying volumes of excess and expired gas 
into the atmosphere, the patient expires anaesthetic gas during 
recovery and there are leaks from anaesthetic apparatus. 
Although no conclusive evidence exists to link prolonged 
exposure to low concentrations of inhalational anaesthetics 
with any risks, it would seem sensible to minimize the degree 
of pollution within the operating theatre environment. This 
can be achieved in a number of ways: 
• reduce the flow of gases, for example by use of a circle 
system; 
• avoid use of gases, for example by use of TIVA, regional 
anaesthesia; 
• use of air conditioning in the theatre; 
• scavenging systems. 
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Mechanical ventilation 
A wide variety of anaesthetic ventilators are available, 
each of which functions in a slightly different way( Figure 
1.6).  
During spontaneous ventilation, gas moves into the 
lungs by a negative intrathoracic pressure. This process is 
reversed during mechanical ventilation. 
A positive pressure is applied to the anaesthetic gases 
to overcome airway resistance and elastic recoil of the chest, 
and flow occurs into the lungs. This technique is usually 
referred to as intermittent positive pressure ventilation 
(IPPV). In both spontaneous and mechanical ventilation, 
expiration occurs by passive recoil of the lungs and chest 
wall. In order to generate a positive pressure, the ventilator 
requires a source of energy: gravity, gas pressure or 
electricity. 
 
                   
Figure 1.6 – Modern electronic     Figure 1.7  – Bag–in–bottle 
ventilator                                           ventilator 
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The effects of positive pressure ventilation: 
• There is an increase in both the physiological dead space 
relative to the tidal volume and ventilation/ perfusion (V/Q) 
mismatch, the effect of which is to impair oxygenation. An 
inspired oxygen concentration of around 30% is used to 
compensate and prevent hypoxaemia. 
• The arterial partial pressure of carbon dioxide (PaCO2) is 
dependent on alveolar ventilation. Overventilation results in 
hypocapnia, causing a respiratory alkalosis. This ‘shifts’ the 
oxyhaemoglobin dissociation curve to the left, increasing the 
affinity of haemoglobin for oxygen. Hypocapnia will induce 
vasoconstriction in many organs, including including the 
brain and heart, reducing blood flow. Underventilation will 
lead to hypercapnia, causing a respiratory acidosis. The 
effects on the oxyhaemoglobin dissociation curve are the 
opposite of above, along with stimulation of the sympathetic 
nervous system causing vasodilatation, hypertension, 
tachycardia and arrhythmias. 
• Excessive tidal volume may cause overdistension of the 
alveoli. In patients with pre–existing lung disease this may 
cause a pneumothorax, and, long term, a condition called 
ventilator–induced lung injury. 
• The positive intrathoracic pressure reduces venous return to 
the heart and cardiac output. 
• Both systemic and pulmonary blood flow are reduced, the 
latter further increasing V/Q mismatch. 
 
Measurement and monitoring 
Measurement and monitoring are closely linked but 
are not synonymous. A measuring instrument becomes a 
monitor when it is capable of deliveri a warning when the 
variable being measured falls outside preset limits. During 
anaesthesia, both the patient and the equipment being used are 
monitored, the complexity of which depends upon a variety of 
factors including: 
• type of operation and operative technique; 
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• anaesthetic technique used; 
• present and previous health of the patient; 
• equipment availableng and the anaesthetist’s ability to use it; 
Monitoring is not without its own potential hazards: 
faulty equipment may endanger the patient, for example from 
electrocution secondary to faulty earthing; the anaesthetist 
may act on faulty data, instituting inappropriate treatment; or 
the patient may be harmed by the complications of the 
technique to establish invasive monitoring, for example 
pneumothorax following central line insertion. 
Ultimately, too many monitors may distract the 
anaesthetist from recognizing problems occurring in other 
areas. 
• preferences of the anaesthetist; 
• any research being undertaken. 
 
Clearly, the anaesthetist has a responsibility to check 
the function of all monitoring equipment before use and 
ensure that the alarm limits are set appropriately. There is 
good evidence that monitoring reduces the risks of adverse 
incidents and accidents. The combination of pulse oximetry, 
capnography and blood pressure monitoring detects the 
majority of serious incidents before the patient suffers serious 
injury. Monitoring should commence before the induction of 
anaesthesia and continue until the patient has recovered from 
the effects of anaesthesia, and the information generated 
should be recorded in the patient’s notes. Ultimately, monitors 
supplement clinical observation; there is no substitute for the 
presence of a trained and experienced anaesthetist throughout 
the entire operative procedu. 
 
Monitoring the patient 
The AAGBI recommends certain monitoring devices 
as essential for the safe conduct of anaesthesia (Figure 1.8)  . 
These consist of: 
• ECG; 
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• non–invasive blood pressure; 
• pulse oximeter; 
• capnography; 
• vapour concentration analyser. 
In addition, the following monitors should be 
immediately available: 
• peripheral nerve stimulator; 
• temperature. 
Finally, additional equipment will be required in 
certain cases, to monitor, for example: 
• invasive blood pressure; 
• urine output; 
• central venous pressure; 
• pulmonary artery pressure; 
• cardiac output. 
 
SAM (really SAMMM') stands for: 
S Suctlon checked and functioning. 
A Airway equipment checked and prepared. (This includes 
checking that you have a functioning and backup 
laryngoscope, an appropriate sized endotracheal tube and 
stylet, oropharyngeal airways, as well as an oxygen source 
and manual resuscitation bag). 
M Machine checked. (see anaesthesia machine checkout 
procedure and make sure you know how to check your 
machine. You can go to the operating room before or after 
scheduled procedures to explore the machine. Ask your staff 
anaesthetist to go through this procedure with you. 
M Monitors available and functioning. 
M Medications prepared and labelled. You should know 
where the emergency drugs are kept and location of  the 
difficult intubation cart. 
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Figure 1.8 – Integrated monitoring system displaying ECG 
and heart rate (beats/min), non–invasive blood pressure 
(mmHg), capnograph and end tidal carbon dioxide (kPa), 
pulse oximeter waveform and saturation (%) 
 
Examples  of tascs for determination of knowledge  lewel 
1. Choose the right combination of components of general 
anesthesia: 
a) Narcotic analgesia and sleep; 
b) Cut consciousness, neurovegetative protection, analgesia 
and muscle relaxation; 
c) Cut consciousness and muscle relaxation; 
d) Anesthesia, muscle relaxation and neurovegetative 
protection. 
 
2. Under which of the following diseases relatively 
contraindicated anesthesia with ketamine (Kalipsol) 
a)   Thyrotoxicosis; 
b)  Myasthenia gravis; 
c)  Pheochromocytoma; 
d)  Epilepsy. 
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3. General anesthesia may be: 
a)   Endotracheal; 
b)   Mask; 
c)   Epidural; 
d)   Intramuscular; 
 
4.Narcosis may be: 
a)  General; 
b)   Local; 
c)   Mask; 
d)   Endotracheal. 
 
5. The Mallampati test is Class 3  if visible: 
a)   Soft palate, fauces, uvula, anterior and posterior faucial 
pillars; 
b)  Soft palate, fauces, uvula; 
c)  Soft palate and the base of uvula; 
 d)  Only hard palate. 
 
6. If patient has severe systemic disease that is a constant 
threat to life, risk of anesthesia according ASA Physical 
Status Classification is: 
a) Class 1; 
b) Class 2;  
c) Class 3;  
d) Class 4. 
 
7.  The method of choice for emergency anesthesia for 
multiple injuries of the lower extremities and pelvis suspected 
in damage to internal organs is: 
a) The mask anesthesia; 
b) Epidural anesthesia; 
c) Combined  endotracheal anesthesia with mechanical 
ventilation; 
d) Spinal anesthesia. 
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8. A patient with very labile psychics is in the state of drastic 
emotional exertion before the operation with a predominance 
of phobia. What preparation will you prefer as the agent for 
premedication? 
a)   Droperidol; 
b)   Morphine; 
c)   Omnopon; 
d)   Midasolam. 
 
9. Anesthesia apparatus is necessary for: 
a) All forms of anesthesia; 
b) All forms of general anesthesia; 
c) Inhalation anesthesia; 
d) Endotracheal anesthesia. 
 
10. Adsorber to anesthesia machine needs: 
a)  Oxygen for regeneration; 
b)  For absorbing moisture; 
c)  For absorption of carbon dioxide; 
d)  For the absorption of the anesthetic. 
 
Correct answers: 
1–b);   2–a),c),d);  3–a),b),d);  4–a),c),d);  5–c);  6–d);  7–c);  
8–d);  9–c),d);  10–c). 
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Topic 2. ANESTESIA 
 
The main aim:  to  know  main 3  phases of the 
general  anesthesia: induction, maintenance and emergence, 
metods of regiona anesthesia ,complications of anesthesia 
  
The student must know:  
– Pharmacocinetics  drugs used for inhalation and non 
inhalation  anaesthesia,opiates and muscle relaxants. 
–  The metods of maintenance  airweys patency. 
–  Actions sequence  during induction to anesthesia, induction 
methods. 
– The technique of oral  intubation. 
– The control of the anaesthesia  depth: Guedel’s stages  of 
anesthesia, bispectral index (BIS). 
–  Monitoring  during maintenance of anesthesia.  
–  The blood loss and fluid management during anesthesia. 
–  Complications of general anesthesia. 
–  Actions sequence  during emergence from anesthesia. 
–  Pharmacocinetics of localv anaesthetics. 
– Regional anaesthetic techniques: brachial plexus block, 
epidural and spinal anaesthesia. 
–  Contraindications to epidural and spinal anaesthesia. 
–  Contraindications to epidural and spinal anaesthesia. 
 
The student must be able: 
–  Select drugs for general anaesthesia. 
– To use simpl devisis for maintenance  airweys patency: 
Saphar manoeuvre,  oropharingeal  and nasopharingeal 
airweys,larindeal mask. 
–  Perform Sellick’s manoeuvre. 
–  To intubate of  fantom. 
–  To use methods of passive and active rewarming. 
–  To use extubation protocol. 
–  To select needles for epidural and spinal anaesthesia. 
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Short methodical instructions for practical study 
At the study beginning the students pass control of 
knowledge–abilities initial level by means of test tasks. 
Students examine patients with different surgical pathology, 
which operative intervention coming, got to know of the 
clinical and laboratory results and additional findings of these 
patients, study hospital charts, determine the surgical risk 
level and choose the optimal type of anaesthesia, on 
possibility are in an operating–room. Also in the intensive 
care department they are examine postsurgical patients, 
estimate the adequate consciousness, breathing, 
hemodynamics and tonus restore, work out the tactic of 
patients management in an early postsurgical period, got to 
know of hospital and anesthesia charts, features of 
management in children's and elderly patients. In default of 
such patients the students decide situational tasks. Curatio and 
answers of students controlled by a teacher.  
In classroom students together with a teacher discuss 
the results of patients examination and students mistakes. 
Then the students pass test control. In the end of the study the 
totals of work summarize, and students get the marks of the 
study work. 
 
Mein material 
Drugs used during general anaesthesia 
Intravenous anesthetics 
Mechanism of action: Usually inhibits the activity or 
activates the inhibitory, signaling pathways in the brain. 
Facilitatory actions on GABA receptors appear most 
important, although modulation of many other receptors and 
channels plays a role as well.  
Uses:  
• Induction of general anesthesia.  
• Supplementation of general anesthetics intraoperatively.  
• Maintainance of general anesthesia  
41 
• Maintainance of continous IV sedation in OR, ICU and 
other remote locations.  
• Protection of the brain in patients’ with increased 
intracranial pressure. 
Propofol (Diprivan)  
Propofol is an alkylphenol, formulated as 1–% solution 
dissolved in 10% intralipid (explaining the milky white color).  
Site of action: GABA
 
receptors in CNS. GABA
 
is inhibitory 
neurotransmitter in CNS. Onset of action is within 30 to 60sec 
after IV injection and duration of action (hypnosis) is between 
3 to 10 minutes.  
Uses:  
• Induction and maintenance of general anesthesia.  
Continous intravenous sedation in the ICU and Operating 
rooms for procedures done under monitored anesthesia care.  
Pharmacology:  
• Metabolized in liver by conjugation to glucuronide and 
sulfate.  
• Formulation: 10 mg/ml  
• Dose: 1–2.5 mg/kg for induction; 50–150 mcg/kg/min. for 
maintenance of general anesthesia  
• 10 to 50 mcg/Kg/min. for sedation in the ICU and remote 
locations.  
 
Effects and side effects:  
• Hypnotic and amnestic properties  
• No analgesic properties  
• Respiratory depression and bronchodilation  
• Cardiovascular depression and hypotension due to peripheral 
vasodilation  
• Antiemetic properties  
• Pain on injection (pretreatment with lidocaine will attenuates 
the pain)  
• Myoclonus (rare) 
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Barbiturates  
Barbiturates are derivatives of barbituric acid. Site of 
action: primarily GABA receptors in CNS. They enhance and 
mimic the activity of GABAА
 
in CNS. They have hypnotic 
and amnestic properties but are not analgesics.  
Thiopental (Sodium Pentothal)  
Uses:  
• Intravenous induction agent with rapid onset and offset time.  
• Attenuates acute rise in blood pressure (e.g. head pinning 
during neurosurgical procedures).  
• Acute perioperative seizure control.  
• Provides brain protection by decreasing cerebral blood flow, 
cerebral oxygen consumption and intracranial pressure (ICP).  
 
Effects and side effects:  
• Thiopental reversibly reduces cerebral electrical activity to 
the level of EEG silence, with a significant reduction in 
cerebral metabolism.  
• Decrease in blood pressure is mainly due to decreased 
peripheral vascular resistance, which can be more pronounced 
in hypovolemic patients or those with cardiovascular disease.  
• Temporary depresses ventilation and decreases cerebral 
responsiveness to increased CO2.  
Contraindications:  
• Hypovolemia  
• Poor cardiac status  
 
Pharmacology:  
• Metabolized in liver  
• Formulation: 25 mg/ml  
• Induction dose: 3–5 mg/kg  
• Onset: 30 seconds  
• Duration of action: 5–10 minutes  
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Etomidate  
Etomidate is an imidazole, supplied as a highly 
hyperosmotic solution (>4500 mOsm/l) in propylene glycol. 
Site of action: GABAА 
 
receptors in CNS.  
Uses:  
Etomidate is a drug of choice for induction of general 
anesthesia in hemodynamically unstable patients or in those 
patients with marginal cardiac reserve.  
Effects and side effects:  
• Cerebral effects: Decreased cerebral blood flow, decreased 
cerebral oxygen consumption and decreased ICP.  
• In contrast to thiopental, etomidate has minimal effects on 
the cardiovascular system.  
• Respiratory effects are minimal but it reduces the cerebral 
response to increased CO2
 
(hypercarbia).  
• Dose–dependent, reversible suppression of adrenal gland by 
inhibiting 11–b–hydroxylase, a key enzyme in steroid 
production.  
• Myoclonus  
• Pain on injection and thrombophlebitis  
• Post–op nausea and vomiting. 
 
Pharmacology:  
• Metabolized in liver by ester hydrolysis or by N–
dealkylation  
• Formulation: 2 mg/ml  
• Dose: 0.2 to 0.6 mg/kg  
• Onset: < 1 min.  
• Peak effect 1 min  
• Duration of action: 3–10 min.  
 
Ketamine  
Ketamine is a phencyclidine derivative (similar to PCP).  
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Site of action: Inhibition of signaling at the NMDA receptor, 
although multiple secondary sites (opioid receptors, 
muscarinic acetylcholine receptors) exist.  
Uses:  
• Induction of anesthesia in children, by IM or IV route  
• Induction of anesthesia in hypovolemic patients (etomidate 
is preferable).  
• Supplementation of sedation during painful procedures due 
to its analgesic property.  
• Ketamine increases cerebral blood flow and ICP; hence, it is 
contraindicated in patients with increased ICP.  
 
Effects and side effects:  
• Potent analgesic  
• "Dissociative" anesthesia  
• Adrenergic activation  
• Bronchodilator and maintains CO2
 
responsiveness  
• Amnesia  
• Nystagmus  
• Induces salivation  
• Dreaming and emergence reactions (less in children)  
 
Contraindications:  
• Increased ICP  
• Open globe– eye injury  
• Ischemic heart disease  
• Psychological disease  
 
Pharmacology:  
• Formulation: Two concentrations: 10 mg/ml and 100 mg/ml. 
Careful!  
• Dose: 0.5–2 mg/kg IV, 4–6 mg/kg IM for induction of 
general anesthesia.  
• Onset: 1 min. IV, 5 min. IM  
• Duration of action: 15 min.  
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Benzodiazepines  
A large family of drugs, only midazolam currently 
used in the OR. Potent sedative and amnestic action 
(anterograde).  
Site of action: GABAА
 
receptors.  
Midazolam (Versed)  
Uses:  
• Sedative and hypnotic agent mainly used for sedation 
perioperatively. Occasionally it is used for induction of 
anesthesia (cardiac surgery)  
• Provides good amnesia in patients who do not tolerate any 
anesthetic (trauma patients). 
 
Effects and side effects:  
• Sedation (especially for therapeutic procedures)  
• Amnesia (anterograde)  
• Modest respiratory depression (by decreasing tidal volume, 
not respiratory rate)  
• Modest hemodynamic and respiratory effects when used in 
conjunction with narcotics.  
 
Contraindications:  
• Elderly patients can exhibit paradoxical reactions 
(disinhibition)  
• Patients with marginal respiratory function ( especially 
patients who have received narcotics)  
 
Pharmacology:  
• Formulation: 1 mg/ml  
• Dose: 0.5– 5 mg/hr for sedation  
• Onset: 5 min.  
• Duration of action: 45 min.  
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  Opiates (Narcotics)  
Opiates are derivatives of morphine and act at opiate 
receptors present at multiple sites. Potent analgesics, some 
have mild sedative properties.  
Uses:  
• Supplementation of general anesthesia  
• Pain relief (analgesia perioperatively)  
• Induction of general anesthesia in cardiac patients (because 
of cardiac stability).  
• Premedication (blunting of hemodynamic response to 
intubation). Narcotics should not be given long before 
induction to pain free patients because of dysphoric reactions.  
 
Side effects:  
• Respiratory depression (they decrease respiratory rate not 
tidal volume)  
• Nausea and vomiting  
• Muscle rigidity (especially if given rapidly in large doses 
such as during induction in cardiac anesthesia).  
• Urinary retention, pruritus, dysphoria. 
 
Contraindications:  
· Increased ICP, neurological disease and respiratory failure.  
 
Morphine  
Use:  
Post–operative pain relief; because of its relatively long 
duration of action, long term ICU pain therapy.  
Effects and side effects:  
• Strong analgesic  
• Histamine release (not seen with most of the other 
compounds), leading to:  
Decrease in blood pressure (hypotension)  
Contraindications:  
· Morphine allergy  
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Pharmacology:  
• Formulation: 10 mg/ml  
• Dose: 0.01–0.1 mg/kg  
• Onset: 10 min.  
• Duration of action: 2 h  
Synthetic narcotic analgesics: fentanyl, alfentanil, 
sufentanil and Remifentanil  
Fentanyl is the "standard" narcotic for perioperative 
use.  
Alfentanil is used primarily for relief of brief, intense 
pain (e.g. head pinning), or for supplementation of anesthesia 
close to the end of a case. It is approximately 5 times less 
potent than fentanyl.  
Sufentanil is approximately 10 times as potent as 
fentanyl, which is not reflected in the formulation!  
Remifentanil is metabolized by plasma esterase, and 
therefore, short–acting. It is administered by continuous 
infusion. 
 
Inhaled Anesthetics  
Inhalation anesthetics are substances that are brought 
into the body via the lungs and are distributed with the blood 
into the different tissues. The main target of inhalation 
anesthetics (or so–called volatile anesthetics) is the brain.  
Inhalation anesthetics act either by amplifying 
inhibitory function or decreasing excitatory transmission at 
the nerve endings in the brain. The role of inhalation agents in 
general anesthesia is changing. Volatile anesthetics are 
seldom used alone in our days. A combination of inhalation 
anesthetics and intravenous drugs is called balanced 
anesthesia. Currently used inhalation anesthetics include 
enflurane, halothane, isoflurane, sevoflurane, desflurane, and 
nitrous oxide. Older volatile anesthetics include ether, 
chloroform, and methoxyflurane. 
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Ideally, inhalation agents should provide a quick 
induction and emergence from anesthesia, good analgesia, 
muscle relaxation, quick changes and easy maintenance of 
anesthesia, and no side effects. Unfortunately, the real world 
of medicine doesn't provide us with such an ideal agent. 
Relatively long and unpleasant induction times can be 
overcome by using an intravenous anesthetic. Neuromuscular 
blockers will provide muscle paralysis and adding opioids can 
enhance analgesia. This technique, the so–called balanced 
anesthesia, allows the anesthesiologist to take advantage of 
different beneficial effects of several drug classes 
Inhalational anesthetics are commonly used in 
anesthesia practice worldwide due to their ease of 
administration and rapid excretion. With the use of inhalation 
agents the depth of anesthesia can be altered rapidly and 
measured readily. Minimum Alveolar Concentration MAC. 
Is the concentration at which 50% of the patients do 
not move in response to skin incision at one atmospheric 
pressure. The value of MAC for each inhalational agent is 
different. 
 
Mechanism of Action of Inhaled Anesthetics  
Inhaled anesthetics act in different ways at the level of 
the central nervous system. They may disrupt normal synaptic 
transmission by interfering with the release of 
neurotransmitters from presynaptic nerve terminal (enhance 
or depress excitatory or inhibitory transmission), by altering 
the re–uptake of neurotransmitters, by changing the binding of 
neurotransmitters to the post–synaptic receptor sites, or by 
influencing the ionic conductance change that follows 
activation of the post–synaptic receptor by neurotransmitters. 
Both, pre– and postsynaptic effects have been found.  
Direct interaction with the neuronal plasma membrane 
is very likely, but indirect action via production of a second 
messenger also remains possible. The high correlation 
between lipid solubility and anesthetic potency suggests that 
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inhalation anesthetics have a hydrophobic site of action. 
Inhalation agents may bind to both membrane lipids and 
proteins. It is at this time not clear which of the different 
theories are most likely to be the main mechanism of action of 
inhalation anesthetics. 
The Meyer–Overton theory describes the correlation 
between lipid solubility of inhaled anesthetics and MAC and 
suggests that anesthesia occurs when a sufficient number of 
inhalation anesthetic molecules dissolve in the lipid cell 
membrane. The Meyer–Overton rule postulates that the 
number of molecules dissolved in the lipid cell membrane and 
not the type of inhalation agent causes anesthesia. 
Combinations of different inhaled anesthetics may have 
additive effects at the level of the cell membrane. 
However, the Meyer–Overton theory does not describe 
why anesthesia occurs. Mullins expanded the Meyer–Overton 
rule by adding the so–called Critical Volume Hypothesis. He 
stated that the absorption of anesthetic molecules could 
expand the volume of a hydrophobic region within the cell 
membrane and subsequently distort channels necessary for 
sodium ion flux and the development of action potentials 
necessary for synaptic transmission. The fact that anesthesia 
occurs with significant increase in volume of hydrophobic 
solvents and is reversible by compressing the volume of the 
expanded hydrophobic region of the cell membrane supports 
Mullins Critical Volume Hypothesis. 
The protein receptor hypothesis postulates that protein 
receptors in the central nervous system are responsible for the 
mechanism of action of inhaled anesthetics. This theory is 
supported by the steep dose response curve for inhaled 
anesthetics. However, it remains unclear if inhaled agents 
disrupt ion flow through membrane channels by an indirect 
action on the lipid membrane, via a second messenger, or by 
direct and specific binding to channel proteins. 
Another theory describes the activation of Gamma–
Aminobutyric acid (GABA) receptors by the inhalation 
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anesthetics. Volatile agents may activate GABA channels and 
hyperpolarize cell membranes. In addition, they may inhibit 
certain calcium channels and therefore prevent release of 
neurotransmitters and inhibit glutamate channels. Volatile 
anesthetics share therefore common cellular actions with other 
sedative, hypnotic or analgesic drugs.  
Each of the mentioned theories describes a unitary 
theory of narcosis. They all concentrate more or less on an 
unique site of action for inhaled anesthetics. The true 
mechanism of action of volatile anesthetics may be a 
combination of two or more such theories described as 
multisite action hypothesis 
 
Effects of inhalational anesthetics  
Respiratory System  
Airway irritation except Sevoflurane and halothane  
Dose related suppression of spontanous ventilation with 
decreased tidal volume  
Progressive decrease in ventilatory response to CO2
 
with 
increasing depth of anesthesia  
Bronchodilation and collapse of alveoli in dependent areas of 
the lungs  
Circulatory system  
Myocardial depression, Hypotension and decreased 
sympathoadrenal response with increasing depth of anesthesia  
Central Nervous system  
Dose dependent increase in cerebral blood flow with cerebral 
vasodilation  
Impaired autoregulation of cerebral blood flow  
Dose dependent decrease in cerebral cortex activity (slow 
waves with greater amplitude) and electrical silence with 
deeper anesthesia.  
Renal system  
Dose dependent decrease in renal blood flow and GFR  
Gastrointestinal Tract  
Nausea and vomiting 
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  Skeletal Muscles  
Potent inhalational agents produce modest skeletal muscle 
relaxation by central depression and enhancement of muscle 
relaxation produced by non–depolarizing muscle relaxants. 
Nitrous oxide (nitrous oxide):  
This is an inorganic nonflammable gas that supports 
combustion. It has a vapor pressure of 39,000 mm Mercury at 
20 degree Celsius and boils at minus 88 degree Celsius. The 
blood/gas coefficient is 0.47 and the MAC in 100 percent 
oxygen is 104. This means that one MAC nitrous oxide can 
only be reached in a hyperbaric chamber.  
Nitrous oxide is stored in blue cylinders (This is the 
case in the USA. In some parts of Europe, blue is the color for 
oxygen and green the color for nitrous oxide). At room 
temperature, nitrous oxide in the cylinder is in equilibrium 
between liquid and gaseous form. The pressure within the 
cylinder is constant as long some of the gas is in liquid form. 
Therefore, there is only little nitrous oxide left when the 
pressure in the cylinder decreases. Nitrous oxide is a weak 
anesthetic. It is used to supplement other inhalation agents. Its 
low solubility results in rapid induction or awakening. 
Administration of high concentrations of nitrous oxide will 
facilitate the increase in alveolar concentration of a 
simultaneously administered second gas. This is called the 
second gas effect. Nitrous oxide is resistant to degradation by 
soda lime and can therefore used in low flow or closed 
systems anesthesia. Unlike other inhalation anesthetics, 
nitrous oxide does not inhibit the hypoxic pulmonary 
vasoconstriction response in the lungs. It might produce an 
increase in pulmonary vascular resistance, especially in 
patients with pre–existing pulmonary hypertension. It is 
therefore contraindicated in patients with intra–cardiac right–
to–left shunt. Nitrous oxide is sympathomimetic and increases 
systemic vascular resistance. It does not cause a decrease in 
blood pressure. Unlike order inhalation anesthetics, nitrous 
oxide does not produce skeletal muscle relaxation. It does not 
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have any significant effect on uterine contractility. It is a weak 
trigger for malignant hyperthermia. 
Nitrous oxide diffuses into air containing cavities 34 
times faster than nitrogen can leave that space. This can cause 
dangerous accumulation of volume and increase in pressure in 
closed spaces such as bowel, middle year, pneumothorax, 
pneumocranium, pneumo–peritoneum, or cuffs of 
endotracheal tubes. In patients with ileus, the volume of air in 
the bowel can double within 4 hours of nitrous oxide 
administration. The volume of air within a pneumothorax can 
double within 10 minutes if 70 percent nitrous oxide is 
administered. This can lead to a life–threatening tension 
pneumothorax. Diffusion of nitrous oxide into air bubbles will 
increase their size. It has therefore to be stopped immediately 
when air embolism is suspected. 
 
Halothane (Fluothane):  
This volatile anesthetic is a nonflammable halogenated 
alkene. It has a vapor pressure of 244 mm Mercury at 20 
degree Celsius and boils at 50.2 degree Celsius. The blood/gas 
coefficient is 2.3 and the MAC in 100 percent oxygen is 0.74 
and in 70 percent nitrous oxide 0.29.  
Halothane is susceptible to decomposition. For this 
reason, it is stored in amber–colored bottles and thymol is 
added as preservative. It is known to sensitize the 
myocardium to the action of epinephrine and norepinephrine 
and to have the potential for serious cardiac dysrhythmias. 
Halothane lowers airway resistance and might be used in the 
treatment of asthma if conventional therapy fails. It is not 
recommended for obstetric anesthesia except when uterine 
relaxation is required. It crosses the placental barrier and can 
cause fetal and neonatal depression resulting in hypotension, 
hypoxemia, and acidosis. Halothane does not cause coronary 
artery vasodilatation and therefore does not lead to coronary 
artery steal syndrome. Decrease in blood pressure is due to 
negative inotropic effects of halothane. Systemic vascular 
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resistance does not change significantly. Increase in cerebral 
blood flow due to cerebral vasodilatation produced by 
halothane is greater than the one produced by isoflurane or 
enflurane. Halothane is able to trigger malignant 
hyperthermia, a potential lethal complication of anesthesia.  
Fulminant hepatic necrosis and/or jaundice (halothane 
hepatitis) are other severe complications of halothane 
anesthesia. Hepatic necrosis occurs in one of 6,000 to 35,000 
cases and is often fatal. Anti–trifluoroacetyl protein antibodies 
probably cause halothane hepatitis. These antibodies may 
mediate massive hepatic necrosis after re–exposure of the 
patient with halothane.  
Halothane has excellent hypnotic but no analgesic 
properties. Induction of anesthesia can be achieved by using 1 
to 3 percent halothane in air or in oxygen, or by using 0.8 
percent halothane in 65 percent nitrous oxide. Induction 
occurs relatively quickly. This is one of the reasons why 
halothane was the drug of choice for mask induction of 
pediatric patients but its popularity changed in the recent 
years with the availability of sevoflurane. Maintenance of 
anesthesia can be achieved with 0.5 to 1.5 percent halothane. 
Emergence might be delayed in obese patients due to storage 
of the inhalation agent in fatty tissues 
Isoflurane (Forane):  
This volatile anesthetic is a nonflammable halogenated 
methyl ethyl ether. It has a vapor pressure of 239 mm 
Mercury at 20 degree Celsius and boils at 48.5 degree Celsius. 
The blood/gas coefficient is 1.4 and the MAC in 100 percent 
oxygen is 1.15 and in 70 percent nitrous oxide 0.50.  
Isoflurane is resistant to degradation by the absorber 
and can therefore be used during low flow or closed system 
anesthesia. Isoflurane produces a dose–dependent reduction in 
blood pressure due to peripheral vasodilatation. It does not 
sensitize the myocardium for arrhythmias. It can cause 
coronary artery vasodilatation that might lead to coronary 
artery steal syndrome. During such an event blood is diverted 
54 
away from critically perfused areas because of vasodilatation 
in healthy parts of the heart. This might lead to myocardial 
ischemia or infarction. However, most clinical studies failed 
to prove higher incident of myocardial ischemia due to 
isoflurane. Isoflurane should be avoided in patients with aortic 
valve stenosis since they poorly tolerate a decrease in 
systemic vascular resistance. Like halothane, it can trigger 
malignant hyperthermia. 
Induction of anesthesia can be achieved by using 3 to 
4 percent isoflurane in air or in oxygen, or by using 1.5 to 3 
percent isoflurane in 65 percent nitrous oxide. Induction with 
isoflurane alone can lead to coughing and apneic periods. 
Therefore, it should be combined with intravenous 
anesthetics. Maintenance of anesthesia can be achieved with 1 
to 2.5 percent isoflurane. Emergence from anesthesia with 
isoflurane is faster than with halothane or enflurane. 
Enflurane (Ethrane):  
This volatile anesthetic is a nonflammable fluorinated 
ethyl methyl ether. It as a vapor pressure of 172 mm Mercury 
at 20 degree Celsius and boils at 56.5 degree Celsius. The 
blood/gas coefficient is 1.8 and the MAC in 100 percent 
oxygen is 1.68 and in 70 percent nitrous oxide 0.57.  
Enflurane is resistant to degradation by soda lime and 
can be therefore used during low flow or closed system 
anesthesia. Its biotransformation releases fluoride ions but 
their concentration does not reach nephrotoxic levels. 
Enflurane produces a dose–dependent reduction in arterial 
blood pressure as consequence of negative inotropy. Like 
isoflurane, enflurane does not sensitize the heart for 
arrhythmias. In addition, it does not cause a coronary artery 
steal syndrome. Enflurane has been found to increase 
intracranial pressure and, especially in combination with 
hyperventilation, to increase the risk of seizure activity. It is 
therefore contraindicated in patients with seizure disorders. 
As halothane and isoflurane, it can trigger malignant 
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hyperthermia. Enflurane enhances the action of paralyzing 
agents more than other inhalation anesthetics. 
Induction of anesthesia can be achieved by using 3 to 
4 percent enflurane in air or in oxygen, or by using 1.5 to 3 
percent enflurane in 65 percent nitrous oxide. Maintenance of 
anesthesia can be achieved with 1 to 3 percent enflurane. 
Emergence from anesthesia with enflurane is a little slower 
than with isoflurane. 
Desflurane (Suprane):  
This volatile anesthetic is a nonflammable fluorinated 
methyl ethyl ether. It has a vapor pressure of 673 mm 
Mercury at 20 degree Celsius and boils at 23.5 degree Celsius. 
The blood/gas coefficient is 0.42 and the MAC in 100 percent 
oxygen is 6.0 and in 60 percent nitrous oxide 2.8.  
Unlike other inhalation anesthetics, desflurane cannot 
be delivered by standard vaporizers. It requires the use of 
electrically heated vaporizers. Desflurane is very resistant to 
degradation by soda lime and can therefore be used during 
low flow or closed system anesthesia. Desflurane produces a 
dose–dependent reduction in arterial blood pressure due to 
peripheral vasodilatation. It might as well cause an increase in 
heart rate. It should therefore not be used in patients with 
aortic valve stenosis. It does not sensitize the heart to 
arrhythmias or cause coronary artery steal syndrome. Like 
other inhalation anesthetics, it can trigger malignant 
hyperthermia. 
Induction of anesthesia can be achieved by using 6 to 
10 percent desflurane in air or in oxygen, or by using 5 to 8 
percent desflurane in 65 percent nitrous oxide. Desflurane 
may cause coughing and excitation during induction and 
should therefore rather not be used without intravenous 
anesthetics. Maintenance of anesthesia can be achieved with 5 
to 7 percent desflurane. The low tissue solubility of desflurane 
results in rapid elimination and awakening.  
Sevoflurane (Ultane):  
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This volatile anesthetic is a nonflammable fluorinated 
isopropyl ether. It has a vapor pressure of 162 mm Mercury at 
20 degree Celsius and boils at 58.5 degree Celsius. The 
blood/gas coefficient is 0.59 and the MAC in 100 percent 
oxygen is 1.71 and in 63.5 percent nitrous oxide 0.66.  
Sevoflurane undergoes temperature dependent 
degradation by baralyme and soda lime. Therefore, it cannot 
be used in low flow or closed systems anesthesia. Sevoflurane 
reacts with CO2 absorbents to form a special haloalkene, the 
so–called Compound A. Compound A is metabolized to 
nephrotoxins and can lead to kidney damage. The minimum 
fresh gas flow has been recommended to be at least two liters 
per minute. Sevoflurane produces a dose–dependent decrease 
in arterial blood pressure due to peripheral vasodilatation. It 
should therefore not be used in patients with aortic valve 
stenosis. It does not sensitize the heart to arrhythmias or cause 
coronary artery steal syndrome. Unlike desflurane, 
sevoflurane does not irritate the airway. Due to its low 
solubility in blood it can be used for rapid induction of 
anesthesia without intravenous anesthetics. This is one of the 
reasons why it is currently replacing halothane for mask 
induction in pediatric patients. Like all other inhalation 
anesthetics, sevoflurane can trigger malignant hyperthermia in 
susceptible patients. 
Induction of anesthesia can be achieved by using 1.5 
to 3 percent sevoflurane in air or in oxygen, or by using 0.7 to 
2 percent sevoflurane in 65 percent nitrous oxide. Sevoflurane 
does not cause coughing and excitation during induction and 
can be used without intravenous anesthetics. Maintenance of 
anesthesia can be achieved with 0.4 to 2 percent sevoflurane. 
The low tissue solubility of sevoflurane results in rapid 
elimination and awakening. 
4. Muscle relaxants  
Muscle relaxants block the nicotinic acetylcholine 
receptors at the muscle endplate, thereby inhibiting 
neuromuscular transmission and inducing muscle flaccidity. 
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Inactivation of the receptor can be attained in two ways: by 
depolarizing the receptor continuously, which leads to a 
complex form of desensitization (depolarizing muscle 
relaxants); or by competitively antagonizing the receptor 
(non–depolarizing muscle relaxants).  
The degree of relaxation can be assessed using a 
twitch monitor. The two standard modes of testing are the 
train–of–four (four pulses at 0.5 sec intervals) and tetanus 
(usually at 50 Hz for 5 seconds).  
Depolarizing muscle relaxants  
The only depolarizer in clinical use is succinylcholine. 
It is the muscle relaxant with the briefest duration of action, 
because of its rapid metabolism by butyrylcholinesterase 
("pseudocholinesterase") in plasma. The rapid onset (30 to 60 
seconds) is dose dependent and minimizes the time for rapid 
sequence intubation. The rapid degradation allows patients to 
manage their own airway quickly again after an unsuccessful 
endotracheal intubation.  
Succinylcholine administration results in a parallel 
decrease in height of all twitches on the train–of–four (no 
"fade"). After administration of high doses and or repeated 
administration of succinylcholine, patient can develop phase 
II block, a pattern similar to that seen with non–depolarizing 
drugs.  
Side effects:  
     • The initial depolarization of muscles causes 
fasciculations due to . These are associated with muscle pain 
postoperatively, and can largely be prevented by 
administration of a small dose of non–depolarizing relaxant 
(curare 3 mg) one minute prior to succinylcholine. In that case 
the dose of succinylcholine should be increased by 50% to 
compensate for the antagonism of succinylcholine by the 
non–depolarizing drug. Intravenous lidocaine, 
benzodiazepines, Ca
+2
 
channel blockers, etc. also appear to 
prevent myalgia.  
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• The muscle depolarization also results in release of 
K+ from myocyte. In patients with upregulated nicotinic 
receptors (burns, major trauma, paralyzed limbs, head trauma, 
neuromuscular disease), the use of succinylcholine can lead to 
cardiac arrest.  
•   Succinylcholine can induce malignant hyperthermia 
in susceptible patients.  
• Prolonged paralysis occurs in case of 
butyrylcholinesterase abnormalities (as succinylcholine is not 
metabolized).  
• Increases in intra–ocular pressure. 
• Increases in intracranial pressure (modest).  
• Bradycardia, particularly in children, after 
administration of a second dose (pre–treat with atropine).  
Contraindications:  
• The difficult airway.  
• Documented or suspected susceptibility to malignant 
hyperthermia.  
• Up–regulated nicotinic receptors (burn patients).  
• Children <5 yr. (Controversial).  
• Patients with open eye injury (controversial)  
• Patients with increased ICP (a relative 
contraindication).  
• Hyperkalemia and renal disease  
• Patients with history of atrial or ventricular 
arrhythmias.  
Pharmacology:  
• Formulation: 20 mg/ml,  
• Dose: 1 to 1.5 mg/kg; in children 2 mg/kg,  
• Onset: 30 sec,  
• Duration of action: 3 to 15 min.  
 
Non–depolarizing muscle relaxants  
There are two main types of non–depolarizing muscle 
relaxants.  
1. Steroidal compounds.  
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Short acting (Rapacurium and mivacurium  
Intermediate acting (cis–atracurium, Vecuronium, 
Rocuronium).  
Long Acting (Pancuronium, Pipecuronium, 
Doxacurium).  
They competitively bind to the nicotinic receptors at 
the neuromuscular junction, preventing depolarization.  
Side effects  
• Histamine release.  
• Vagolytic effect (muscarinic inhibition) ( steroidal 
compounds).  
• Sympathomimetic effect (autonomic ganglia 
stimulation).  
 
Contraindications:  
Few. Non–depolarizing muscle relaxants are very safe 
drugs, as long as the airway is adequately protected.  
Caution using pancuronium with Demerol. 
Reversal  
Inhibitors of plasma cholinesterases, induce increased 
availability of acetylcholine at the neuromuscular junction, 
which competitively reverses the neuromuscular blockade.  
Side effects:  
• Bradycardia from cardiac muscarinic stimulation,  
• Bronchoconstriction.  
 
These side effects can be (partially) attenuated by 
administration of a muscarinic antagonist, which is usually 
given at the same time as the reversal drug. Two 
cholinesterase inhibitors are used clinically: neostigmine and 
edrophonium.  
Neostigmine  
Neostigmine is slower in onset than edrophonium, but 
it forms covalent (strong) bond with plasma cholinesterase, 
thus it can reverse a deeper neuromuscular block. The 
muscarinic antagonist glycopyrrolate (7–15 mcg/kg), which 
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has a longer duration of action and a longer time to onset than 
atropine, is often used with neostigmine to minimize 
cardiovascular changes and other unwanted nicotinic effects.  
Pharmacology:  
• Formulation: 1 mg/ml,  
• Dose: 0.04–0.07 mg/kg,  
• Onset: full reversal is attained in approximately 10 – 
15 min.  
• Duration of action: 1.5 h  
 
Edrophonium Edrophonium, when given 
intravenously, has rapid onset of action than neostigmine. At 
equivalent doses neostigmine and edrophonium has similar 
duration of action. Atropine (7–10 mcg/Kg) is often used in 
combination with edrophonium to block muscarinic effects. 
The degree of block that edrophonium is able to antagonize, 
however, is much less profound, as it forms ionic (weaker) 
bond with actelycholinesterase.  
Pharmacology:  
• Formulation: 10 mg/kg,  
• Dose: 0.5–1 mg/kg,  
• Onset: full reversal is attained in approximately 5 
min.  
• Duration of action: 1 to 1.5 hr. (a long–acting 
relaxants may outlast edrophonium).  
 
Managing the airway 
Maintenance of a patent airway is an essential 
prerequisite for the safe and successful conduct of 
anaesthesia. However, it is a skill that should be acquired by 
all doctors, as during resuscitation patients often have an 
obstructed airway either as the cause or result of their loss of 
consciousness. The descriptions of airway management 
techniques that follow are intended to supplement practice 
either on a manikin or, preferably, on an anaesthetized patient 
under the direction of a skilled anaesthetist. 
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Basic techniques 
Anaesthesia frequently results in loss of the airway, 
and this is most easily restored by a combination of the head 
tilt and a jaw thrust (see page 100). When holding a facemask 
in position with the index finger and thumb, the jaw thrust is 
achieved by lifting the angle of the mandible with the 
remaining fingers of one or both hands. The overall effect 
desired is that the patient’s mandible is ‘lifted’ into the mask 
rather than that the mask is being pushed  into the face (Fig. 
2.1). 
Facemasks 
• A commonly used type in adults is the BOC 
anatomical facemask (Figure 2.1), designed to fit the contours 
of the face with the minimum of pressure. 
• Leakage of anaesthetic gases is minimized by an air–
filled cuff around the edge. 
• Masks are made in a variety of sizes, and the smallest 
one that provides a good seal should be used. 
• Some masks have a transparent body allowing 
identification of vomit, making them popular for resuscitation. 
• All masks must be disinfected between Alternatively 
single use masks are available. 
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Figure 2.1 – Mask being held on a patient’s face 
The oropharyngeal airway 
The oropharyngeal (Guedel) airway, and to a lesser 
extent the nasopharyngeal airway, are used in conjunction 
with the techniques described above to help maintain the 
airway after the induction of anaesthesia( Figure 2.2). 
 
 
Figure 2.2 – The sequence of inserting an oropharyngeal 
airway 
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Figure 2.3 – Insertion of a nasopharyngeal airway 
Nasopharyngeal airway 
• Round, malleable plastic tubes, bevelled at the 
pharyngeal end and flanged at the nasal end. 
• Sized on their internal diameter in millimetres, length 
increasing with diameter. The common sizes in adults are 6–8 
mm, for small to large adults, respectively. 
• A guide to the correct size is made by comparing the 
diameter to the external nares. 
• Prior to insertion, the patency of the nostril (usually 
the right) should be checked and the airway lubricated. 
• The airway is inserted along the floor of the nose, 
with the bevel facing medially to avoid catching the turbinates 
(Fig. 2.3). 
• A safety pin may be inserted through the flange to 
prevent inhalation of the airway. 
• If obstruction is encountered, force should not be 
used as severe bleeding may be provoked. Instead, the other 
nostril can be tried ( Figure 2.3). 
 
The laryngeal mask airway (LMA) 
Originally designed for use in spontaneously breathing 
patients, it consists of a ‘mask’ that sits over the laryngeal 
opening, attached to which is a tube that protrudes from the 
mouth and connects directly to the anaesthetic breathing 
system. On the perimeter of the mask is an inflatable cuff that 
creates a seal and helps to stabilize it (Fig. 2.4a). The LMA is 
produced in a variety of sizes suitable for all patients, from 
neonates to adults, with sizes 3, 4 and 5 being the most 
commonly used in female and male adults. Patients can be 
ventilated via the LMA provided that high inflation pressures 
are avoided, otherwise leakage occurs past the cuff. This 
reduces ventilation and may cause gastric inflation. 
The LMA is reusable, provided that it issterilized 
between each patient. There are now four additional types of 
LMAs available: 
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• A version with a reinforced tube to prevent kinking 
(Fig. 2.4b). 
• The Proseal LMA (Fig. 2.4c): this has an additional 
posterior cuff to improve the seal around the larynx and 
reduce leak when the patient is ventilated. It also has a 
secondary tube to allow drainage of gastric contents. 
• The intubating LMA (Fig. 2.4d): as the name 
suggests this device is used as a conduit to perform tracheal 
intubation without the need for laryngoscopy. 
• A disposable version of the original for single use, 
for example in infected cases. 
The use of the laryngeal mask overcomes some of the 
problems of the previous techniques: 
• It is not affected by the shape of the patient’s face or 
the absence of teeth. 
• The anaesthetist is not required to hold it in position, 
avoiding fatigue and allowing any other problems to be dealt 
with. 
• It significantly reduces the risk of aspiration of 
regurgitated gastric contents, but does not eliminate it 
completely. 
Its use is relatively contraindicated where there is an 
increased risk of regurgitation, for example in emergency 
cases, pregnancy and patients with a hiatus hernia. The LMA 
has proved to be a valuable aid in those patients who are 
difficult to intubate, as it can usually be inserted to facilitate 
oxygenation while additional help or equipment is obtained 
(see below). 
 
Technique for insertion of the standard LMA 
The patient’s refle xes must be suppressed to a level 
similar to that required for the insertion of an oropharyngeal 
airway to prevent coughing or laryngospasm. 
• The cuff is deflated (Fig. 2.4a) and the mask lightly 
lubricated. 
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• A head tilt is performed, the patient’s mouth opened 
fully and the tip of the mask inserted along the hard palate 
with the open side facing but not touching the tongue  
• The mask is further inserted, using the index finger 
to provide support for the tube (Fig. 2.4c). Eventually, 
resistance will be felt at the point where the tip of the mask 
lies at the upper oesophageal sphincter (Fig. 2.4d). 
• The cuff is now fully inflated using an air–filled 
syringe attached to the valve at the end of the pilot tube 
(Figure 2.4). 
• The laryngeal mask is secured either by a length of 
bandage or adhesive strapping attached to the protruding tube. 
• A ‘bite block’ may be inserted to reduce the risk of 
damage to the LMA  
 
Figure 2.4 – Technique for insertion of the standard 
LMA 
66 
Problems with airways 
Snoring, indrawing of the supraclavicular, suprasternal 
and intercostal spaces, use of the accessory muscles or 
paradoxical respiratory move– ment (see–saw respiration) 
suggest that the above methods are failing to maintain a patent 
airway. 
Other problems with these techniques include: 
• inability to maintain a good seal between the 
patient’s face and the mask, particularly in those without 
teeth; 
• fatigue, when holding the mask for prolonged 
periods; 
• the risk of aspiration, due to the loss of upper airway 
reflexes; 
• the anaesthetist not being free to deal with any other 
problems that may arise. 
The laryngeal mask airway or tracheal intubation may 
be used to overcome these problems. 
overy. 
The technique of tracheal intubation. 
The technique of tracheal intubation involves five 
steps. 
I. Positioning the patient. 
11. Opening the patients mouth. 
111. Performing laryngoscopy. 
IV. Insertion of the ETT  
V. Confirmation of correct placement  and securing 
the ETT tube. 
 
Equipment for tracheal intubation 
The equipment used will be determined by the 
circumstances and by the preferences of the individual 
anaesthetist. The following is a list of the basic needs for 
adult oral intubation. 
• Laryngoscope: with a curved (Macintosh) blade and 
functioning light( Figure 2.5). 
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• Tracheal tubes (cuffed): in a variety of sizes. The 
internal diameter is expressed in millimetres and the length in 
centimetres. They may be lightly lubricated. 
• For males: 8.0–9.0 mm internal diameter, 22–24 cm 
length. 
• For females: 7.5–8.5 mm internal diameter, 20–22 
cm length. 
• Syringe: to inflate the cuff once the tube is in place. 
• Catheter mount: or ‘elbow’ to connect the tube to the 
anaesthetic system or ventilator tubing. 
• Suction: switched on and immediately to hand in 
case the patient vomits or regurgitates. 
• Stethoscope: to check correct placement of the tube 
by listening for breath sounds during ventilation. 
• Extras: a semi–rigid introducer to help mould the 
tube to a particular shape; Magill’s forceps, designed to reach 
into the pharynx to remove debris or direct the tip of a tube; 
bandage or tape to secure the tube. 
 
Figure 2.5 – An assortment       Figure 2.6 – Tracheal tubes 
 of laryngoscope blades 
 
Tracheal tubes 
Mostly manufactured from plastic (PVC), and for 
single use to eliminate cross–infection (Fig. 2.6B). They are 
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available in 0.5mm diameter intervals, and long enough to be 
used orally or nasally. A standard 15mm connector is 
provided to allow connection to the breathing system. In adult 
anaesthesia, a tracheal tube with an inflatable cuff is used to 
prevent leakage of anaesthetic gases back past the tube when 
positive pressure ventilation is used. This also helps prevent 
aspiration of any foreign material into the lungs (Figure 2.6). 
The cuff is inflated by injecting air via a pilot tube, at 
the distal end of which is a one–way valve to prevent 
deflation and a small ‘balloon’ to indicate when the cuff is 
inflated. A wide variety of specialized tubes have been 
developed, examples of which are shown in. 
• Reinforced tubes are used to prevent kinking and 
subsequent obstruction as a result of the positioning of the 
patient’s head (Fig. 2.6C). 
• Preformed tubes are used during surgery on the head 
and neck, and are designed to take the connections away from 
the surgical field (Fig. 2.6D). 
• Double lumen tubes are effectively two tubes welded 
together side–by–side, with one tube extending distally 
beyond the other. They are used during thoracic surgery, and 
allow one lung to be deflated whilst ventilation is maintained 
via the bronchial portion in the opposite lung . 
• Uncuffed tubes are used in children up to 
approximately 10 years of age as the narrowing in the 
subglottic region provides a natural seal. 
The technique of oral  intubation 
Preoxygenation 
All patients who are to be intubated are asked to 
breathe 100% oxygen via a close–fitting facemask for 2–3 
mins (‘preoxygenation’). This provides a reservoir of oxygen 
in the patient’s lungs, reducing the risk of hypoxia if difficulty 
is encountered with intubation. Once this has been 
accomplished, the appropriate drugs will be administered to 
render the patient unconscious and abolish laryngeal reflexes. 
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Positioning 
The patient’s head is placed on a small pillow with the 
neck flexed and the head extended at the atlanto–occipital 
joint, the ‘sniffing the morning air’ position. The patient’s 
mouth is fully opened using the index finger and thumb of the 
right hand in a scissor action (Figure 2.7). 
  
Figure 2.7  – The sniffing position    Figure 2.8   – Schematic view 
                                                         of the laryngoscopy and 
                                                         intubation with a acintosh blade 
 
Laryngoscopy 
The laryngoscope is held in the left hand and the blade 
introduced into the mouth along the righthand side of the 
tongue, displacing it to the left. The blade is advanced until 
the tip lies in the gap between the base of the tongue and the 
epiglottis, the vallecula. Force is then applied in the direction 
in which the handle of the laryngoscope is pointing. The effort 
comes from the upper arm not the wrist, to lift the tongue and 
epiglottis to expose the larynx, seen as a triangular opening 
with the apex anteriorly and the whitish coloured true cords 
laterally (Figure 2.8).  
The tracheal tube is introduced into the right side of 
the mouth, advanced and seen to pass through the cords until 
the cuff lies just below the cords. The tube is then held firmly 
and the laryngoscope is carefully removed, and the cuff is 
inflated sufficiently to prevent any leak during ventilation. 
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Finally the position of the tube is confirmed and secured in 
place. For nasotracheal intubation a well–lubricated tube is 
introduced, usually via the right nostril along the floor of the 
nose with the bevel pointing medially to avoid damage to the 
turbinates. It is advanced into the oropharynx, where it is 
usually visualized using a laryngoscope in the manner 
described above. It can then either be advanced directly into 
the larynx by pushing on the proximal end, or the tip picked 
up with Magill’s forceps (which are designed not to impair 
the view of the larynx) and directed into the larynx. The 
procedure then continues as for oral intubation. 
Confirming the position of the tracheal tube 
This can be achieved using a number of techniques: 
• Measuring the carbon dioxide in expired gas 
(capnography): less than 0.2% indicates oesophageal 
intubation. 
• Oesophageal detector: a 50 mL syringe is attached to 
the tracheal tube and the plunger rapidly withdrawn. If the 
tracheal tube is in the oesophagus, resistance is felt and air 
cannot be aspirated; if it is in the trachea, air is easily 
aspirated. 
• Direct visualization: of the tracheal tube passing 
between the vocal cords. 
• Fogging: on clear plastic tube connectors during 
expiration. 
• Less reliable signs are: 
• diminished breath sounds on auscultation; 
• decreased chest movement on ventilation; 
• gurgling sounds over the epigastrium and ‘burping’ 
sounds as gas escapes; 
• a decrease in oxygen saturation detected by pulse 
oximetry. This occurs late, particularly if the patient has been 
preoxygenated. 
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Figure 2.9  – Sites for auscultation of breath sounds at the 
apices and over the stomach 
 
Complications of tracheal intubation 
The following complications are the more common 
ones, not an attempt to cover all occurrences. 
Hypoxia due to: 
• Unrecognized oesophageal intubation  
If there is any doubt about the position of the tube it 
should be removed and the patient ventilated via a facemask. 
• Failed intubation and inability to ventilate the 
patient 
This is usually a result of abnormal anatomy or airway 
pathology. Many cases are predictable at the preoperative 
assessment.  
• Failed ventilation after intubation 
 Possible causes include the tube becoming kinked, 
disconnected, or inserted too far and passing into one main 
bronchus; severe bronchospasm and tension pneumothorax. 
• Aspiration  
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Regurgitated gastric contents can cause blockage of 
the airways directly, or secondary to laryngeal spasm and 
bronchospasm. Cricoid pressure can be used to reduce the risk 
of regurgitation prior to intubation (see below). 
Trauma 
• Direct  
During laryngoscopy and insertion of the tube, damage 
to lips, teeth, tongue, pharynx, larynx, trachea, and nose and 
nasopharynx durin nasal intubation; causing soft tissue 
swelling or bleeding. 
• Indirect  
To the recurrent laryngeal nerves, and the cervical 
spine and cord, particularly where there is pre–existing 
degenerative disease or trauma. 
Reflex activity 
• Hypertension and arrhythmias  
Occurs in response to laryngoscopy and intubation. 
May jeopardize patients with coronary artery disease. In 
patients at risk, specific action is taken to attenuate the 
response; for example pretreatment with beta blockers or 
potent analgesics (fentanyl, remifentanil). 
• Vomiting  
This may be stimulated when laryngoscopy is 
attempted in patients who are inadequately anaesthetized. It is 
more frequent when there is material in the stomach; for 
example in emergencies when the patient is not starved, 
inpatients with intestinal obstruction, or when gastric 
emptying is delayed, as after opiate analgesics or following 
trauma. 
• Laryngeal spasm  
Reflex adduction of the vocal cords as a result of 
stimulation of the epiglottis or larynx. 
Difficult  intubation 
Occasionally, intubation of the trachea is made 
difficult because of an inability to visualize the larynx. This 
may have been predicted at the preoperative assessment or 
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may be unexpected. A variety of techniques have been 
described to help solve this problem and include the 
following: 
• Manipulation of the thyroid cartilage by backwards 
and upwards pressure by an assistant to try and bring the 
larynx or its posterior aspect into view. 
• At laryngoscopy, a gum elastic bougie, 60cm long, is 
inserted blindly into the trachea, over which the tracheal tube 
is ‘railroaded’ into place. 
• A fibreoptic bronchoscope is introduced into the 
trachea via the mouth or nose, and is used as a guide over 
which a tube can be passed into the trachea. This technique 
has the advantage that it can be used in either anaesthetized or 
awake patients. 
• An LMA or ILM can be inserted and used as a 
conduit to pass a tracheal tube directly or via a fibreoptic 
scope.  
 
Induction of general anesthesia 
1. ASA standard monitors (Pulse oximeter, NIBP cuff, 
ECG and temperature).  
2. Preoxygenation with 100% Oxygen or 
Denitrogenation with proper fitting mask.  
3. Inhalation or Intravenous induction of general 
anesthesia.  
4. Endotracheal intubation and securing the ET tube. 
5. Protection of the pressure points. 
Induction is the process that produces a state of 
surgical anaesthesia in a patient. The term is used only in the 
context of general anaesthesia and not with local anaesthesia. 
It is the first step in the process of anaesthesia whereby the 
patient is rendered unconscious, preventing both awareness 
of, and response to, surgical stimuli. Anaesthesia and 
physiological sleep are different because sleep has structured, 
specific EEG patterns and endocrine changes, whereas 
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anaesthesia is associated with a diffuse damping–down of 
EEG function and a stress–type endocrine response.  
The process of induction should ensure patient safety, 
produce a state of unconsciousness, ensure optimal conditions 
for the surgeon and prepare the patient for waking and 
recovery.  
Before anaesthesia is induced, the anaesthetist must: 
• assess the patient as completely as circumstances 
allow, and institute preoperative preparations (e.g. intravenous 
fluids, sedative drugs, analgesics), 
• discuss the surgery with the surgeon, particularly in 
complex or unusual cases, 
• plan the anaesthetic technique, 
• ensure all necessary equipment and drugs are 
available, and that the equipment is working, 
On arrival in the anaesthetic suite, the anaesthetist 
must ensure: 
• the correct patient has arrived,  
• the correct operation is planned on the correct side,  
• consent has been given, 
• jewellery or prostheses have been removed or 
declared, 
• blood for transfusion is available if required.  
 
Induction methods 
Most anaesthetic inductions are performed using 
intravenous or inhalational (‘gas’) induction; each has 
advantages and disadvantages. Less commonly, induction 
may be carried out by the intramuscular route in 
uncooperative patients, children or those with difficult venous 
access. Ketamine, 10 mg/kg, provides up to 30 minutes of 
surgical anaesthesia, but induction times are unpredictable 
(15–45 minutes) and recovery is slow. Rectal induction with 
thiopentone, methohexitone, chloral hydrate or 
benzodiazepines was popular for children at one time, but is 
seldom used now. Oral induction is effectively a heavy 
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sedative or ‘premedicant’, rather than induction, and recovery 
time is prolonged.  
There are several tasks to be accomplished with any 
form of induction: 
• last–minute preliminary checks (as specified above), 
• establish monitoring, 
• establish intravenous access, 
• produce unconsciousness, 
• secure the airway, 
• establish ventilation, 
• commence analgesia (systemic or local), 
• position the patient,  
• establish maintenance of anaesthesia. 
 
Intravenous and inhalational induction 
Intravenous                                                 Inhalation 
Advantages                                                Advantages 
• Rapid onset                                 • Does not require IV access 
• Patient comfort                        • Useful for children 
• Airway protection in rapid–      • Useful for adults with  
sequence induction   needle–phobia 
 
 
Disadvantages                                          Disadvantages 
• Contraindicated in patients          • Slow induction  
with a ‘difficult airway’                 • Excitement’ phase  
                                                     • Risk of vomiting  
                                                     • Risk of arrhythmias  
 
 
Intravenous induction 
Pulse oximetry and ECG monitoring should be 
established before intravenous access because occasionally a 
cardiovascular event (e.g. vasovagal syncope) occurs during 
cannulation. Intravascular access commonly consists of a 
simple venous cannula; however, complex cases may require 
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an arterial line, a central venous line and/or a pulmonary 
artery catheter. These may be sited with local anaesthesia 
before induction, to provide additional monitoring if 
haemodynamic instability is expected.  
Following intravenous access, preliminary drugs (e.g. 
analgesics, antibiotics, anti–emetics) may be given. These 
vary according to the clinical circumstances and a detailed 
discussion is beyond the scope of this article. A regional 
analgesic block, if required, may also be given at this stage. 
Pre–oxygenation: some anaesthetists routinely pre–
oxygenate their patients before induction. The correct 
technique is for the patient to breathe 100% oxygen via an 
anaesthetic circuit and close–fitting mask for about 3 minutes 
of tidal volume breathing. Alternatively, pre–oxygenation by 
three vital capacity breaths has been demonstrated to be 
effective. The aim is to replace nitrogen–containing air in the 
resting volume of the lungs (the functional residual capacity, 
FRC) with a high oxygen concentration. The gas within the 
FRC acts as an important oxygen store, and therefore pre–
oxygenation lengthens the time before hypoxaemia occurs 
following the onset of apnoea. This may provide valuable 
time in which the airway can be secured if an unexpectedly 
difficult airway is encountered. Mask phobia and the 
difficulties in achieving a mask seal in non–compliant patients 
and children are the only significant contraindications to pre–
oxygenation. Pre–oxygenation is mandatory in rapid–
sequence induction. 
Intravenous drugs: slow, smooth injection of an 
intravenous anaesthetic agent usually results in loss of 
consciousness in less than 1 minute. Thiopentone, for 
example, starts to work in a period of one ‘arm–brain 
circulation time’. This is the period of time taken for the drug 
to travel from the site of injection (the arm) to the site of 
action (the brain) and is about 15 seconds in a healthy patient. 
The dose is carefully titrated according to patient response. 
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Typical induction doses for healthy individuals are shown in 
Figure 3, but dose reduction may be required in: 
• patients who are less fit, 
• the elderly or frai, 
• neonates, 
• patients with hypotension or poor cardiac reserve, 
• patients with chronic renal or liver disease, 
• patients with raised intracranial pressure, 
• patients who have been premedicated. 
It can be difficult to judge when enough induction 
agent has been given. Care and experience are needed to 
titrate dose to effect but some indicators include: 
• loss of response to verbal command, 
• loss of eyelash reflex (in which brushing the eyelash 
produces a blink response), 
• relaxation of a motor posture (e.g. a raised arm or a 
grip on an object), 
• cooperation with bag/mask ventilation. 
The eyelash reflex has conventionally been regarded 
as a good end–point for thiopentone induction, but it is less 
reliable in propofol induction, for which loss of verbal 
response or motor relaxation is a more useful end–point. 
Induction doses of intravenous drugs 
• Propofol   –   1.5–2.5  mg/kg.   Popular and widely 
used drug associated with rapid and ‘clear– headed' recovery. 
Rapid metabolism and lack of cumulative effects has made it 
popular for total intravenous  anaesthesia 
• Thiopentone   –    3–5 mg/kg (2.5% solution).  
The ‘gold–standard’ against which all other drugs are 
judged. Smooth induction in one arm–brain circulation time. 
• Etomidate – 0.2–0.3 mg/kg  Marked cardiovascular 
stability makes this drug popular for use in unstable patients.  
• Ketamine – 0.5–2 mg/kg  Useful for sedation with 
profound analgesia. Increases pulse rate and blood pressure 
and useful for the induction of patients suffering from acute 
trauma. 
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• Midazolam 0.15–0.5 mg/kg  A benzodiazepine that 
may provide stable induction for the elderly and frail, in 
combination with an opioid. 
. 
Inhalational induction 
Gas induction, controversially, is often used as a 
means of inducing anaesthesia (particularly in a child) without 
having to site an intravenous cannula first. However, in the 
event of difficulties (e.g. laryngospasm, arrhythmias) instant 
intravenous access should be available, because otherwise the 
anaesthetist controlling the airway will be unable to attempt 
rapid cannulation. For this reason, some anaesthetists seldom 
perform gas induction; others permit gas induction if a second 
anaesthetist is present to assist with intravenous cannulation. 
Gas induction of children and adults has taken place without 
intravenous access for over 150 years, in most cases safely 
and without incident. 
Indications: gas induction (with intravenous access) is 
indicated for patients in whom airway difficulties are 
expected. In these cases, the patient continues to breathe 
spontaneously throughout and apnoea is avoided, since it may 
then be impossible to manually ventilate the lungs with bag 
and mask.  
Upper airway obstruction is an important indication 
for inhalation induction, and in these circumstances fibre–
optic techniques for intubating the trachea are contraindicated 
for fear of producing complete airway obstruction. However, 
in patients with an unobstructed ‘difficult’ airway, the 
increasing availability of fibre–optic intubation equipment 
and the growing skill of anaesthetists in awake intubation 
techniques may reduce the need for gas induction. The 
difficult airway may best be secured even before anaesthesia 
is induced. 
Technique: there is controversy over whether to induce 
in 100% oxygen or to use nitrous oxide as well. 
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• Concurrent use of volatile and nitrous oxide exploits 
the second–gas effect for a cumulatively more rapid 
induction. The rapid absorption of the second gas (nitrous 
oxide) has the effect of increasing the alveolar concentration 
of the first agent. The partial pressure of anaesthetic gas in the 
alveolus reflects the partial pressure of anaesthetic in the brain 
and hence the anaesthetic effect. 
• ‘Pre–induction’, with 33% oxygen and 66% nitrous 
oxide only, may render a child sleepy enough not to resist 
when the odour of the volatile agent is added. Clearly the 
more nitrous oxide is used the more anaesthetic effect is 
achieved; but likewise the less reserve there is against 
desaturation. A minimum of 30% oxygen should be given. 
• Induction in 100% oxygen is least smooth, but 
should laryngospasm occur, it is an advantage to have as 
much of the lung FRC filled with oxygen as possible. This 
maximizes oxygen stores and thus delays the onset of 
hypoxaemia.  
Conventional practice for inhalational induction with 
halothane is to start with a low inspired concentration of 
0.5%, and to increase it by 0.5% every four breaths up to 4%.  
Sevoflurane has greatly enhanced gas induction, 
because it is faster, better tolerated by patients, and is less 
arrhythmogenic than halothane. It has been suggested that the 
lower incidence of arrhythmias has contributed to a decrease 
in dental anaesthetic deaths in recent years. The high blood–
gas solubility of sevoflurane accounts for its rapid onset and 
offset. Because sevoflurane is less pungent it is often used in 
high concentrations (maximum 8% on most vaporizers) for 
faster induction.  
Enflurane is seldom used for gas inductions because it 
is slow; isoflurane and desflurane are almost never used 
because they are pungent and irritating to the airway.  
The last–minute checks before inhalational induction 
are the same as those for the intravenous route. Monitoring 
should be established; some children make this difficult, but 
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ECG should be the minimum monitoring instituted. Induction 
should ideally take place via a tight–fitting face mask (even 
small leaks may significantly delay induction). However, the 
use of a cupped hand may be less threatening to a small child 
in the first instance.  
‘Single–breath induction’ has been described with 
halothane and sevoflurane. A Mapleson A breathing system 
containing a 4–litre reservoir bag is filled with a maximum 
concentration of volatile anaesthetic (4% halothane or 8% 
sevoflurane) in 66% nitrous oxide and 33% oxygen. The 
patient is asked to exhale to residual volume, then, via a tight–
fitting mask, to inhale a full vital–capacity breath of gas, and 
then to hold their breath for as long as possible. This 
technique produces a faster induction than conventional tidal 
volume inhalational induction in cooperative adults. In the 
case of single–breath 8% sevoflurane, the speed of induction 
is comparable with induction with intravenous propofol. It 
may be a useful technique to use in cooperative needle–
phobic adults, but it offers few other advantages.  
Four main variables determine the speed of 
inhalational anaesthetic induction. 
• The inspired partial pressure of the anaesthetic agent 
relative to its minimum alveolar concentration (MAC) alters 
the speed of induction. MAC is the partial pressure of the 
agent, expressed in volumes %, which at equilibrium prevents 
gross muscle movement in response to a skin incision in 50% 
of patients. It is thus the effective dose in 50% of patients and 
is a measure of anaesthetic potency. 
• The faster the patient breathes, or the greater the 
alveolar ventilation, the faster the alveolar partial pressure of 
the agent approaches the inspired partial pressure. In a child, 
crying speeds up gas induction by increasing minute 
ventilation. 
• The higher the cardiac output the more anaesthetic 
agent is removed from the alveoli and hence the slower the 
partial pressure rises in the alveoli. Thus, an anxious, 
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hyperdynamic patient is slow to induce, whereas a shocked 
patient with a low cardiac output is quicker. 
• The higher the solubility of an agent (i.e. a high 
blood–gas solubility coefficient), the more the agent will 
dissolve in blood and thus a lower partial pressure will be 
generated. Agents with a low solubility (e.g. sevoflurane) 
result in more rapid induction. 
During a gas induction, most patients pass briefly 
through a phase of excitability during which they may be 
agitated and at increased risk of laryngospasm or, more rarely, 
arrhythmias. If a child is being induced, it is useful to warn 
the parents of this disinhibition in advance. The disinhibition 
is not remembered by the patient.  
Once the patient is unconscious, anaesthesia should be 
deepened, assisting the ventilation by hand, using bag and 
mask if necessary. If not already obtained, intravenous access 
should be secured, which requires the help of an assistant. 
Muscle relaxants may then be given intravenously to assist in 
securing the airway. If the patient is sufficiently deeply 
anaesthetized, as evidenced by a regular respiratory pattern 
and a forward gaze in eyes with small pupils, the airway may 
be secured (even by intubation) purely under inhalational 
anaesthesia. Nevertheless, it is valuable to have intravenous 
access before attempting to manipulate the airway, in case any 
untoward airway reflexes are produced (e.g. arrhythmias, 
laryngospasm). With the airway secured, the remainder of the 
induction sequence proceeds as above. 
Further procedures: the induction agent may be 
followed by a muscle relaxant, particularly if tracheal 
intubation is planned. It is important to confirm that the 
patient’s lungs can be ventilated via a bag and mask before 
paralysing. A muscle relaxant should not be given until it has 
been confirmed that ventilation is possible. Once anaesthesia 
is adequate, a clear airway is established using a simple face 
mask (with or without an oral or nasal airway), laryngeal 
mask airway or tracheal intubation. If the level of anaesthesia 
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proves to be inadequate to allow an airway or tracheal tube to 
be tolerated, it may be deepened either with supplementary 
doses of intravenous agent, or by ventilating with volatile 
anaesthetic. With the airway secure, ventilation can continue 
by the patient’s own effort, by manual ‘hand’ ventilation, or 
by mechanical ventilator.  
At this stage, further invasive procedures may take 
place, such as additional vascular access, regional blocks, 
bladder catheterization, passing of a nasogastric tube or 
insertion of a temperature probe. 
Transfer to theatre: if anaesthesia has been induced in 
the anaesthetic room, the patient is now transferred to theatre. 
This is potentially hazardous because for a short time the 
patient is separated from monitoring equipment and the 
mechanical ventilator. The patient is also potentially unstable 
because of the effects of induction drugs and is at risk of 
injury during the physical transfer. It is the anaesthetist’s 
responsibility to guarantee the patient’s safety. It should be 
ensured that ventilation and anaesthetic maintenance are re–
established in good time, that tubes and lines are not 
dislodged, and that changes in clinical condition are detected 
promptly, in particular, cardiovascular instability, desaturation 
or signs of waking from anaesthesia.  
Once in theatre, the priorities are:  
• prompt transfer on to the operating table 
• prompt re–establishment of ventilation 
• prompt re–establishment of anaesthetic maintenance 
if using volatile anaesthetic drugs 
• check correct drug delivery if using intravenous 
maintenance technique 
• prompt re–establishment of monitoring equipment 
• safe positioning of the patient 
• commencement of maintenance fluids and 
temperature control. 
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Drug injection: the chosen drug is rapidly adminstered. 
Thiopentone is the drug of choice because of its rapid onset of 
action in one arm–brain circulation time, but propofol or 
etomidate are alternatives, albeit slightly slower–acting. The 
use of rapid–acting opioids such as alfentanil, 10 μg/kg, or 
fentanyl, 1 μg/kg, helps to reduce the pressor response to 
laryngoscopy. 
 
Cricoid pressure: or Sellick’s manoeuvre, is 
traditionally practised in rapid–sequence induction and is 
applied by the anaesthetic assistant as the patient starts to lose 
consciousness. Pressure is applied to the cricoid cartilage to 
compress it against the oesophagus, preventing passive 
regurgitation of stomach contents.  
If active vomiting occurs, it is recommended that 
cricoid pressure be removed to prevent oesophageal rupture – 
suction, head–down tilt and turning the patient’s head to one 
side is then used instead. Otherwise, cricoid pressure is 
removed only on the instruction of the anaesthetist, once the 
airway has been secured with a cuffed tube. Occasionally, it 
may be removed to facilitate an intubation that is being made 
more difficult by its continued application. 
 
Muscle relaxation: suxamethonium, 1.5 mg/kg, is the 
drug of choice. Its rapid onset produces ideal intubating 
conditions, with a peak effect of muscle relaxation within 50 
seconds of injection. It is important to allow the drug time to 
work, and not to begin the intubation sequence before muscle 
fasciculations have subsided.  
The duration of apnoea is usually about 5 minutes in 
healthy individuals, and thus spontaneous respiration may be 
re–established early in the event of a failed intubation. 
Suxamethonium is contraindicated in patients with: 
• previous allergy, 
• susceptibility to malignant hyperpyrexia, 
• myotonia, 
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• severe burns, muscle damage or paraplegia (of over 1 
week’s duration,,) 
• known raised serum potassium. 
In these patients, rocuronium, 0.6–0.9 mg/kg, may 
provide relaxation as rapidly as suxamethonium, but with 
longer duration. Rocuronium is also the drug of choice in 
patients with reduced or absent plasma cholinesterase activity, 
in whom suxamethonium has a long and unpredictable 
duration of action. 
Intubation: the trachea is intubated with a cuffed tube 
following unconsciousness and muscle relaxation. Uncuffed 
tubes are used in children to avoid local pressure on the 
tracheal wall and to maximize the internal diameter of tube 
available. If difficulty is encountered with direct 
laryngoscopy, then simple steps may be taken to facilitate 
intubation: 
• manipulate the larynx (the assistant providing the 
cricoid pressure may be distorting the view of the larynx) 
• change to a larger blade laryngoscope, 
• change to a different type of blade (e.g. a McCoy 
levering blade), 
• use the gum–elastic bougie (this thin, flexible stylet 
may be used to pass through the cords providing a ‘track’ over 
which the tracheal tube can be railroaded). 
Before the cricoid pressure is released, the correct 
position of the tube must be checked carefully by auscultation 
and capnometry. Once the cuff has been inflated and the 
airway has been secured, a nasogastric tube should be passed 
and aspirated, if not done previously. The rest of the 
anaesthetic proceeds as usual; but at the end of the procedure 
extubation should take place with the patient awake, with 
their protective airway reflexes re–established, positioned on 
their side in a head–down tilt, and with suction available 
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Maintenance of anaesthesia 
This contribution is an overview of what is meant, and 
required, by maintenance of anaesthesia. Many of the topics 
are covered in greater detail in separate contributions; the aim 
here is to put these topics in context.  
Maintenance of general anaesthesia involves four 
priorities: 
• keeping the patient safe, 
• keeping the patient comfortable, 
• presenting the best possible operating conditions for 
the surgeon, 
• preparing the patient for the postoperative period. 
 
Keeping the patient safe 
 
There are several aspects involved in keeping the 
patient safe:  
• airway, breathing and circulation, 
• temperature control, 
• monitoring, 
• positioning. 
 
Airway: this will usually have been established at the 
time of induction. However, it should not be assumed that this 
remains secure. Airway disconnection or obstruction may 
occur and the anaesthetist must be able to detect and correct 
these incidents promptly, assisted by monitors such as the 
capnograph, pulse oximeter, disconnect alarm and airway 
pressure monitor. Movement of the tracheal tube (either 
towards the right main bronchus or withdrawal from the 
trachea) or dislodgement of the laryngeal mask airway (LMA) 
are particularly likely to occur when patients are transferred to 
the operating table or when changes are made to patient 
position. These periods require increased vigilance by the 
anaesthetist. The integrity of the airway should be rechecked 
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both clinically and by monitoring after each patient 
movement.  
Tracheostomy, rigid bronchoscopy or ‘one–lung’ 
thoracic surgery may require intraoperative changes to the 
airway. The anaesthetist must be prepared for such changes 
and, if necessary, should formulate a plan with the surgeon in 
advance as to how the airway will be managed. 
Breathing will often depend on whether muscle 
relaxants are being employed as part of the anaesthetic 
technique. Although the use of muscle relaxants is not 
essential for controlled ventilation, they are usually employed 
for ventilated patients. Surgical factors often influence the 
decision to use muscle relaxants. For example, abdominal 
surgery is greatly facilitated by muscle relaxation. In 
specialized surgery, such as ophthalmic surgery or 
neurosurgery, where the slightest move or cough may have 
disastrous consequences and carbon dioxide must be 
controlled, paralysis is ideal. Otherwise, anaesthetists have 
widely differing views as to whether breathing should be 
controlled. Some anaesthetists use muscle relaxants almost 
routinely for any operation lasting longer than about 30 
minutes, on the basis that carbon dioxide retention is avoided, 
potent short–acting opioids can be used without fear of 
respiratory depression, and good lung aeration with avoidance 
of atelectasis may be easier to achieve. Others control 
ventilation less often unless indicated for reasons of airway 
management or the requirements of surgery. Some advantages 
and disadvantages of paralysis and ventilation are listed .  
The technique of ‘paralysing and ventilating’ may be 
preferred when a tracheal tube is present. It is likely that a 
relaxant will already have been given to enable intubation. 
Also, the presence of a tube within the trachea is a potent 
stimulus, and unless local anaesthesia has been applied to the 
respiratory tract, a deeper level of anaesthesia may otherwise 
be needed for the patient to breathe spontaneously without 
coughing. Lighter planes can be tolerated when a laryngeal 
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mask or oropharyngeal airway are employed, because these 
devices are less stimulating to the patient. Paralysing and 
ventilating may also be used for longer operations, where 
carbon dioxide control and prevention of atelectasis is 
important.  
However, avoiding relaxants wherever possible can 
reduce two important complications of general anaesthesia:  
• unrecognized awareness – patient movement usually 
warns of light anaesthesia before the patient becomes aware 
• accidental hypoxia – the spontaneously breathing 
patient may maintain oxygenation even in the event of circuit 
disconnection. 
Ventilator settings – most anaesthesia ventilators are 
time–cycled and volume– or flow–driven. A rate, usually with 
a ratio of inspiratory time to expiratory time (I:E), and a tidal 
volume or flow need to be set. Most adults have a minute 
volume of 80–100 ml/kg, therefore a tidal volume of 8 ml/kg 
(e.g. 500–600 ml) and a rate of 10 breaths/minute is a good 
starting point; this can be adjusted according to the observed 
end–tidal partial pressure of carbon dioxide (PE’CO2). For 
routine surgery, a PE’CO2 of about 4.5 kPa should be aimed 
for. If metabolic rate and cardiac output (and hence 
pulmonary perfusion) are assumed to be constant, then 
PE’CO2 varies inversely with the alveolar ventilation.  
In general, an I:E ratio of 1:2 is often the best 
compromise between maintaining low inflation pressures (e.g. 
15–20 cm H2O), satisfactory oxygenation (SpO2 > 95%) and 
adequate carbon dioxide removal (PE’CO2 4.5 kPa). 
However, this can be decreased to 1:1.5 or even 1:1 to 
prolong inspiratory time. This may be useful in some patients 
to help decrease high airway pressures (e.g. > 25–30 cm H2O) 
or improve oxygenation (e.g. in the obese). Some patients 
with asthma or chronic airway disease may benefit from a 
longer expiratory time to allow the lungs to empty, and an I:E 
ratio of 1:3 or 1:4 may be preferable.  
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Children have a proportionately higher minute 
ventilation than adults – up to 200 ml/kg in infancy, 
approaching adult values weight–for–weight by about age 10 
years. Given that their tidal volume is slightly less weight–
for–weight than adults (7 ml/kg), this increased minute 
volume must be provided for by an increase in rate. For 
example, in a 5 kg infant, a minute volume of 1000 ml might 
be provided by 30 breaths each of about 33 ml/minute.  
However, paediatric ventilation is complicated by the 
obligatory leak around the uncuffed tube. Volume control is 
unlikely to inflate the lungs to the set volume (especially if a 
Newton valve is used with T–piece ventilation). This is 
usually overcome by increasing the tidal volume by titrating 
against inflation pressure and/or PE’CO2. Some modern 
anaesthesia ventilators have pressure control capabilities (e.g. 
the Draeger Julian). Specific compliance varies little with 
age, therefore pressure control mode can be used to deliver an 
inflation pressure of 15–20 cm H2O. This provides an 
adequate tidal volume for any age, despite small to moderate 
leaks, as long as lung compliance is normal.  
Regardless of the mode of ventilation, a fresh gas flow 
must be selected. This depends on the breathing system in use 
as well as the size of the patient. A high flow should be used 
initially (e.g. 6 litres/minute), regardless of the circuit being 
used. This allows time for denitrogenation and equilibration 
of inhaled anaesthetic agent during this early period of rapid 
anaesthetic uptake. After about 10 minutes, flows can be 
reduced considerably if the system permits. The circle system 
with carbon dioxide absorber is widely used, and modern 
lightweight valves and low–resistance tubing make it suitable 
for paediatric use well below the traditional lower patient 
weight limit of 20 kg. With appropriate monitoring of gas 
concentrations within the circle, this permits total fresh gas 
flows of 1 litre/minute or less. Higher flows are required for 
T–pieces such as the Bain and Jackson Rees systems. 
Formulae exist for each of these circuits to predict the flow of 
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fresh gas required per kilogram patient weight to eliminate 
rebreathing for controlled and spontaneous respiration. 
However, a more practical approach is to reduce the fresh gas 
flow gradually, stopping when rebreathing of carbon dioxide 
begins to appear on the capnograph.  
General anaesthesia, particularly when using volatile 
anaesthetic agents, causes the development of atelectasis in 
the dependent parts of the lung and impairs the pulmonary 
vascular response to hypoxia (hypoxic pulmonary 
vasoconstriction). These two factors produce a small but 
noticeable degree of shunt, usually about 10%. This can be 
corrected by giving anaesthetized patients higher inspired 
oxygen than the 21% present in air; 30% is usually given, 
though this can be titrated against observed oxygen saturation. 
 
The fluid management 
Circulation: appropriate fluid management is an 
important component of anaesthetic maintenance. Intravenous 
fluid requirements may range from none in short and 
relatively non–invasive procedures, to many times the 
circulating volume in long and traumatic procedures.  
Fluid requirement consists of: 
• replacement of existing deficit – crystalloid or blood 
• metabolic maintenance requirements – crystalloid 
• replacing additional ongoing losses – crystalloid, 
colloid or blood.  
Existing deficit – in the adult elective surgical patient, 
who has been starved for at least 4 hours preoperatively (and 
sometimes much longer), a deficit of 500 ml of crystalloid can 
be assumed. This deficit is generally well tolerated and does 
not necessarily need replacing, but it decreases the patient’s 
margin of reserve against any further losses, or against 
ongoing postoperative dehydration as a result of nausea or 
vomiting. Many anaesthetists routinely administer 500–1000 
ml of crystalloid in all patients except those at risk from fluid 
overload (e.g. those with renal or cardiac failure). There is 
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evidence to suggest that this may improve the quality of early 
recovery and help to decrease postoperative nausea.  
In the emergency patient, fluid deficit may be 
considerable, as a result of either trauma–related blood loss, 
or anorexia, vomiting and/or interstitial (third–space) fluid 
loss from surgical pathology. In either case, the deficit should 
be assessed and replaced with the appropriate fluid. The larger 
the deficit, the more important that it be replaced before 
induction, whenever circumstances permit. The exception to 
this rule is during major ongoing blood loss, such as a 
ruptured aortic aneurysm or major trauma, where the priority 
is stopping the bleeding rather than prolonging attempts to 
normalize the circulation preoperatively.  
Maintenance – for many patients this is the least 
important component of intraoperative fluid management – 
the average adult requirement of about 100 ml/hour is 
negligible in the context of a short procedure and other fluid 
losses. However, in small children, maintenance requirements 
are proportionately larger and more significant. Paediatric 
maintenance fluid is usually calculated according to: 4 
ml/kg/hour for the first 10 kg, plus 2 ml/kg/hour for the next 
10 kg, plus 1 ml/kg/hour for the remainder. Thus, a 25 kg 
child would have a maintenance requirement of 40 + 20 + 5 = 
65 ml/hour. The smaller the child, the less reserve there is for 
managing without ongoing maintenance fluids, and the 
greater the impact of preoperative starvation.  
Infants have small glycogen reserves, and therefore 
need intravenous dextrose (e.g. as 5% dextrose in 0.18% 
saline) as maintenance to sustain their blood sugar levels. For 
longer procedures, careful attention must be paid to 
electrolyte balance, because infants have less ability to correct 
excessive salt loads or water loads.  
Ongoing losses – the most significant aspect of 
intraoperative fluid management can be the most difficult to 
estimate.  
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Losses from extravascular spaces (e.g. gastrointestinal, 
evaporative, third–space fluid losses) are usually crystalloid 
losses. Evaporative losses can be large – an adult may lose in 
excess of 1 litre/hour from a laparotomy or thoracotomy 
wound, and even larger amounts from extensive open skin 
wounds such as burns or large graft sites. There is no way of 
measuring these losses directly, and measures such as blood 
pressure, pulse rate or central venous pressure (CVP) provide 
only an indirect measure of total body water. Urine output 
may be the most useful clinical measure. Blood tests such as 
plasma urea, sodium and haematocrit may provide 
information regarding the hydration state, and plasma 
electrolytes and haematocrit are now commonly available 
from blood gas machines.  
Losses also occur from the intravascular space (i.e. 
blood). Losses in suction bottles may be complicated by wash, 
faeces, urine or amniotic fluid. Visual estimates of blood loss 
on swabs are often inaccurate – weighing of swabs is more 
precise, but still neglects losses on drapes, gloves and 
instruments. A dilutional technique relies on washing all 
swabs, instruments and gloves in a fixed volume of water, 
which can then be measured colorimetrically to give an 
accurate measure of blood loss. Such instruments are not 
widely available. Intravascular loss may be estimated 
indirectly from clinical measures such as blood pressure, 
pulse rate or CVP, though other anaesthetic factors such as the 
balance between surgical stimulation and depth of anaesthesia 
complicate these measures. Estimation of haemoglobin is 
useful only when adequate intravascular volume has been 
replaced. Blood losses may initially be replaced by colloid 
solution (e.g. a gelatin solution or hydroxyethyl starch), but 
larger losses (> 20% blood volume) may require replacement 
by packed–cell blood. Very large losses (> 1 blood volume) 
may require supplementation with fresh frozen plasma and/or 
platelets to maintain clotting function.  
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In practice, it is likely that fluid losses are under–
replaced in many patients. This is offset by the hormonal 
‘stress response’ to surgery: aldosterone, cortisol and 
antidiuretic hormone levels rise and atrial natriuretic peptide 
falls; all contribute to postoperative water retention. 
 
Intraoperative fluid administration 
The type and volume of fluid administered during 
surgery varies for each and every patient, but must take into 
account: 
• any deficit the patient has accrued; 
• maintenance requirements during the procedure; 
• losses due to surgery; 
• any vasodilatation secondary to the use of a regional 
anaesthetic technique 
 
Intravenous fluids 
During anaesthesia fluids are given intravenously to 
replace losses due to surgery and provide the patient’s normal 
daily requirements. Three types are used: crystalloids, 
colloids, and blood and its components. 
 
Crystalloids 
These are solutions of crystalline solids in water.  
Those containing sodium in similar concentrations to 
plasma are rapidly distributed throughout the extracellular 
fluid space (i.e. intravascular and interstitial volumes). 
Ultimately, only 25–30% of the volume administered remains 
intravascular. If such fluids are used to restore the circulating 
volume, three to four times the deficit will need to be given. If 
crystalloids containing a lower concentration of sodium than 
plasma (e.g. 4% glucose plus 0.18% saline) are given, then 
once the glucose is metabolized the remaining fluid is 
distributed throughout the entire body water (i.e. extracellular 
and intracellular volumes), and as little as 10% will remain 
intravascular. Crystalloids are used primarily either as an 
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emergency resuscitation fluid or to provide a patient’s daily 
requirements of water and sodium. 
 
Colloids 
These are suspensions of high molecular weight 
particles. The most commonly used are derived from gelatin 
(Haemaccel, Gelofusine), protein (albumin) or starch 
(Hespan, HAES–steril). 
Colloids primarily expand the intravascular volume 
and can initially be given in a volume similar to the deficit to 
maintain the circulating volume. However, they have a finite 
life in the plasma and will eventually be either metabolized or 
excreted and therefore need replacing. 
 
Blood and blood components 
There are several forms of blood and its components 
available. In the intraoperative period the most commonly 
used are red cell products, platelet concentrates and clotting 
factors. 
• Whole blood Despite its name, this is basically red 
cells, plasma proteins and clotting factors (levels of V and 
VIII are low). There are no platelets. Each unit contains 
approximately 510mL with a haematocrit of 35–45%. Not 
widely available. 
• Red cell concentrate This is the by–product of the 
removal of plasma from whole blood. Each unit contains 
250mL with a haematocrit of 60–75%, and is hence very 
viscous with a poor flow rate. 
• Red cells in optimal additive solution (SAG–M) A 
red cell concentrate to which a mixture of saline, adenine and 
glucose and mannitol has been added. This improves both red 
cell survival and flow characteristics. Each unit contains 
_300mL with a haematocrit of 50–70%. White cells are 
routinely removed  to prevent the risk of prion transmission. 
• Platelet concentrates Supplied either as ‘units’ 
containing 50–60mL (55 \ 109 platelets) or as bags equivalent 
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to four units. Four units or one bag will raise the platelet count 
by 30–40000mm3. Given via a standard giving set without the 
use of a microaggregate filter, as this will result in the loss of 
significant numbers of platelets. 
• Fresh frozen plasma (FFP) This consists of the 
plasma separated from a single donation and frozen within 6 
h. Each pack contains 200–250mL, with normal levels of 
clotting factors (except factor VIII, 70% normal). It should be 
infused as soon as it has thawed. 
• Cryoprecipitate This is produced as a precipitate 
formed on the controlled thawing of FFP, which is collected 
and suspended in plasma. It contains large amounts of factor 
VIII and fibrinogen. It is supplied as a pooled donation from 
six packs of FFPin one unit and must be used as soon as 
possible after thawing. 
 
Risks of intravenous blood and blood products 
All blood donations are routinely tested for hepatitis B 
surface antigen, hepatitis C, syphilis and antibodies to the 
HIV. However, a period exists between exposure and the 
development of antibodies. The resultant infected red cells 
would not be detected by current screening techniques. The 
risk is very small, and has been estimated for hepatitis B at 1 
:105 and for HIV at 1 :106 units transfused. 
In order to try and eliminate these risks, techniques 
now exist for using the patient’s own blood in the 
perioperative period. 
• Predepositing blood Over a period of 4 weeks prior 
to surgery, the patient builds up a bank of two to four units of 
blood for retransfusion perioperatively. 
• Preoperative haemodilution Following induction of 
anaesthesia 0.5–1.5 L of blood is removed and replaced with 
colloid. This can then be transfused at the end of surgery. 
• Cell savers These devices collect blood lost during 
surgery via a suction system; the red cells are separated, 
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washed and resuspended, ready for retransfusion to the 
patient. 
 
Intraoperative fluid administration 
The type and volume of fluid administered during 
surgery varies for each and every patient, but must take into 
account: 
• any deficit the patient has accrued; 
• maintenance requirements during the procedure; 
• losses due to surgery; 
• any vasodilatation secondary to the use of a regional 
anaesthetic technique. 
 
Temperature control: there is now good evidence 
that the maintenance of a physiological body temperature 
reduces postoperative morbidity. Patients suffering from head 
injury or undergoing certain neurosurgical procedures are 
possible exceptions. Shivering increases oxygen consumption, 
and predisposes to myocardial ischaemia, dysrhythmias, 
hypotension and acidosis. Hypothermia also increases 
susceptibility to infection and tends to lengthen hospital stay.  
Temperature control is of particular importance in 
patients at the extremes of age (who have less intrinsic control 
over body temperature and a larger surface area–to–volume 
ratio through which to lose heat), in operations involving open 
body cavities, and in all patients undergoing lengthy 
procedures. About 20% of trauma patients who arrive at 
hospital are hypothermic (core temperature < 35°C).  
A change in core temperature as a result of general 
anaesthesia is a three–phase response. 
• The first phase is a brisk fall in core temperature as a 
result of vasodilatation, caused by redistribution of heat to the 
peripheries. Core temperature may be as low as 35.5°C in 
some patients after transfer to the operating theatre from the 
anaesthetic room. 
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• The second phase is a slower but more sustained fall 
as a result of accelerated loss of heat to the environment from 
the warmer peripheries. 
• The third phase is a stable equilibrium at a lower 
core temperature.  
It is important to note that the anaesthetic itself brings 
about these changes, which are independent of the nature of 
the surgery, though surgery may modify the pattern. The use 
of spinal or epidural anaesthesia instead of general 
anaesthesia reduces, but does not abolish, the three–phase 
response described above.  
Passive rewarming is the prevention of heat loss, 
typically by raising the temperature of the environment. 
Passive rewarming can serve to modify only the second phase 
of the heat loss response. Covering with blankets or the use of 
foil ‘space’ blankets decreases heat loss by reduced transfer of 
heat by convection, conduction, evaporation and radiation.  
Dry inspired anaesthetic gases need to be humidified, 
and a heat and moisture exchange filter in the breathing 
system reduces heat loss by evaporation from the respiratory 
tract (latent heat). Low flows in a circle system (e.g. 1 
litre/minute) further reduce the quantity of dry gas needing to 
be humidified and help retain heat and moisture within the 
breathing system.  
A ‘normal’ operating room temperature of 21°C is a 
compromise between that which is warm enough for the 
patient, but cool enough for the comfort of theatre personnel. 
An increase in theatre temperature (e.g. to 25°C) helps to 
reduce the gradient for heat loss in patients at high risk (e.g. 
young children, patients with extensive burns).  
Active rewarming is the addition of heat into the 
patient. It may be used to prevent or reverse the first phase of 
the temperature drop. The local environmental temperature 
can be raised so much that the transfer of heat is reversed. 
Warm air convection blankets (e.g. the Bair Hugger) are 
considered as active rewarming.  
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Intravenous fluid warmers play an increasingly 
important role the greater the volume of intravenous fluid 
given. A fluid–warming device should be used in all at–risk 
patients and especially when stored blood is administered. 
Ventilatory gases may be warmed using a heated humidifier. 
Overhead radiant heaters may be used when a large area of 
the body needs to be exposed, and neonates may undergo 
surgery on an open incubator such as the Resuscitaire.  
Cardiopulmonary bypass represents the ultimate in 
active rewarming, but is practical only in cardiothoracic 
surgery or in uncommon resuscitation situations.  
Care is needed not to overheat the patient and 
temperature monitoring is necessary when active rewarming 
methods are used. Monitoring probes are available for a 
variety of body cavities, including nasopharynx, oesophagus, 
rectum, bladder and tympanic membrane. In routine clinical 
practice, core temperature is usually measured by 
nasopharyngeal or rectal temperature probes. Surface 
temperature monitors do not reflect core temperature, but the 
core–peripheral gradient may provide a useful measure of 
peripheral vasodilatation. A gradient of less than 2°C implies 
good peripheral perfusion. 
Monitoring. The  recommendations on standards of 
monitoring:   
• An anaesthetist must be present throughout the 
conduct of general anaesthesia. 
• Monitoring should be commenced before induction 
and continued until the patient has recovered from the effects 
of anaesthesia. 
• These recommendations also apply to the 
administration of local anaesthesia, regional analgesia or 
sedation where there is a risk of unconsciousness or 
cardiovascular or respiratory complications. 
• The anaesthetist should check all equipment before 
use. Monitoring of anaesthetic machine function during the 
administration of anaesthesia should include an oxygen 
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analyser with alarms. During spontaneous ventilation, clinical 
observation and a capnometer should be used to detect leaks, 
disconnection, and rebreathing and high pressure in the 
breathing system. Measurement of airway pressure, expired 
volume and carbon dioxide concentration is strongly 
recommended when mechanical ventilation is employed. 
• A pulse oximeter and capnometer must be available 
for every patient. 
• It is strongly recommended that clinical observation 
of the patient should be supplemented by continuous 
monitoring devices displaying heart rate, pulse volume or 
arterial pressure, oxygen saturation, the electrocardiogram and 
expired carbon dioxide concentration. Devices for measuring 
intravascular pressures, body temperature and other 
parameters should be used when appropriate. It is useful to 
have both waveform and numerical displays. 
• Intermittent non–invasive arterial pressure 
measurement must be recorded regularly if invasive 
monitoring is not indicated. If neuromuscular blocking drugs 
are used, a means of assessing neuromuscular function should 
be available. 
• Additional monitoring may be required in certain 
situations. These recommendations may be extended at any 
time on the judgement of the anaesthetist. 
 
Blood sugar should be monitored in infants and 
diabetic patients. The blood sugar of diabetic patients should 
be known before.45 
Positioning: an unconscious patient cannot move to 
relieve an uncomfortable position, and it is the anaesthetist’s 
responsibility to prevent discomfort from becoming damage. 
The anaesthetist is also responsible for protecting the patient 
during movement on and off the operating table, and during 
changes of position. Traditionally, the anaesthetist has 
particular responsibility for the head and airway. It must be 
ensured that all members of the team are working to a 
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common agenda and with coordinated timing. It is usually 
easiest and safest to disconnect as much equipment as 
possible before moving the patient. 
 
Figura 2.9 – Standards of monitoring 
 
Prophylaxis against venous thromboembolism – the 
thrombotic process often starts intraoperatively. It is difficult 
to identify patients at high risk, though coexisting medical 
illness, major surgery, malignancy, trauma (especially hip and 
pelvis), obesity, high–dose oestrogen therapy and age greater 
than 40 years are well–known risk factors. 
Thromboprophylaxis should commence before anaesthesia; 
100 
gradated compression stockings and low–dose unfractionated 
heparin, 5000 IU s.c. twice daily, continued until full 
mobilization, is popular and effective. When positioning for 
surgery, raising the heels on foam pads prevents venous stasis 
in the calves. Intermittent pneumatic compression pumps 
assist venous return, but it is not known whether this reduces 
the incidence of postoperative pulmonary embolism. 
Maintenance of unconsciousness is usually achieved 
by anaesthetic drug delivery via the inhalational or 
intravenous route, or both. The intramuscular route is seldom 
used in hospital practice owing to the relatively slow onset of 
drug action, unpredictable duration and delayed recovery. 
Ketamine, 10 mg/kg, is the only useful intramuscular agent, 
with an onset of 5–10 minutes producing up to 30 minutes of 
anaesthesia. It has a role in the provision of emergency 
anaesthesia in difficult locations.  
Inhalational route – this is the most widely used 
technique, using a volatile anaesthetic agent with or without 
nitrous oxide. It therefore requires a supply of compressed 
gas, a vaporizer and a breathing system for drug delivery. 
Compressed gas may not be required if a ‘drawover’ type 
vaporizer is used.  
The potency of an inhaled anaesthetic agent may be 
described in terms of its minimum alveolar concentration 
(MAC). MAC is defined as the alveolar concentration of the 
anaesthetic agent which at equilibrium is required to prevent 
gross reflex muscular movement in response to a standardized 
skin incision in 50% of healthy, unpremedicated patients. It is 
therefore a measure of anaesthetic potency, and is the 
effective dose in 50% of the population (ED50). It should be 
borne in mind that not all operations are ‘a standardized skin 
incision’. The amount of anaesthetic needed to remove a 
foreign body from the nose is very different from that needed 
for an anal stretch. It is important to know the MAC of 
individual inhalational agents and the factors on which they 
depend (Figures 3 and 4).  
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Of any given inhalational anaesthetic, 0.7–1.3 MAC 
will anaesthetize 95% of the population. MACs are also 
additive: 0.5 MAC of nitrous oxide (52%) plus 0.5 MAC of 
isoflurane (0.6%) is equivalent to 1 MAC of any other 
inhalational agent given alone.  
The principle of MAC acts as a useful guide. It allows 
the anaesthetist to select a vapour concentration that is likely 
to maintain unconsciousness. The state of anaesthesia is 
related to the partial pressure of anaesthetic within the brain, 
which is taken to be equivalent to the alveolar partial pressure. 
This can be measured by analysis of the end–tidal partial 
pressure of the anaesthetic agent. What is dialled on the 
vaporizer or the nitrous flowmeter is not necessarily what is in 
the patient’s alveoli – the fresh gas flow takes time to 
equilibrate both with the dead space of the circuit and with the 
uptake by the patient. Observing how the ratio of end–tidal to 
inspired partial pressure varies with time can assess this rate 
of uptake (or ‘wash–in’).  
MAC is useful to estimate the amount of anaesthetic 
required. In clinical practice this must be adjusted against 
indicators such as pulse rate, blood pressure, respiratory rate, 
patient movement, pupillary size, lacrimation and sweating. 
Many of these variables may be abolished by factors other 
than anaesthetic depth. Tachycardia may be prevented by co–
administered β–blockers, hypertension masked by 
hypovolaemia, respiratory rate and patient movement 
abolished by paralysing drugs, and pupillary size altered by 
use of opioids or anti–muscarinic drugs. Thus, lacrimation 
and sweating, though crude indicators of inadequate 
anaesthesia, reflect the need for clinical observation in 
addition to monitoring. 
Intravenous route – a popular alternative to 
inhalational anaesthesia is total intravenous anaesthesia 
(TIVA). Many intravenous anaesthetics have been used for 
TIVA, including barbiturates, ketamine, etomidate and 
propofol. The pharmaco–kinetic profile of propofol makes 
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this drug the most commonly used for TIVA. It has a high 
clearance (1300–1900 ml/minute), short metabolic half–life 
(60–100 minutes) and inactive metabolites. For short 
procedures, propofol may be administered following initial 
intravenous induction by intermittent bolus with no special 
infusion equipment (e.g. 50 mg as required every 3–5 
minutes).  
For longer procedures, the advent of reliable electronic 
syringe pumps, and in particular the development of target–
controlled infusion (TCI) software, have contributed to the 
widespread use of TIVA techniques. Some advantages and 
disadvantages of inhalational or TIVA maintenance are shown 
in Figure 5.  
Consider a three–compartment model: vascular space, 
richly perfused organs, and poorly perfused organs plus 
clearance. A large initial bolus of propofol is needed to fill the 
vascular compartment, namely the induction dose. Thereafter 
an initially high rate of infusion is needed to keep up with 
losses to the richly perfused compartment until it approaches 
saturation. Then a slower rate is required to keep up with 
losses to the poorly perfused but difficult to saturate 
compartment, and with metabolic clearance.  
The ‘Bristol regimen’ reflects these kinetics. This 
regimen aims to maintain a plasma propofol concentration of 
about 3 μg/ml by giving patients receiving 67% nitrous oxide 
an initial bolus of 1 mg/kg, followed immediately by infusion 
at 10 mg/kg/hour for 10 minutes, then 8 mg/kg/hour for 10 
minutes, then 6 mg/kg/hour thereafter. A dose of 10 
mg/kg/hour is equal to the patient's weight (in kg) as ml/ hour 
of 1% propofol – hence a 60 kg patient will initially receive 
60 ml/hour of 1% propofol. At the end of the operation, 
switching off the propofol allows rapid redistribution from the 
vascular compartment (and therefore from the richly perfused 
compartment also) to the still unsaturated third compartment. 
It is this rapid redistribution that allows a prompt wake–up 
even after a long period of TIVA.  
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TCI microprocessor–controlled technology (e.g. as 
incorporated in the Graseby 3500 ‘Diprifusor’ syringe pump) 
requires manual input of patient age, weight and desired 
plasma concentration. The pump then administers propofol 
according to the three–compartment pharmacokinetic model 
incorporated into its software. Change to a higher propofol 
concentration is achieved by a rapid zero–order infusion, and 
the plasma concentration is calculated until the new predicted 
value is reached. Change to a lower concentration is achieved 
by temporary cessation of drug infusion until the predicted 
plasma level falls to the required level, followed by 
continuation of infusion at a lower rate. The system is used in 
a similar fashion to adjusting the vaporizer setting during 
inhalational anaesthesia; the predicted plasma concentration 
of drug is analogous to the end–tidal concentration of the 
inhalational agent. Maintenance of satisfactory anaesthesia 
requires a plasma concentration of propofol of 2–6 mg/ml, 
depending on patient fitness, coexisting drug therapy and 
degree of surgical stimulation. 
Analgesia: modern inhalational or intravenous 
anaesthetic drugs possess little analgesic activity, with the 
exception of ketamine. For all but the simplest procedures, 
analgesia must be provided by systemic analgesics (usually 
opioids) or by local anaesthetics. Analgesia has several 
effects. 
• It reduces the required MAC (or plasma 
concentration) of co–administered anaesthetic drugs. 
Analgesia is an important component of the balanced 
anaesthetic technique.  
• It reduces the immediate autonomic activity in 
response to pain. Sympathetic stimulation otherwise results in 
cardiovascular and respiratory responses that may lead to 
myocardial ischaemia and dysrhythmias. 
• It reduces the neuroendocrine ‘stress response’ 
caused by surgery.  
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Opioid analgesics such as fentanyl, 15 μg/kg, reduce 
circulating concentrations of the stress hormones that increase 
after moderate and major surgery (e.g. noradrenaline, 
adrenaline, cortisol, growth hormone, glucagon, antidiuretic 
hormone). The stress response is largely detrimental and leads 
to increased catabolism, metabolic rate and oxygen 
consumption. This response is not significant in minor 
surgery.  
The short–acting synthetic opioid drugs such as 
fentanyl and alfentanil are widely used to provide 
intraoperative analgesia. Fentanyl, a synthetic opioid 
structurally related to pethidine, is the most popular (1–2 
μg/kg for minor procedures, onset 1–2 minutes, duration 30 
minutes). Its potency and minimal effect on pulse and blood 
pressure make it commonly used for the provision of intense 
analgesia during surgery. These drugs are unsuitable for 
routine use in postoperative analgesia because of their short 
duration of action and their tendency to produce marked 
respiratory depression. They are commonly substituted by 
longer–acting analgesics (e.g. morphine 0.1–0.2 mg/kg i.v.) 
towards the end of the procedure to provide pain relief 
following surgery. 
The control of the anaesthesia  depth 
Monitoring and controlling the depth of anesthesia is 
really important, since over dosing and under dosing can be 
dangerous for the patients. 
Advanced monitoring of drug effect might help to 
optimizequality of drug delivery, possibly reduce costs and 
improve patient outcomes. 
Guedel’s stages of anaesthesia 
Stage I (stage of analgesia or disorientation): from 
beginning of induction of general anesthesia to loss of 
consciousness.  
Stage II (stage of excitement or delirium): from loss of 
consciousness to onset of automatic breathing. Eyelash reflex 
disappear but other reflexes remain intact and coughing, 
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vomiting and struggling may occur; respiration can be 
irregular with breath–holding.  
Stage III (stage of surgical anesthesia): from onset of 
automatic respiration to respiratory paralysis.  
It is divided into four planes:  
Plane I – from onset of automatic respiration to 
cessation of eyeball movements. Eyelid reflex is lost, 
swallowing reflex disappears, marked eyeball movement may 
occur but conjunctival reflex is lost at the bottom of the plane  
Plane II – from cessation of eyeball movements to 
beginning of paralysis of intercostal muscles. Laryngeal reflex 
is lost although inflammation of the upper respiratory tract 
increases reflex irritability, corneal reflex disappears, 
secretion of tears increases (a useful sign of light anesthesia), 
respiration is automatic and regular, movement and deep 
breathing as a response to skin stimulation disappears.  
Plane III – from beginning to completion of intercostal 
muscle paralysis. Diaphragmatic respiration persists but there 
is progressive intercostal paralysis, pupils dilated and light 
reflex is abolished. The laryngeal reflex lost in plane II can 
still be initiated by painful stimuli arising from the dilatation 
of anus or cervix. This was the desired plane for surgery when 
muscle relaxants were not used.  
Plane IV – from complete intercostal para ysis to 
diaphragmatic paralysis (apnea).  
Stage IV: from stoppage of respiration till death. 
Anesthetic overdose cause medullary paralysis with 
respiratory arrest and vasomotor collapse. Pupils are widely 
dilated and muscles are relaxed.  
Bispectral index (BIS) is one of several technologies 
used to monitor depth of anesthesia. BIS monitors are 
intended to replace or supplement Guedel's classification 
system for determining depth of anesthesia. Titrating 
anesthetic agents to a specific bispectral index during general 
anesthesia in adults (and children over 1 year old) allows the 
anesthetist to adjust the amount of anesthetic agent to the 
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needs of the patient, possibly resulting in a more rapid 
emergence from anesthesia. Use of the BIS monitor could 
reduce the incidence of intraoperative awareness during 
anaesthesia. 
The bispectral index is a statistically based, 
empirically derived complex parameter. It is a weighted sum 
of several electroencephalographic subparameters, including a 
time domain, frequency domain, and high order spectral 
subparameters. The BIS monitor provides a single 
dimensionless number, which ranges from 0 (equivalent to 
EEG silence) to 100. A BIS value between 40 and 60 
indicates an appropriate level for general anesthesia, as 
recommended by the manufacturer. The BIS monitor thus 
gives the anesthetist an indication of how "deep" under 
anesthesia the patient is.
[
 The essence of BIS is to take a 
complex signal (the EEG), analyse it, and process the result 
into a single number. Several other systems claim to be able 
to perform the same thing. This calculation is very computer–
intensive. The recent availability of cheap, fast computer 
processors has enabled great advances in this field. When a 
subject is awake, the cerebral cortex is very active, and the 
EEG reflects vigorous activity. When asleep or under general 
anesthesia, the pattern of activity changes. Overall, there is a 
change from higher–frequency signals to lower–frequency 
signals (which can be shown by Fourier analysis), and there is 
a tendency for signal correlation from different parts of the 
cortex to become more random. 
 
Emergence from  general anesthesia 
Emergence is the process of return to baseline 
physiologic function of all organ systems after the cessation 
of administration of general anaesthetic agent(s).  
 
Emergence from  general anesthesia includes 
1. Reversal of muscle relaxation.  
2. Turning off the inhalation agents and nitrous oxide.  
107 
3. Meeting the extubation criteria.  
4. Extubation of trachea.  
5. Transfer of the patient to post anesthesia care unit.  
First, the patient’s neuromuscular blockade must be 
re–assessed, and if necessary reversed and then rechecked 
with a twitch monitor.  Next, the patient has to be able to 
breathe on his own, and ideally follow commands, 
demonstrating purposeful movement and the ability to protect 
his airway following extubation.  Suction must always be 
close at hand, since many patients can become nauseous after 
extubation, or simply have copious oropharyngeal secretions.  
Once the patient is reversed, awake, suctioned, and extubated, 
care must be taken in transferring him to the gurney and 
oxygen must be readily available for transportation to the 
recovery room/Post–Anesthesia Care Unit (PACU).  Finally, 
remember that whenever extubating a patient, you must be 
fully prepared to reintubate if necessary, which means having 
drugs and equipment handy.  
 
Extubation management 
Extubation refers to removal of the endotracheal tube 
(ETT). It is the final step in liberating a patient from 
mechanical ventilation. Issues that need to be considered prior 
to extubation, the extubation procedure itself, and 
management after extubation are described here. Outcomes 
following extubation are also discussed. Predictors of 
weaning success and methods of weaning from mechanical 
ventilation are reviewed separately. 
Prior to extubation 
At the end of the weaning process, it may be apparent 
that a patient no longer requires mechanical ventilation to 
maintain sufficient ventilation and oxygenation. However, 
extubation should not be ordered until it has been determined 
that the patient is able to protect the airway and the airway is 
patent. 
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Airway protection 
Airway protection is the ability to guard against 
aspiration during spontaneous breathing. It requires sufficient 
cough strength and an adequate level of consciousness, each 
of which should be assessed prior to extubation. The amount 
of secretions should also be considered prior to extubation 
because airway protection is significantly more difficult when 
secretions are increased. 
Extubation failure is highest when a combination of 
risk factors is present. As an example, when reduced cough 
peak expiratory flow rate (≤60 L/min), increased sputum 
volume (>2.5 mL/hr), and impaired neurologic function 
(inability to follow commands) are present, the incidence of 
extubation failure was 100 percent, compared to 3 percent 
when none of the risk factors were present . 
Universally accepted threshold levels of cough 
strength, level of consciousness, and suctioning frequency that 
prohibit extubation have not been established. For many 
patients, it seems reasonable to delay extubation if the cough 
strength is weak, the GCS is <8, or suctioning is required 
more frequently than every two to three hours. However, the 
final decision to delay or proceed with extubation should be 
made on a case–by–case basis since delayed extubation is 
associated with adverse outcomes, such as ventilator–
associated pneumonia and increased length of stay . 
Weaning from mechanical ventilation: Readiness 
testing. 
Discontinuing mechanical ventilation is a two–step 
process: 
Readiness testing – During readiness testing, objective 
clinical criteria are evaluated to determine whether a patient is 
ready to begin weaning. Some clinicians also consider 
physiological tests, known as weaning predictors, because 
they are hesitant to begin weaning on the basis of clinical 
criteria alone. The clinical criteria and weaning predictors are 
defined and described below. 
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Weaning is the process of decreasing ventilator 
support and allowing patients to assume a greater proportion 
of their ventilation. It may involve either an immediate shift 
from full ventilatory support to a period of breathing without 
assistance from the ventilator (ie, a spontaneous breathing 
trial [SBT]) or a gradual reduction in the amount of ventilator 
support.  Regardless of which approach is chosen, extubation 
is considered once the patient demonstrates the ability to 
breathe without the ventilator and both airway patency and 
airway protection have been assessed. 
 
Extubation protocol 
Inclusion 
Resolution of clinical issue requiring intubation: 
Sat > 95% on Fi02 < 40%, PEEP < 5 cm H20, 
RR < 30, SBP >100, HR < 130. 
Patient not known to be a difficult intubation. 
Preparation 
Turn off sedatives. 
Leave opioids on at a low dose (e.g., fentanyl 50 pg/h). 
Allow patient  to regain  full mental status. 
If patient shows signs of discomfort, consider 
administering more pain medication. 
Patient should be able to understand and respond to 
commands. 
Testing for Readiness 
Ask patient to raise arm and  leave  in air for 15 
seconds. 
Ask patient to raise their head off the bed. 
Ask patient to cough, they should be able to generate a 
strong cough. 
Place Patient on Pressure Support at a setting of 5 cm 
H20. Sit patient up to at least 45*. Observe for 15*30 minutes. 
If Sat < 90%, HR > 140, SBP > 200, severe anxiety, or 
decreased LOC–discontinue extubation attempt. 
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Procedure 
Have a nebulizer filled with normal saline attached to 
a mask. 
Sit pt up to at least 45°. 
Suction ET tube with bronchial suction catheter. 
Suction oropharynx with Yankeur suction. 
Deflate the ET tube cuff. 
Have the patient cough, pull the tube during the cough 
Suction the oropharynx again. 
Encourage the patient to keep coughing up any 
secretions. 
Place the nebulizer mask on the patient at 4–6 LPM. 
After Extubation 
Patient should receive close monitoring for at least 60 
minutes. 
If patient develops respiratory distress, NIV will often 
be sufficient to avoid reintubation. 
 
Complications of general anesthesia 
Complications related to the delivery of anesthesia 
care are inevitable. Even the most experienced, diligent and 
careful practitioner will have to manage complication despite 
acting well within the standard of care. These complication 
will range from minor (e.g. – infiltrated intravenous line ) to 
catastrophic (hypoxic brain injury or death). These 
complications will trigger institutional review, peer review 
and potential legal action. Litigation may occur despite the 
best effort to communicate with the patient family about the 
intraoperative events, management decisions and avoidance of 
catastrophic complications. It is essential to document the 
preoperative airway examination, to record maneuvers such as 
preoxygenetion and cricoid pressure and details of 
laryngoscopy and write a complete post anesthesia note so 
that the action of anesthesiologist can be defended should 
litigation occur. 
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Perioperative mortality is usually define as death 
within 48hr of surgery. It is clear that most perioperative 
fatalities are due to patient’s – Preoperative disease . – or the 
surgical procedure. Recent perioperative mortality rate is 
1:20,000. 
Anesthetics mishaps can be categorized as:– 
1.Unpreventable: sudden death syndrome, fatal idiosyncratic 
drug reactions.  
2. Preventable incidents: human error, equipment 
malfunctions and misuse. Common human error:  
unrecognized breathing circuit disconnection, mistaken drug 
administration,  airway mismanagement,  anesthesia machine 
misuse, fluid mismanagement, intravenous line disconnection. 
 
                   Complications  
 Cardiovascular 
 – Myocardial ischemia and infarction. 
 – Hypotension. 
 – Hypertension. 
 – Cardiac arrhythmias. 
 – Stroke.  
 – Air or gas embolism. 
 – Thromboembolism.  
Respiratory 
 – Due to ET. 
 – Upper airway obst. 
 – Lower airway obst. 
 – Atelctasis and infection.  
 – Sleep apnea. 
 – Pulmonary barotraumas. 
– Pneumothorax. 
– Inadequate ventilation. 
– Decrease compliance. 
– Increased CO2 production. 
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Neurological 
 – Abnormal muscle movt , convulsion. 
 – Delayed recovery. 
 – Acute dystonic reactions. 
 – Awareness . 
 Complication due to posture.  
 – Regurgitation, Aspiration. 
 – Malignant hyperthermia. 
 – Masseter m. spasm. 
 – Stress response. 
 – Hypothermia. 
 – Hypoxia. 
 – Hypercarbia. 
 – Anaphylactic reaction. 
 – Electrical.  
 – Fire explogions.  
 – Ophthalmic. 
 – Pollution. 
 – Radiation. 
 – Infection.  
 
The respiratory system complications 
(A), vomiting, reflux and choking and vomiting is a 
reflex action by forcing the discharge of gastric contents. 
Reflux of gastric contents by gravity or because of the effects 
of intra–abdominal pressure reflux into the throat cavity. 
Vomiting or regurgitation was easily result in aspiration, 
which leads to airway obstruction, choking or aspiration 
pneumonia, one of the main risk for the whole Ma. 
Vomiting and reflux often occurs in three square meals, the 
increase of intraabdominal pressure (such as intestinal 
obstruction, maternal), trauma, blood loss, shock, high 
intracranial pressure and coma patients. Certain drugs such as 
ether, the role of thiopental, abdominal viscera and throat 
operation of mechanical stimulation, oxygen and carbon 
dioxide accumulation and so influential. To prevent vomiting 
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and reflux caused by aspiration of the accident, should not eat 
or drink before anesthesia, the use of sedation, antiemetic or 
anti–acid drugs, needed for decompression. Of anesthesia in 
patients with full stomach should first awake intubation or 
rapid intubation, esophageal blocker can also be used, and 
strive to smooth induction of anesthesia. 
Under general anesthesia vomiting and reflux, they should 
immediately take head–down, so that the glottis above the 
esophageal entrance, head to one side to facilitate the timely 
removal of respiratory secretions. As a result of aspiration of 
acid gastric juice, especially occur when the acid aspiration 
syndrome, in addition to endotracheal suctioning, the use of 
dexamethasone, aminophylline, antibiotics and other 
medication, and the acid is diluted and used in 10 ml of saline 
were washing and cleaning endotracheal suction, and artificial 
respiration. 
(B) is divided into parts of respiratory tract obstruction 
by airway obstruction and lower respiratory tract obstruction 
or both. Into mechanical obstruction by nature, such as tongue 
fall, secretions or foreign body obstruction and functional 
obstruction such as laryngeal or bronchial spasm. 
Intraoperative bronchospasm :  
Respiratory inflammation  
Increased excitability of the vagus nerve  
Increased the release of histamine bronchospasm –> 
Propranolol and other non–selective B–blocker 
Endotracheal tube inserted too deep 
Existing asthma and other diseases 
Performance: shortness of breath, difficulty breathing, 
three concave disease, cyanosis, heart rate, arrhythmia, SO2 
decreased respiratory resistance increased, wheezing and 
other lung.  
Treatment: find out the reasons, eliminate the original 
stimulus, applied the expansion of bronchus drugs 
(aminophylline, selective Î²2 agonist), and with the 
application of hormones.  
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1. Glossocoma jaw relaxation under general 
anesthesia, so that the tongue blocking the throat after the fall 
channel, resulting in partial or complete upper airway 
obstruction, can be heard snoring sounds (snoring), normal 
sleep may also appear. Treatment includes: 1)  hold jaw; 2) 
into the oropharyngeal or nasopharyngeal airway; 3) partial 
side or shoulder padded head tilt the head back position 
.Unawakened under anesthesia should not be cushions the 
head, in order to avoid falling behind the tongue. 
(1) The base of the tongue and blocking the respiratory 
tract after the fall.  
(2) airway can take the lead to the back,  
(3) oropharyngeal airway Law, 
(4) nasopharyngeal airway Law, 
Zebian: lili correction. 
First, the vagus nerve reflex  including: 
1) OCR: oppression can lead to heart rate, cardiac 
arrest; nausea and vomiting. 
2) The carotid sinus reflex: stimulation can cause 
changes in blood pressure reflex, heart rate, reflex syncope, 
cardiac arrhythmias. 
3) The vagus–vagal reflex: the most common, vagus 
nerve stimulation of oppression by the regional if, through the 
inhibition of nerve fibers inhibit the heart of the heart, can 
cause arrhythmias and even cardiac arrest. 
Parts: ear, nose throat, heart, lung, trachea, esophagus, 
liver, stomach, gallbladder, pancreas, spleen, small intestine, 
large intestine, rectum, bladder, reproductive system. More 
common following surgery: Department of Otolaryngology – 
biliary tract – the heart – the neck – the esophagus. The rest 
are mostly incidental. These parts of the surgical compression 
or stimulation, vagus – vagal reflex, resulting in unexpected 
changes in the cardiovascular. 
2. Diagnosis: 
Can occur at any age, children with more performance 
for the reflex laryngospasm, tonsils, palate repair, throat direct 
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examination when the possibility of large, adult to the high 
incidence of gallbladder surgery. 
In addition to mechanical stimulation surgery, the 
following factors increase the incidence of: 
Students with high sensitivity idiosyncratic unstable 
autonomic function 
Hypoxemia and hypercapnia 
Hypotension, acidosis 
Too shallow or incomplete narcotic analgesia sick 
sinus surgery, a few in pre–block and pre–excitation 
syndrome 
Sudden unexpected death syndrome: reflex 
laryngospasm, hypoxia asphyxia, respiratory center 
depression. Cardiac depression, cardiac arrest. 
3. Processing:  
1)  mental preparation: surgical site and the operation 
is easy to cause, whether the original vagal nervous. 
2) anesthesia: depth appropriate, to an additional local 
anesthesia block. 
3) drugs: atropine, may give (different view), can be 
combined with ephedrine. 
4) cardiac arrest: immediate chest compressions, 
controlled breathing. Emphasis: prevention, close observation, 
early detection, timely treatment, the recovery success rate. 
Intraoperative hypoxaemia: decreased mainly as SPO2 
Pathophysiology: 
Hypotonic hypoxia: allergies can cause bronchospasm, 
ventilation ventilation dysfunction; 
Hypoxia the blood: methemoglobinemia after 
poisoning, such as procaine; 
Cyclic hypoxia: Hemorrhagic shock, protein loss 
decreased colloid osmotic pressure caused by pulmonary 
interstitial edema. 
More common in: 
Pulmonary disease (pneumothorax, pulmonary edema, 
atelectasis, chronic bronchitis and emphysema the original); 
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Heart disease (previous myocardial infarction, heart function 
insufficiency, cardiac ischemia, arrhythmia, etc.); 
The pulmonary embolism:  
1. Reason: emboli include blood clots (the most 
common, and the calf and femoral vein deep vein thrombosis 
the most common, such as indwelling catheters), air 
embolism, fat bolt, bolt of amniotic fluid, thrombosis and so 
on. The incidence of fatal pulmonary embolism: General 
elective surgery 0.1–0.8%, elective 0.3% –1.7% of hip 
surgery, emergency hip surgery 4% –7%. 
2. Pathophysiology: Pulmonary embolism and damage 
lung tissue, pulmonary circulation, right ventricular and left 
ventricular function. 
The main changes are as follows: 
(1) Respiratory: 
Increase in physiological dead space, ventilation / 
perfusion imbalance  
Alveolar collapse and atelectasis, right–left shunt 
Embolism atelectasis, pulmonary hypertension 
Gas exchange, hypoxemia. 
(2) pulmonary infarction: some patients will occur 
(because of the bronchial circulation.) 
(3) blood flow dynamics: decreased pulmonary blood 
flow increased pulmonary resistance load of pulmonary 
hypertension increases right heart right heart failure. 
3. Diagnosis: 
Symptoms: The most common are chest pain, 
breathing difficulties (there is no such two can not be 
diagnosed), while there is irritability, cough, fear, hemoptysis, 
syncope. 
Signs: shortness of breath, rapid heartbeat, jugular 
vein distention, cyanosis, fever, pleural crepitus, pulmonary 
second sound hyperthyroidism, pulmonary valve area systolic 
murmur, hepatomegaly, hypotension, shock. 
Other: ECG, approximately 40% of the patients had 
left axis deviation or right side, pulmonary P wave, 
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ventricular premature beats, atrial fibrillation. X ray, 
ultrasound, scans can help diagnose. 
4. Treatment and Care: 
(1). General support: oxygen, transfusion, boost, 
inotropic agents, anti–arrhythmia. 
(2). Heparin therapy: venous thrombosis in heparin are 
required to quickly build, continuous intravenous injection 
once or q4h until the prolonged prothrombin time 1.5–2 times 
the normal time of 5–10 days. Serious bleeding disabled. 
(3). Long–term anticoagulation: China Flynn can be 
oral (warfarin), the basic method as above. 
(4). Thrombolytic therapy: streptokinase, urokinase, 
tissue plasminogen activator f. 
(5). Other methods: vena cava occlusion, 
embolectomy and so on. 
  
Severe intraoperative hemodynamic changes: 
Abnormal heart rate too deep anesthesia 
Intraoperative bleeding VF –> –> drop in blood 
pressure  
Heart attack cardiac arrest  
Arrhythmias during anesthesia: 
A variety of arrhythmias can occur, such as 
tachycardia, bradycardia, atrial premature, ventricular 
premature premature junction, atrial fibrillation, 
atrioventricular block and so on. Including the elderly, the 
original heart disease–prone. 
VIII, endotracheal tube blockage: to occur in infants 
and young children Cause: The catheter tip sharp, young 
tracheal mucosa, bleeding, secretions mixed easily in front of 
the formation of scabs. 
Performance: CO2 accumulation induced heart rate, 
facial flushing, the misconception that "good", the further 
development of the induced fall in blood pressure, pulse small 
speed, cardiac arrest. 
Treatment: urgent change management. 
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Severe hypotension (surgery, anesthesia, etc.); 
Oxygen deficiency (including mechanical barriers, etc.). 
 
The Malignant Hyperthermia: 
Malignant Hyperthermia is an acute, fatal inherited 
metabolic disease. By the anesthesia (inhalation) and 
succinylcholine in susceptible individuals inspired, the 
performance characteristics of skeletal muscle metabolism in 
hyperthyroidism anesthesia for the crisis. 70 –90% early 
mortality rate, now reduced to 5 –10%, although a small but 
attention should be paid. 
1. Diagnosis: 
Sudden muscle hyperactivity syndrome. Sharp 
increase in skeletal muscle metabolic, showing oxygen 
consumption, CO2, lactic acid and heat production were 
significantly increased. Induced respiratory acidosis, 
metabolic acidosis, muscle rigidity, high fever, muscle fiber 
damage hyperkalemia, myoglobinuria, CK increased, 
arrhythmia, and even cardiac arrest, brain damage, pulmonary 
edema, coagulation barriers, tube failure. 
2. Incidence: rare, occurring in various reports vary, it 
is reported incidence of 1:15000 anesthetics – 1: 200000, 
children <15 years old accounted for 52.1%, 56.8% men. 
Can cause all of the volatile anesthetic, and when combined 
with the high incidence of forest Sikao. 
3. Treatment: 
(1). Integrated treatment: withdrawal, oxygen 
inhalation, hyperventilation and support. 
(2). Note Dantrolene: 2.5 mg / kg, i vein, can be used 
repeatedly until symptom control. 
(3). To correct respiratory acidosis: arterial blood gas 
guide, or directly to the baking soda 1–2mmol / kg i vein. 
(4). Lower the body temperature: core temperature 
measurement, gastric lavage with cold saline irrigation, 
bladder, rectum, or other cooling measures. 
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(5). Antiarrhythmic: but not with calcium channel 
blockers.  
(6). Against hyperkalemia: hyperventilation, NaHCO3, 
intravenous glucose and insulin, can be fatal hyperkalemia 
when calcium chloride or calcium gluconate. 
(7). Diuretic: mannitol, furosemide and so on. 
(8). Cardiac arrest: note that the treatment with anti–
potassium. Prevention: ready to dantrolene. 
Low body temperature: with the following factors: 
1) peripheral serious environmental temperature;  
2) Enter the large number of short–term cold liquids 
(including laparoscopic lavage, abdominal cavity fluid); 
3) central cooling effect of certain anesthetics; 
4) respiratory loss of moisture and heat (open or semi–
closed inhalation anesthesia). 
Performance: heart rate, blood pressure, SPO2 
decreased, confusion, no spontaneous breathing, body 
temperature range. 
Treatment: Rapid rewarming, closely monitored, 
controlled breathing, CVP, until recovery. Acute pulmonary 
edema: 
Reason: 
1) cardiac overload: Enter the excess liquid, such as 
application of vasoconstrictor drugs, particularly more 
common in children and heart function insufficiency; 
2) heart failure; 
3) hypoalbuminemia: the original or input over the 
blood–thinning liquid crystals; 
4) respiratory tract obstruction: severe hypoxia and 
CO2 accumulation, aspiration, allergies and so on. 
Performance: R rapid, TV down, coarse breath sounds 
lungs, blisters sound, SPO2 drop and so on; 
Treatment: control infusion, given cedilanid, 
furosemide, aminophylline, dexamethasone, and so on. 
Acute cerebral edema: Postoperative mortality 
Possible reasons: 
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1) the expansion of acute cerebral palsy, cerebral 
blood flow increased; 
2) surgical operation on the brain tissue extrusion or 
gross; 
3) position; 
4) hypoxia, CO2 storage; 
5) The volume of transfusion over; 
6) The anesthetic itself; 
7) anesthesia too shallow. 
Performance: a sudden increase in intracranial 
pressure and brain swelling bone window, blood pressure and 
heart first and then decreased 
Treatment: fully oxygen supply, adequate 
hyperventilation, mannitol diuretic hormone. 
Prevention: For the reasons to avoid inhalation of 
anesthetic drugs and with intravenous anesthetics such as 
fentanyl, SP, etomidate, muscle relaxants used non–
depolarizing muscle relaxants appropriate. 
 
Local and regional anaesthesia 
When referring to local and regional techniques and 
the drugs used, the terms ‘analgesia’ and ‘anaesthesia’ are 
used loosely and interchangeably. For clarity and consistency 
the following terms will be us. 
Analgesia The state when only relief of pain is 
provided. This may allow some minor surgical procedures to 
be performed, for example infiltration analgesia for suturing. 
 Anaesthesia The state when analgesia is accompanied 
by muscle relaxation, usually to allow major surgery to be 
undertaken. Regional anaesthesia may be used alone or in 
combination with general anaesthesia. 
All drugs will be referred to as local anaesthetics 
irrespective of the technique for which they are being useded: 
Local anaesthetic drugs 
EMLA 
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This is a eutectic mixture of local anaesthetics 
lignocaine and prilocaine in equal proportions (25mg of each 
per gram). It is applied as a cream to the skin and produces 
surface analgesia in approximately 60 mins. It is used to 
reduce the pain associated with venepuncture in children. 
Ametop 
This is a topical preparation of 4% amethocaine. It is 
used like EMLA to produce surface analgesia, but in a slightly 
shorter time. A synopsis of the drugs used for local and 
regional anaesthesia is given in Table 2.15. 
Epinephrine (adrenaline) 
This is added to local anaesthetics to reduce the rate of 
absorption, reduce toxicity and extend their duration of action. 
This is most effective during infiltration anaesthesia and nerve 
blocks, and less effective in epidurals or spinals. Some 
authorities recommend that solutions containing epinephrine 
should never be used intrathecally. Only very small 
concentrations of epinephrine are required to obtain intense 
vasoconstriction (a–adrenergic effect). The concentration is 
expressed as the weight of epinephrine (g) per volume of 
solution (mL). Commonly used concentrations range from 
1:80000 to 1 : 200000. 
Local anaesthetics containing vasoconstrictors must 
never be used around extremities (e.g. fingers, toes, penis), as 
the vasoconstriction can cause fatal tissue ischaemia. The 
maximum safe dose in an adult is 250 mg, that is, 20 mL of 
1:80000 or 50 mL of 1:200000. This should be reduced by 
50% in patients with ischaemic heart disease. 
 
Calculation of doses 
For any drug it is essential that the correct dose is 
given and the maximum safe dose never exceeded. This can 
be confusing with local anaesthetic drugs as the volume 
containing the required dose will vary depending upon the 
concentration (expressed in per cent), and a range of 
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concentrations exists for each drug. The relationship between 
concentration, volume and dose is given by the formula: 
Local anaesthetic toxicity 
This is usually the result of one of the following: 
 – Rapid absorption of a normally safe dose Use of an 
excessively concentrated solution or injection into a vascular 
area results in rapid absorption. It can also occur during 
intravenous regional anaesthesia (IVRA–see below) if the 
tourniquet is released too soon or accidentally. 
 – Inadvertent IV injection Failure to aspirate prior to 
injection via virtually any route. 
  – Administration of an overdose Failure or error in 
either calculating the maximum safe dose or taking into 
account any pre–existing cardiac or hepatic disease. 
Signs and symptoms of toxicity are due to effects on 
the central nervous system and the cardiovascular system. 
These are dependent on the plasma concentration and initially 
may represent either a mild toxicity or, more significantly, the 
early stages of a more severe reaction. 
– Mild or early: circumoral paraesthesia, numbness of 
the tongue, visual disturbances, lightheaded ness, slurred 
speech, twitching, restlessness, mild 
hypotension and bradycardia. 
– Severe or late: grand mal convulsions followed by 
coma, respiratory depression and, eventually, apnoea, 
cardiovascular collapse with profound hypotension and 
bradycardia, and ultimately, cardiac arrest. 
 
Management of toxicity 
If a patient complains of any of the above symptoms 
or exhibits signs, stop giving the local anaesthetic 
immediately! The next steps consist of: 
– Airway Maintain using basic techniques. Tracheal 
intubation will be needed if the protective reflexes are absent 
to protect against aspiration. 
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– Breathing Give oxygen (100%) with support of 
ventilation if inadequate. 
– Circulation Raise the patient’s legs to encourage 
venous return and start an IV infusion of crystalloid or 
colloid. Treat a bradycardia with IV atropine. 
If no major pulse is palpable, start external cardiac 
compression. If inotropes and vasopressors are required, 
invasive monitoring will be needed and this should be 
performed on the intensive care unit. 
– Convulsions These must be treated early. Diazepam 
5–10mg intravenously can be used initially but this may cause 
significant respiratory depression. If the convulsions do not 
respond or they recur, then seek assistance. 
Because of the risk of an inadvertent overdose of a 
local anaesthetic drug, they should only be given where full 
facilities for monitoring and resuscitation are immediately 
available. In this way the patient will recover without any 
permanent sequelae. 
 
The role of local and regional anaesthesia 
Regional anaesthesia is not just an answer to the 
problem of anaesthesia in patients regarded as not well 
enough for general anaesthesia. The decision to use any of 
these techniques should be based on the advantages offered to 
both the patient and surgeon. 
The following are some of the considerations taken 
into account. 
– Analgesia or anaesthesia is provided predominantly 
in the area required, thereby avoiding the systemic effects of 
drugs. 
– In patients with chronic respiratory disease, 
spontaneous ventilation can be preserved and respiratory 
depressant drugs avoided. 
– There is generally less disturbance of the control of 
coexisting systemic disease requiring medical therapy, for 
example diabetes mellitus. 
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– The airway reflexes are preserved and in a patient 
with a full stomach, particularly due to delayed gastric 
emptying (e.g. pregnancy), the risk of aspiration is reduced. 
– Central neural blockade may improve access and 
facilitate surgery, for example by causing contraction of the 
bowel or by providing profound muscle relaxation. 
– Blood loss can be reduced with controlled 
hypotension. 
– There is a considerable reduction in the equipment 
required and the cost of anaesthesia. This may be important in 
underdeveloped areas. 
–  When used in conjunction with general anaesthesia, 
only sufficient anaesthetic (inhalational or IV) is required to 
maintain unconsciousness, with analgesia and muscle 
relaxation provided by the regional technique. 
–  Some techniques can be continued postoperatively 
to provide pain relief, for example an epidural. 
– Complications after major surgery, particularly 
orthopaedic surgery, are significantly reduced. 
 A patient should never be forced to accept a local or 
regional technique. Initial objections and fears are best 
alleviated, and usually overcome, by explanation of the 
advantages and reassurance. 
Whenever a local or regional anaesthetic technique is 
used, facilities for resuscitation must always be immediately 
available in order that allergic reactions and toxicity can be 
dealt with effectively. At a minimum this will include the 
following: 
– Equipment to maintain and secure the airway, give 
oxygen and provide ventilation. 
–  Intravenous cannulae and a range of fluids. 
–  Drugs, including epinephrine, atropine, vasopressors 
and anticonvulsants. 
– Suction. 
– A surface for the patient that is capable of being 
tipped head–down. 
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Local and regional anaesthetic techniques 
Local anaesthetics can be used: 
– topically to a mucous membrane, for example the 
eye or urethra; 
– for subcutaneous infiltration; 
– intravenously after the application of a tourniquet 
(IVRA); 
– directly around nerves, for example the brachial 
plexus; 
– in the extradural space (‘epidural anaesthesia’); 
– in the subarachnoid space (‘spinal anaesthesia’). 
The latter two techniques are more correctly called 
‘central neural blockade’; however, the term ‘spinal 
anaesthesia’ is commonly used when local anaesthetic is 
injected into the subarachnoid space and it is in this context 
that it will be used.  
 
Infiltration analgesia  
Lignocaine 0.5% is used for short procedures, for 
example suturing a wound, and 0.5% bupivacaine for pain 
relief from a surgical incision. A solution containing 
epinephrine can be used if a large dose or a prolonged effect 
is required, providing that tissues around end arteries are 
avoided. Infiltration analgesia is not instantaneous and lack of 
patience is the commonest reason for failure. The technique 
used is as follows: 
– Calculate the maximum volume of drug that can be 
used. 
– Clean the skin surrounding the wound with an 
appropriate solution and allow to dry. 
– Insert the needle subcutaneously, avoiding any 
obvious blood vessels. 
–Aspirate to ensure that the tip of the needle does not 
lie in a blood vessel. 
– Inject the local anaesthetic in a constant flow as the 
needle is withdrawn. Too–rapid injection will cause pain. 
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– Second and subsequent punctures should be made 
through an area of skin already anaesthetized. 
When suturing, the needle is inserted into an area of 
intact skin at one end of the wound and advanced parallel to 
the wound, and local anaesthetic is injected as described. In a 
clean wound, local anaesthetic can be injected directly into 
the exposed wound edge. This technique can be also used at 
the end of surgery to help reduce wound pain postoperatively. 
 
IVRA, bier’s block 
Local anaesthetic is injected into the veins of an 
exsanguinated limb and retained by using an arterial 
tourniquet. Anaesthesia is produced in 10– 15mins and the 
duration is limited by discomfort caused by the tourniquet. 
Sensation returns soon after release of the tourniquet. This is a 
useful technique for surgery of the distal upper limb. Correct 
functioning of the tourniquet is essential otherwise there is the 
risk of the patient being given the equivalent of a massive 
intravenous injection. 
Contraindications are relatively few but include 
patients with impaired peripheral circulation or sickle–cell 
disease. 
Brachial plexus block. The nerves of the brachial 
plexus can be anaesthetized by injecting the local anaesthetic 
drug either above the level of the clavicle (supraclavicular 
approach) or where they enter the arm through the axilla 
along with the axillary artery and vein (axillary approach). A 
nerve stimulator is frequently used to locate the nerves more 
precisely. 
These techniques can be used for a wide range of 
surgical procedures below the elbow and will frequently 
provide good analgesia in the immediate postoperative period. 
As the block may last several hours, it is important to warn 
both the surgeon and patient of this. 
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Epidural anaesthesia 
Epidural (extradural) anaesthesia involves the 
deposition of a local anaesthetic drug into the potential space 
outside the dura .This space extends from the craniocervical 
junction at C1 to the sacrococcygeal membrane, and 
anaesthesia can theoretically be safely instituted at any level 
in between. In practice, an epidural is sited adjacent to the 
nerve roots that supply the surgical site; that is, the lumbar 
region is used for pelvic and lower limb surgery and the 
thoracic region for abdominal surgery. A single injection of 
local anaesthetic can be given, but more commonly a catheter 
is inserted into the epidural space and either repeated 
injections or a constant infusion of a local anaesthetic drug is 
used. 
 
Figure 2–10. Set for epidural anaesthesia 
 
To aid identification of the epidural space, a technique 
termed ‘loss of resistance’ is used. The (Tuohy) needle is 
advanced until its tip is embedded within the ligamentum 
flavum (yellow ligament). 
This blocks the tip and causes marked resistance to 
attempted injection of either air or saline from a syringe 
attached to the needle. As the needle is advanced further, the 
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ligament is pierced, resistance disappears dramatically and air 
or saline is injected easily. 
A plastic catheter is then inserted into the epidural 
space via the needle. The catheter is marked at 5cm intervals 
to 20cm and at 1cm intervals between 5 and 15 cm. If the 
depth of the epidural space is noted, this allows the length of 
catheter in the space to be determined. 
Varying concentrations of local anaesthetics are used 
depending on what effect is required. For example, 
bupivacaine 0.5–0.75% will be needed for surgical 
anaesthesia with muscle relaxation, but only 0.1–0.2% for 
postoperative analgesia. Local anaesthetic will spread from 
the level of injection both up and down the epidural space. 
The extent of anaesthesia is determined by: 
 –The spinal level of insertion of the epidural. For a 
given volume, spread is greater in the thoracic region than in 
the lumbar region. 
– The volume of local anaesthetic injected. 
– Gravity: tipping the patient head–down encourages 
spread cranially, while head–up tends to limit spread. 
The spread of anaesthesia is described with reference 
to the limits of the dermatomes affected; for example: the 
inguinal ligament, T12; the umbilicus, T10; and the nipples, 
T4. An opioid is often given with the local anaesthetic to 
improve the quality and duration of analgesia, for example 
fentanyl 50mg. For details of infusions of local anaesthetics 
and opioids for postoperative analgesia. 
 
Spinal anaesthesia 
Spinal (intrathecal) anaesthesia results from the 
injection of a local anaesthetic drug directly into the 
cerebrospinal fluid (CSF), within the subarachnoid space . 
The spinal can only be inserted below the second lumbar and 
above the first sacral needle vertebrae; the upper limit is 
determined by the termination of the spinal cord, and the 
lower limit by the fact that the sacral vertebrae are fused and 
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access becomes virtually impossible. A single injection of 
local anaesthetic is usually used, thereby limiting the duration 
of the technique. 
 
Figure 2–11. Spinal needles 
  
A fine, 22–29 gauge needle with a ‘pencil point’ or 
tapered point  (for example Whitacre or Sprotte needle) is 
used (Figure 2–11). The small diameter and shape are an 
attempt to reduce the incidence of postdural puncture 
headache (see below). To aid passage of this needle through 
the skin and interspinous ligament, a short, wide–bore needle 
is introduced initially and the spinal needle passed through its 
lume. 
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Figure 2–12. Sites for spinal anesthetics. 
 
Factors influencing the spread of the local anaesthetic 
drug within the CSF, and hence the extent of anaesthesia, 
include: 
 – Use of hyperbaric solutions (i.e. its specific gravity 
is greater than that of CSF), for example ‘heavy’ bupivacaine 
(0.5%). This is achieved by the addition of 8% dextrose. 
Posture is then used to control spread. 
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 – Positioning of the patient either during or after the 
injection. Maintenance of the sitting position after injection 
results in a block of the low lumbar and sacral nerves. In the 
supine position, the block will extend to the thoracic nerves 
around T5–6, the point of maximum backwards curve 
(kyphosis) of the thoracic spine. Further extension can be 
obtained with a head–down tilt. 
–  Increasing the dose (volume and/or concentration) 
of local anaesthetic drug. 
– The higher the placement of the spinal anaesthetic in 
the lumbar region, the higher the level of block obtained. 
Small doses of an opioid, for example morphine 0.1–
0.25 mg, may be injected with the local anaesthetic. This 
extends the duration of analgesia for up to 24 h 
postoperatively. 
Monitoring during local and regional anaesthesia 
During epidural and spinal anaesthesia, the guidelines 
on monitoring (see page 49) should be followed. A conscious 
patient is not an excuse for inadequate monitoring! Particular 
attention must be paid to the cardiovascular system as a result 
of the profound effects these techniques can have. 
Maintenance of verbal contact with the patient is useful as it 
gives an indication of cerebral perfusion. 
Incidence of common complications with spinal 
anaesthesia. 
– Hypotension 33%. 
– Nausea 18%. 
– Bradycardia 13%. 
– Vomiting 7%. 
– Dysrhythmias 2%. 
Early signs of inadequate cardiac output are 
complaints of nausea and faintness, and subsequent vomiting. 
The first indication of extensive spread of anaesthesia may be 
a complaint of difficulty with breathing or numbness in the 
fingers. 
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Clearly, these valuable signs and symptoms will be 
lost if the patient is heavily sedated. 
Complications of central neural blockade 
These are usually mild and rarely cause any lasting 
morbidity. Those commonly seen intraoperatively are due 
predominantly to the effects of the local anaesthetic. Their 
management is covered below.  
Hypotension and bradycardia 
Anaesthesia of the lumbar and thoracic nerves causes 
progressive sympathetic block, a reduction in the peripheral 
resistance and venous return to the heart and fall in cardiac 
output. If the block extends cranially beyond T5, the 
cardioaccelerator nerves are also blocked, and the unopposed 
vagal tone results in a bradycardia. Small falls in blood 
pressure are tolerated and may be helpful in reducing blood 
loss. If the blood pressure falls >25% of resting value, or the 
patient becomes symptomatic (see below), treatment consists 
of: 
– oxygen via a facemask; 
– IV fluids (crystalloids or colloids) to increasevenous 
return; 
– vasopressors to counteract the vasodilatation, either 
ephedrine, an a– and b–agonist (3mg IV) or metaraminol, an 
a–agonist (0.25 mg IV); 
– atropine 0.5 mg IV for a bradycardia. 
Nausea and vomiting 
These are most often the first indications of 
hypotension and cerebral hypoxia, but can also result from 
vagal stimulation during upper abdominal surgery. Any 
hypotension or hypoxia is corrected as described above. If due 
to surgery, try to reduce the degree of manipulation. If this is 
not possible then it may be necessary to convert to general 
anaesthesia. Atropine 0.3–0.6 mg is frequently effective, 
particularly if there is a bradycardia. Antiemetics can be tried 
(e.g. metoclopramide 10mg intravenously), but this must not 
be at the expense of the above. 
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Postdural puncture headache 
Caused by a persistent leak of CSF from the needle 
hole in the lumbar dura. The incidence is greatest with large 
holes, that is, when a hole is made accidentally with a Tuohy 
needle, and least after spinal anaesthesia using fine needles 
(e.g. 26 gauge) with a pencil or tapered point (<1%). Patients 
usually complain of a headache that is frontal or occipital, 
postural, worse when standing and exacerbated by straining. 
The majority will resolve spontaneously. Persistent headaches 
can be relieved (>90%) by injecting 20–30 mL of the patient’s 
own venous blood into the epidural space (epidural blood 
patch) under strict aseptic  conditions. 
 
Contraindications to epidural and spinal 
anaesthesia 
Hypovolaemia Either as a result of blood loss or 
dehydration. 
Such patients are likely to experience severe falls in 
cardiac output as compensatory vasoconstriction is lost. 
A low, fixed cardiac output As seen with severe aortic 
or mitral stenosis. The reduced venous return further reduces 
cardiac output, jeopardizing perfusion of vital organs. 
Local skin sepsis. Risk of introducing infection. 
Coagulopathy. Either as a result of a bleeding diathesis 
(e.g. haemophilia) or therapeutic anticoagulation. This risks 
causing an epidural haematoma. There may also be a very 
small risk in patients taking aspirin and associated drugs 
which reduce platelet activity. Where heparins are used 
perioperatively to reduce the risk of deep venous thrombosis, 
these may be started after the insertion of the epidural or 
spinal. 
Raised intracranial pressure. Risk of precipitating 
coning. 
Known allergy to amide local anaesthetic drugs. 
A patient who is totally uncooperative. 
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Concurrent disease of the CNS Some would caution 
against the use of these techniques for fear of being blamed 
for any subsequent deterioration. 
Previous spinal surgery or has abnormal spinal 
anatomy Although not an absolute contraindication, epidural 
or spinal anaesthesia may be technically difficult. 
 
Examples  of tascs for determination  
of knowledge lewel 
1. What anesthetics, from those given below, has the 
least toxic properties in relation to vitally important human 
organs? 
a)   Nitrous oxide. 
b)   Fluothane. 
c)  Cyclopropane. 
d)  Halothane. 
 
2. A patient, 53 years of age, with disturbed hepatic 
function, is admitted for the operation on the abdominal 
cavity. Which of the given below anesthetics has the greatest 
hepatotoxicity and undesirable in carrying out general 
anesthesia? 
a)  Cyclopropane. 
b)  Nitrous oxide. 
c)  Fluothane. 
d)  Ketamine. 
 
3. In the process of anesthesia and controlled 
respiration by semiclosed circuit because of the technical 
error, committed in the operation of narcosis apparatus, the 
patient developed progressively increasing hypertension and 
tachycardia, replaced by bradycardia and catastrophic drop of 
blood pressure. The attention was paid to the increased skin 
moisture. What error, in all probability, was committed by 
anesthesiologist? 
a)  Oxygen dosimeter is not open. 
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b)  Absorber is not switched on. 
c)  Depressurization of the apparatus has occurred. 
d)  Intubation tube came out from the trachea. 
 
4. In a 20–year old female patient being on the 
operating table after an extubation of trachea, bradypnea, 
tachycardia and acrocyanosis were noted. A muscular tension, 
in hand shaking, is diminished. She cannot lift her head 
independently. What is the doctor's tactics? 
a)  To administer cardiac glycosides. 
b)  APV with a mask method. 
c)  Administration of anticoagulants. 
d)  To transfer to the ward. 
 
5.  The patient, aged 41, with phlegmon of the oral 
cavity and disturbance of patency of the air conducting ways 
owing to this phlegmon, is indicated narcosis with: 
a)  Calypsol i/v without APV. 
b)  Thiopental i/v without APV. 
c)  I/v with APV through tracheostoma. 
d)  With a mask. 
 
6.  In order to intubate trachea they apply: 
a)  Fogg's  straight  blade. 
b)  Mackintosh's  curved  blade. 
c)  Air duct. 
d)  Gegars  retractor. 
 
7. The minimum concentration of anesthetic in the 
alveolar air, causing the absence of motor response to pain in 
50% of patients, is called: 
a) a minimum pulmonary concentration; 
b) minimum alveolar concentration; 
c) the maximum analgesic concentration; 
g) The minimum analgesic concentration. 
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8. Upon reaching what level of surgical anesthesia is 
possible to safely perform abdominal surgery? 
a) 1–1; 
b) III–1; 
c) III–2; 
d) III–3. 
 
9. What complications can be caused by epidural 
anesthesia: 
a) meningitis; 
b) hypotension; 
c) paralytic ileus; 
d) spinal anesthesia. 
 
10.  The cause of regurgitation in anesthesia can be: 
a) increasing intragastric and intra–abdominal 
pressure; 
b) functional deficiency of the cardiac sphincter; 
c) hypoxia from airway obstruction; 
g) the availability of content in the stomach; 
d) all answers are correct. 
 
Correct answers: 
1.–a);   2.–c);   3.–b);   4.–b);   5.–c);   6.–b);   7.–b);   
8.–b);   9.–a),b),d);   10.–d). 
  
137 
Topic 3. POSTANESTESIA CARE 
 
The main aim: to know foundations of observation 
and treatment patients in postoperative intensive care unit.  
 
The student must know:  
–Arrangement and equipment of postoperative 
intensive care unit. 
– Postoperativ complications and their management. 
– Postoperative intravenous fluid therapy. 
– Ttreatment of postoperative pain. 
– Analgesic techniques used postoperatively. 
– Criterias for Discharging of the patient. 
 
The student must be able: 
–  To use pulse oximeter. 
–  To use ECG monitoring device.  
           –  To appoint treatment of  hypoxaemia. 
–  To use defibrillator. 
– To calculate Postoperative intravenous fluid 
requirements. 
Mein material 
The recovery area 
The vast majority of patients recover from anaesthesia 
and surgery uneventfully, but a small and unpredictable 
number suffer complications. It is now accepted that all 
patients recovering from anaesthesia should be nursed in an 
area with appropriate facilities to deal with any of the 
problems that may arise, and by trained staff. Most patients 
will recover on a trolley capable of being tipped head–down. 
Patients who have undergone prolonged surgery, or where a 
prolonged stay is expected, may be recovered on their beds to 
minimize the number of transfers. 
Each patient should be cared for in a dedicated area 
equipped with: 
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– oxygen supply plus appropriate circuits for 
administration; 
– suction; 
– ECG monitoring device; 
– pulse oximeter; 
–non–invasive blood pressure monitor. 
In addition the following must be available 
immediately: 
– Airway equipment Oral and nasal airways, a range of 
endotracheal tubes, laryngoscopes, a bronchoscope and the 
instruments to perform a cricothyroidotomy and 
tracheostomy. 
– Breathing and ventilation equipment Self–inflating 
bag–valve–masks, a mechanical ventilator and a chest drain 
set. 
– Circulation equipment A defibrillator, drugs for 
cardiopulmonary resuscitation, a range of IV solutions, 
pressure infusers and devices for IV access. 
– Drugs For resuscitation and anaesthesia. 
– Monitoring equipment Transducers and a monitor 
capable of displaying two or three pressure waveforms, end–
tidal carbon dioxide monitor and thermometer. 
Chapter 3 
Postanaesthesia care 
A patient who cannot maintain his/her own airway 
should never be left alone. 
The length of time any patient spends in recovery will 
depend upon a variety of factors, including length and type of 
surgery, anaesthetic technique and the occurrence of any 
complications. Most units have a policy determining the 
minimum length of stay, which is usually around 30mins, and 
agreed discharge criteria. 
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Postoperativ complications and their management 
Hypoxaemia 
This is the most important respiratory complication 
after anaesthesia and surgery. It may start at recovery and in 
some patients persist for 3 days or more after surgery. The 
presence of cyanosis is very insensitive and when detectable 
the arterial PO2 will be <8kPa (55 mmHg), a saturation of 
85%. The advent of pulse oximetry has had a major impact on 
the prevention of hypoxaemia and should be used routinely in 
all patients. If hypoxaemia is severe, persistent or when there 
is any doubt, arterial blood gas analysis should be performed. 
Hypoxaemia can be caused by a number of factors, either 
alone or in combination: 
– alveolar hypoventilation; 
– ventilation and perfusion mismatch within the lungs; 
– diffusion hypoxia; 
– pulmonary diffusion defects; 
– a reduced inspired oxygen concentration. 
Alveolar hypoventilation 
This is the commonest cause of hypoxaemia and 
results in insufficient influx of oxygen into the alveoli to 
replace that taken up by the blood. As a result, alveolar PO2 
(PAO2) and arterial PO2 (PaO2) fall. In most patients, 
increasing their inspired oxygen concentration will restore 
alveolar and arterial PO2. Eventually a point is reached where 
there is only ventilation of ‘dead space’, that is, the volume of 
the airways that plays no part in gas exchange. No oxygen 
reaches the alveoli irrespective of the inspired oxygen 
concentration and profound hypoxaemia will follow. 
Hypoventilation is always accompanied by hypercapnia, as 
there is an inverse relationship between arterial carbon 
dioxide (PacO2) and alveolar ventilation. 
 Common causes of hypoventilation include: 
– Obstruction of the airway. Most often due to the 
tongue. Consider vomit, blood or swelling (e.g. post–thyroid 
surgery). Partial obstruction causes noisy breathing; in 
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complete obstruction there is little noise despite vigorous 
efforts. There may be a characteristic ‘see–saw’ or 
paradoxical pattern of ventilation. A tracheal tug may be seen. 
It is prevented by recovering patients in the lateral position, 
particularly those recovering from surgery where there is a 
risk of bleeding into the airway (e.g. ear, nose and throat 
(ENT) surgery), or regurgitation (bowel obstruction or a 
history of reflux). If it is not possible to turn the patient (e.g. 
after a hip replacement), perform a chin lift or jaw thrust. 
An oropharyngeal or nasopharyngeal airway may be 
required to help maintain the airway. No patient should be 
handed to the care of the recovery nurse with noisy respiration 
of unknown cause. 
– Central respiratory depression. The residual effects 
of anaesthetic drugs decrease the ventilatory response to 
hypoxia and hypercarbia and also reduce the level of 
consciousness. Support ventilation until effects have worn off 
or reversed. Opioid analgesics (in excess) cause respiratory 
depression and reduce the level of consciousness. If severe, 
the administration of the specific antagonist naloxone may be 
required . 
– Hypothermia. Reduces ventilation but, in the 
absence of any contributing factors, it is usually adequate for 
the body’s needs. 
– Cerebral haemorrhage or ischaemia. May cause 
direct damage to the respiratory centre or, more commonly, a 
deeply unconscious to maintain a patent airway. 
– Impaired mechanics of ventilation. Pain, particularly 
after upper abdominal or thoracic surgery, prevents coughing, 
leading to sputum retention and atelectasis. Provide adequate 
analgesia (consider central neural block). Residual 
neuromuscular blockade is suggested by unsustained, jerky 
movements with rapid, shallow breathing in a hypertensive, 
tachycardic patient. For test to confirm the diagnosis. The 
patient should be given oxygen, reassured, sat upright to 
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improve the efficiency of ventilation, and a (further) dose of 
neostigmine and an anticholinergic given. 
– Pneumothorax or haemothorax. Prevents ventilation 
of the underlying lung. Will require insertion of chest drain. 
– Diaphragmatic splintin. Abdominal distension and 
obesity push the diaphragm into the thorax and increase the 
work of breathing. Such patients are greatly helped by being 
sat up. 
– Ventilation and perfusion mismatch. Normally, 
ventilation of the alveoli (V) and perfusion with blood (Q) are 
well matched (V/Q = 1) to ensure that the haemoglobin in 
blood leaving the lungs is saturated with oxygen. During 
anaesthesia and the recovery period, this process is disturbed 
(ventilation/perfusion (V/Q) mismatch). Areas develop where: 
– Perfusion exceeds ventilation (V/Q < 1): this results 
in haemoglobin with a reduced oxygen content. 
 –Ventilation exceeds perfusion (V/Q > 1): this can be 
considered wasted ventilation. Only a small additional volume 
of oxygen is taken up as the haemoglobin is already almost 
fully saturated (98%). In the most extreme situation, there is 
perfusion of areas of the lung but no ventilation (V/Q = 0). 
Blood leaving these areas remains ‘venous’ and is often 
referred to as ‘shunted blood’. This is then mixed with 
oxygenated blood leaving ventilated areas of the lungs. The 
net result is: 
– Blood perfusing alveoli ventilated with air has an 
oxygen content of approximately 20 mL/100 mL of  blood. 
– Blood perfusing unventilated alveoli remains 
venous, with an oxygen content of 15 mL/100 mL of blood. 
– The final oxygen content of blood leaving the lungs 
will be dependent on the relative proportions of shunted blood 
and non–shunted blood. 
For an equivalent blood flow, areas of V/Q < 1 
decrease oxygen content more than increasing the oxygen 
concentration in areas of V/Q > 1 increases content. 
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The aetiology of V/Q mismatch is multifactorial but 
the following are recognized as being of importance: 
– Mechanical ventilation reduces cardiac output. This 
reduces perfusion of non–dependent areas of the lungs, whilst 
ventilation is maintained. This is worst in the lateral position, 
when the upper lung is better ventilated and the lower lung 
better perfused. 
– A reduced functional residual capacity (FRC). In 
supine, anaesthetized patients, particularly those over 50 years 
of age, the FRC falls below their closing capacity – the lung 
volume below which some airways close and distal alveoli are 
no longer ventilated. Eventually, areas of atelectasis develop, 
mainly in dependent areas of the lung that are perfused but not 
ventilated. 
– Pain restricts breathing and coughing, leading to 
poor ventilation of the lung bases, sputum retention, basal 
atelectasis and, ultimately, infection. 
This is more prevalent in the following circumstances: 
– smokers; 
– obesity; 
– pre–existing lung disease; 
– elderly; 
– after upper gastrointestinal or thoracic surgery; 
– 3 days after surgery. 
The effects of small areas of V/Q mismatch can be 
corrected by increasing the inspired oxygen concentration. 
However, because of the disproportionate effect of areas V/Q 
< 1, once more than 30% of the pulmonary blood flow is 
passing through such areas, even breathing 100% oxygen will 
not eliminate hypoxaemia. The oxygen content of the 
pulmonary blood flow through areas ventilated with 100% 
oxygen will only increase by 1 mL/100 mL of blood (21 
mL/100 mL of blood, insufficient to offset the lack from the 
areas of low V/Q. 
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Diffusion hypoxia 
Nitrous oxide absorbed during anaesthesia has to be 
excreted during recovery. As it is very insoluble in blood, it 
rapidly diffuses down a concentration gradient into the 
alveoli, where it reduces the partial pressure of oxygen in the 
alveoli, making the patient hypoxaemic. This can be treated 
by giving oxygen via a facemask to increase the inspired 
oxygen concentration (see below). 
Pulmonary diffusion defects Any chronic condition 
causing thickening of the alveolar membrane, for example 
fibrosing alveolitis, impairs transfer of oxygen into the blood. 
In the recovery period it may occur secondary to the 
development of pulmonary oedema following fluid overload 
or impaired left ventricular function. It should be treated by 
first administering oxygen to increase the partial pressure of 
oxygen in the alveoli and then by management of any 
underlying cause. 
 
A reduced inspired oxygen concentration 
As the inspired oxygen concentration is a prime 
determinant of the amount of oxygen in the alveoli, reducing 
this will lead to hypoxaemia. There are no circumstances 
where it is appropriate to administer less than 21% oxygen. 
Management of hypoxaemia 
All patients should be given oxygen in the immediate 
postoperative period to: 
– counter the effects of diffusion hypoxia when nitrous 
oxide has been used; 
– compensate for any hypoventilation; 
– compensate for V/Q mismatch; 
– meet the increased oxygen demand when shivering. 
Patients who continue to hypoventilate, have persistent 
V/Q mismatch, are obese, anaemic or have ischaemic heart 
disease, will require additional oxygen for an extended period 
of time. This is best determined either by arterial blood gas 
analysis or by using a pulse oximeter. 
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Devices used for delivery of oxygen 
Variable–performance devices: masks or nasal 
cannulae. 
These are adequate for the majority of patients 
recovering from anaesthesia and surgery. The precise 
concentration of oxygen inspired by the patient is unknown as 
it is dependent upon the patient’s respiratory pattern and the 
flow of oxygen used (usually 2–12 L/min). The inspired gas 
consists of a mixture of: 
– oxygen flowing into the mask; 
– oxygen that has accumulated under the mask during 
the expiratory pause; 
– alveolar gas from the previous breath which has 
collected under the mask; 
– air entrained during peak inspiratory flow from the 
holes in the side of the mask and from leaks between the mask 
and face. 
Examples of this type of device are Hudson and MC 
masks. As a guide, they increase the inspired oxygen 
concentration to 25–60% with oxygen flows of 2–12 L/min. 
Patients unable to tolerate a facemask who can nose breathe 
may find either a single foam–tipped catheter or double 
catheters, placed just inside the vestibule of the nose, more 
comfortable. Lower flows of oxygen are used, 2–4 L/min 
increasing the inspired oxygen concentration to 25–40%. 
If higher inspired oxygen concentrations are needed in 
a spontaneously breathing patient, a Hudson mask with a 
reservoir can be used .A one–way valve diverts the oxygen 
flow into the reservoir during expiration. During inspiration, 
the contents of the reservoir, along with the high flow of 
oxygen (12–15L/min), result in minimal entrainment of air, 
raising the inspired concentration to _85%. An inspired 
oxygen concentration of 100% can only be achieved by using 
either an anaesthetic system with a close–fitting facemask or a 
self–inflating bag with reservoir and non–rebreathing valve 
and an oxygen flow of 12–15 L/min. 
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Fixed–performance devices 
These are used when it is important to deliver a precise 
concentration of oxygen, unaffected by the patient’s 
ventilatory pattern. These masks work on the principle of high 
airflow oxygen enrichment (HAFOE). Oxygen is fed into a 
Venturi that entrains a much greater but constant flow of air. 
The total flow into the mask may be as high as 45L/min. The 
high gas flow has two effects: it meets the patient’s peak 
inspiratory flow, reducing entrainment of air, and flushes 
expiratory gas, reducing rebreathing. Masks deliver either a 
fixed concentration or have interchangeable Venturis to vary 
the oxygen concentration . 
The above systems all deliver dry gas to the patient 
that may cause crusting or thickening of secretions and 
difficulty with clearance. For prolonged use, a HAFOE 
system should be used with a humidifier. 
Hypotension 
This can be due to a variety of factors, alone or in 
combination, that reduce the cardiac output, the systemic 
vascular resistance or both: 
– hypovolaemia; 
– reduced myocardial contractility; 
– vasodilatation; 
– cardiac arrhythmias. 
Hypovolaemia. 
This is the commonest cause of hypotension after 
anaesthesia and surgery. Although intraoperative blood loss is 
usually obvious, continued bleeding, especially in the absence 
of surgical drains, may not be. Fluid loss may also occur as a 
result of tissue damage leading to oedema, or from 
evaporation during prolonged surgery on body cavities, for 
example the abdomen or thorax (see below). The diagnosis 
can be confirmed by finding: 
– Reduced peripheral perfusion; cold clammy skin or 
delayed capillary refill (>2s) in the absence of fear, pain and 
hypothermia. 
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– Tachycardia; a pulse rate >100 beats/min of poor 
volume. 
– Hypotension. Initially, systolic blood pressure may 
be reduced minimally but the diastolic elevated as a result of 
compensatory vasoconstriction (narrow pulse pressure). The 
blood pressure must always be interpreted in conjunction with 
the other assessments. 
– Inadequate urine output (<0.5mL/kg/h), best 
measured hourly via a catheter and urometer. 
Consider also the following as causes of reduced urine 
output: 
– a blocked catheter (blood clot or lubricant); 
– hypotension; 
– hypoxia; 
– renal damage intraoperatively (e.g. duringaortic 
aneurysm surgery). 
Management  
– Ensure adequate oxygenation and ventilation. 
– Intravenous fluid, either crystalloid or colloid, 
should be given, using a pressure infusor to speed 
administration. 
– Consider cross–matching blood if not already done. 
– Stop any external haemorrhage with direct pressure. 
– Get surgical assistance if internal haemorrhage 
suspected. 
Monitoring of the patient’s central venous pressure 
(CVP) may be indicated if cardiac function is in question. In 
the presence of significant hypovolaemia do not waste time 
inserting a CVP line for venous access alone. The trend of the 
patient’s acid–base status is a useful indicator of therapeutic 
success. 
 
Reduced myocardial contractility 
The commonest cause is ischaemic heart disease, 
causing any degree of left ventricular failure. 
 Thediagnosis should be considered on finding: 
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– poor peripheral circulation; 
– tachycardia; 
– tachypnoea; 
– distended neck veins; 
– basal crepitations on auscultation of the lungs; 
– wheeze with a productive cough; 
– a triple rhythm on auscultation of the heart. 
It is not uncommon to mistake this condition 
forhypovolaemia based on the first three findings. A chest X–
ray is usually diagnostic. 
Management 
– Sit the patient upright. 
– Give 100% oxygen. 
– Monitor the ECG, blood pressure and peripheral 
oxygen saturation. 
If the diagnosis is unclear, a fluid challenge (maximum 
5mL/kg) can be given and the response observed; an 
improvement in the circulatory status suggests hypovolaemia. 
Where there is no doubt about the diagnosis, fluids can be 
restricted initially and a diuretic (e.g. frusemide 20–40mg) 
given intravenously. Trends in the CVP can be monitored as a 
guide to therapy. Patients with ventricular failure are best 
cared for in a critical care area. If there is acute myocardial 
infarction, contractility may only improve with the use of 
inotropes in conjunction with vasodilators, and this is best 
undertaken on the intensive care unit (ICU). 
Unfortunately thrombolysis is contraindicated after 
surgery. 
Vasodilatation 
This is common during spinal or epidural anaesthesia. 
Another example is following prostate surgery under 
spinal anaesthesia. As the legs are taken down from the 
lithotomy position, vasodilatation in the lower limbs is 
unmasked, and as the patient is moved to the recovery area he 
becomes profoundly hypotensive. 
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The development of septic shock may present initially 
as peripheral vasodilatation, hypotension and tachycardia in 
the absence of blood loss. The patient may be pyrexial and if 
the cardiac output is measured, it is usually elevated. 
Gradually, vasoconstriction ensues along with a fall in cardiac 
output. The diagnosis should be suspected in any patient who 
has had surgery associated with a septic focus, for example 
free infection in the peritoneal cavity or where there is 
infection in the genitourinary tract. This usually presents 
several hours after the patient has left the recovery area, often 
during the night following daytime surgery. The causative 
micro–organism is often a Gramnegative bacterium. 
 
Management 
Hypotension secondary to regional anaesthesia is 
corrected by the administration of fluids (crystalloid, colloid), 
the use of vasopressors (e.g. ephedrine), or a combination of 
both. Oxygen should always be given. The combination of 
hypovolaemia and vasodilatation will cause profound 
hypotension. Patients developing septic shock require early 
diagnosis, invasive monitoring and circulatory support in a 
critical care area. Antibiotic therapy should be guided by a 
microbiologist. 
Cardiac arrhythmias 
Occur more frequently in the presence of: 
– hypoxaemia; 
– hypovolaemia; 
– hypercarbia; 
– hypothermia; 
– sepsis; 
– pre–existing ischaemic heart disease; 
– electrolyte abnormalities; 
– hypo/hyperkalaemia, hypocalcaemia,  
hypomagnesaemia; 
– acid–base disturbances; 
– inotropes, antiarrhythmics, bronchodilators; 
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– antidepressants in overdose. 
Tachycardias result in insufficient time for ventricular 
filling, thereby reducing cardiac output, while bradycardias 
reduce the heart rate below the point where no further 
increase in ventricular filling can occur to maintain cardiac 
output. 
Coronary artery flow is dependent on diastolic 
pressure and time. Hypotension and tachycardia are therefore 
particularly dangerous. 
 
Management 
Correction of the underlying problem will result in 
spontaneous resolution of most arrhythmias. Specific 
intervention is required if there is a significant reduction in 
cardiac output and hypotension. The Resuscitation Council 
(UK) publishes guidelines that are regularly updated. 
 Sinus tachycardia (>100 beats/min). The commonest 
arrhythmia after anaesthesia and surgery, usually as a result of 
pain or hypovolaemia. If there is associated pyrexia, it may be 
an early indication of sepsis. Treatment consists of oxygen, 
analgesia and adequate fluid replacement. If the tachycardia 
persists, then providing there is no contraindication a small 
dose of a beta blocker may be given intravenously whilst 
monitoring the ECG. Rarely, the development of an 
unexplained tachycardia after anaesthesia may be the first 
sign of malignant hyperpyrexia. 
– Supraventricular tachycardia. The most common is 
atrial fibrillation usually secondary to ischaemic heart disease 
or the presence of sepsis. Treatment will depend on the rate 
and reduction in cardiacoutput: 
– heart rate 100–150 /min with critical perfusion will 
require cardioversion followed by IV amiodarone 300mg over 
1h; 
– heart rate <100 /min with good perfusion, consider 
amiodarone 300 mg IV over 1 h. 
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– Sinus bradycardia (<60 beats/min).  Usually the 
result of: 
– an inadequate dose of an anticholinergic (e.g. 
glycopyrrolate) given with neostigmine to reverse 
neuromuscular block; 
– excessive suction to clear pharyngeal or tracheal 
secretions; 
– traction on the viscera during surgery; 
– excessive high spread of spinal or 
epiduralanaesthesia; 
– the development of acute inferior myocardial 
infarction; 
– excessive beta–blockade preoperatively or 
intraoperatively. 
Treatment should consist of removing any provoking 
stimuli and administering oxygen. If symptomatic, atropine 
0.5mg intravenously may be required. 
 
Hypertension 
This is most common in patients with pre–existing 
hypertension. It may be exacerbated or caused by: 
– Pain. 
– Hypoxaemia. 
– Hypercarbia. 
– Confusion or delirium. 
– Hypothermia. 
A coexisting tachycardia is particularly dangerous in 
the presence of ischaemic heart disease as this may cause an 
acute myocardial infarction. If the blood pressure remains 
elevated after correcting the above, a vasodilator or beta 
blocker may be necessary. Senior help should be sought. 
Postoperative nausea and vomiting  (PONV) 
This occurs in up to 80% of patients following 
anaesthesia and surgery. A variety of factors have been 
identified which increase the incidence: 
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– Age and sex: more common in young women and 
children. 
– Site of surgery: abdominal, middle ear or the 
posterior cranial fossa. 
– Giving opioid analgesics pre–, intra– and 
postoperatively. 
– Anaesthetic drugs: etomidate, nitrous oxide. 
– Gastric dilatation, caused by manual ventilation with 
a bag and mask without a clear airway. 
– Hypotension associated with epidural or 
spinalanaesthesia. 
– Patients prone to travel sickness. 
Patients identified as being at risk of PONV should be 
given an anti–emetic before emergence from anaesthesia. 
Failure of treatment may be addressed in the recovery area by 
giving a second or third drug from different classes of 
compound. 
Drugs used to treat nausea and vomiting. 
Before resorting to the administration of drugs to treat 
nausea and vomiting, it is essential to make sure that the 
patient is not hypoxaemic or hypotensive. 
– Antihistamines Cyclizine. Adults 50mg 
intramuscularly, up to 6 hourly. Also has anticholinergic 
actions; may cause a tachycardia when given IV. 
• 5–HT3 (hydroxytryptamine) antagonists Ondansetron 
(Zofran). Adults 4–8mg intravenously or orally, 8 hourly. Has 
both central and peripheral actions; in the gut it blocks 5–HT3 
receptors in the mucosal vagal afferents. It does not cause 
dystonic movements. 
• Dopamine antagonists Metoclopramide (Maxolon). 
Adults 10mg intravenously, intramuscularly or orally, 6 
hourly. Although a specific anti–emetic, minimal effect 
against PONV. Not related to the major tranquillizers and has 
no sedative or antihistamine effects. Has an effect at the 
chemoreceptor trigger zone and increases gastric motility. An 
alternative is domperidone (Motilium) 10 mg orally. 
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– Phenothiazine derivatives. Prochlorperazine 
(Stemetil). Adults 12.5 mg intramuscularly 6 hourly or 15–30 
mg orally, daily in divided doses. May cause hypotension due 
to alpha–blockade. Some have antihistamine activity and may 
cause dystonic muscle movements. 
– Anticholinergic drugs Atropine and hyoscine; the 
latter is available as a transdermal patch. Severe side–effects, 
particularly dry mouth and blurred vision. 
– Steroids Dexamethasone 8  mg IV may be useful in 
resistant cases. 
 
Postoperative intravenous fluid therapy 
Oral intake should be encouraged as not all patients 
require routine IV fluids after anaesthesia and surgery. For 
those that do, the volume and type of fluid will be determined 
by a variety of factors, including: 
– the site of surgery; 
– the extent of tissue damage; 
– blood loss during and after surgery; 
– any delay in starting to drink; 
– continuing losses from the gastrointestinal tract. 
A wide range of fluids are available, and for each 
patient the type and volume will be dependent upon the 
calculated maintenance requirements of water and electrolytes 
plus the replacement of any abnormal losses. This is 
complemented by clinical evaluation of the patient to ensure 
that they are adequately hydrated, as assessed by degree of 
thirst, moisture of mucous membranes, blood pressure, pulse, 
peripheral circulation and an adequate urine output. In 
complex cases, monitoring the trend of the CVP may also 
prove useful. 
 
Minor surgery 
Following minor surgical procedures (i.e. taking less 
than 30 mins, with minimal blood loss and tissue tissue 
trauma), most patients start drinking within 1–2 h of surgery 
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and IV fluid is not required. If a patient has failed to drink 
within 4–6 h (usually as a result of nausea and vomiting), 
consideration should be given to commencing IV fluids. 
Providing that the volume of vomit is not excessive, only 
maintenance fluids are required. These are calculated at 1.5 
mL/kg/h, but must take into account the accrued deficit. 
For example, a 70 kg patient starved from 0800 to 
1400, who is still unable to take fluids by mouth at 1800 will 
require: 
An appropriate rate for the IV fluid would be: 
– 1000 mL over the first 4 h; 
– 1000 mL over the following 6 h; 
– 500 mL over the last 4 h. 
This should contain the daily requirement of Na++ 1–
1.5 mmol/kg and could be given either as: 1000 mL 5% 
glucose and 500mL 0.9% normal saline; or 1000 mL 4% 
glucose/0.18% saline, and 500 mL 4% glucose/0.18% saline. 
The patient should be reviewed at 0800 with regard to 
further management. 
 
Major surgery 
Following major surgery, postoperative fluid balance 
is more complex. Assuming that appropriate volumes of 
water, electrolytes and blood have been given during the 
operation, then postoperatively the fluid and electrolyte 
requirements will depend upon: 
– the volume needed for ongoing maintenance, which 
will be increased if the patient is pyrexial; 
– replacement of continuing losses from the 
gastrointestinal tract, for example via a nasogastric tube; 
– any continued bleeding; 
– rewarming of cold peripheries causing 
vasodilatation. 
The patient who has undergone major surgery will 
require close monitoring to ensure that sufficient volumes of 
the correct fluid are administered. A standard postoperative 
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regimen for the first 24 h postoperatively might therefore 
consist of: 
– 1.5 mL/kg/h water, increased by 10% for each °C if 
the patient is pyrexial; 
– sodium, 1 mmol/kg; 
– replacement of measured gastrointestinal losses with 
an equal volume of Hartmann’s solution; 
–  replacement of blood loss of <500 mL with either: 
– Hartmann’s solution (three times the volume of 
blood lost will be needed as it is distributed throughout the 
extracellular fluid (ECF));  
– colloid, the same volume as the blood loss; 
– blood loss >1000 mL will require transfusion with 
stored blood. 
It is essential that the patient is reviewed at the end of 
the day as described above to ensure that the volumes and 
type of fluid prescribed are adequate for the patient’s needs. 
On the second and subsequent days, the same basic principles 
are used. In addition: 
– The fluid balance of the previous 24 h must be 
checked. 
– Ensure that all sources of fluid loss are recorded. 
The patient’s serum electrolytes must be checked to 
ensure adequate replacement. 
– The urine output for the previous 6 and 24 h should 
be noted; if decreasing, consider other causes of fluid loss, for 
example increasing pyrexia, development of an ileus. 
– Potassium will be required (in addition to sodium) at 
the rate of 1mmol/kg per 24 h. If surgery is associated with 
significant tissue trauma (e.g. total hip replacement, major 
gastrointestinal surgery), then there will be continued losses 
into the tissues, which have the same effect as any other form 
of fluid loss and are often referred to as ‘third space losses’. 
Such volumes are difficult to measure and usually become 
evident as a result of the above regimen failing to keep the 
patient adequately hydrated. This is usually seen as thirst, a 
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dry mouth, cool peripheries with empty superficial veins, 
hypotension, tachycardia and a decrease in the urine output to 
less than 0.5 mL/kg/h. An additional 1 L of Hartmann’s 
solution per 24 h may need to be added to the above regimen 
to account for such losses and adjusted according to the 
patient’s response. These losses may continue for up to 48 h 
after surgery and sufficient extra volumes of fluid should be 
administered to maintain hydration and an adequate 
circulating volume. Where large volumes of fluid are required 
and/or there is underlying heart disease, then the CVP should 
be measured and the trend noted  and serum electrolytes 
monitored twice daily. 
The stress response 
Following major surgery and trauma, various 
neuroendocrine responses result in an increased secretion of a 
variety of hormones. Antidiuretic hormone (ADH) secretion 
is maximal during surgery and may remain elevated for 
several days. The effect of this is to increase water absorption 
by the kidneys and reduce urine output. Aldosterone secretion 
is raised secondary to increased cortisol levels and activation 
of the renin–angiotensin system. This results in sodium 
retention and increased urinary excretion of potassium. 
Despite this retention of water and sodium, it is important that 
fluid input is not restricted in these patients, as the continued 
losses identified above more than offset the volume retained. 
After 2–3 days, hormone levels return to normal and 
this is followed by an increase in the volume of urine passed, 
which may be augmented by loss of fluid as tissue oedema 
resolves. 
Postoperative analgesia 
After injury, acute pain limits activity until healing has 
taken place. Modern surgical treatment restores function more 
rapidly, a process facilitated by the elimination of 
postoperative pain. A good example is the internal fixation of 
fractures, followed by potent analgesia allowing early 
mobilization. 
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Ineffective treatment of postoperative pain not only 
delays this process, but also has other important 
consequences: 
–Physical immobility: 
–reduced cough, sputum retention and pneumonia; 
– muscle wasting, skin breakdown and cardiovascular 
deconditioning; 
– thromboembolic disease–deep venous thrombosis 
and pulmonary embolus; 
– delayed bone and soft tissue healing. 
– Psychological reaction: 
–reluctance to undergo further, necessary 
surgicalprocedures. 
– Economic costs: 
– prolonged hospital stay, increased medical 
complications; 
– increased time away from norma loccupations. 
– Development of chronic pain syndromes. 
Sometimes pain is a useful aid to diagnosis and must 
be recognized and acted upon, for example: 
– pain due to ischaemia from tissue swelling, 
haematoma formation restricting the circulation causing a 
compartment syndrome or by dressings becoming too tight; 
– pain of infection from cellulitis, peritonitis or 
pneumonia; 
– referred visceral pain in myocardial infarction (arm 
or neck) or pancreatitis (to the back). What to expect 
postoperatively, what types of analgesia are available and also 
by allowing patients to explore their concerns. 
– Patients who have a pre–existing chronic pain 
problem are vulnerable to suffering with additional acute pain   
Their nervous systems can be considered to be sensitized to 
pain and will react more strongly to noxious stimuli. Bad 
previous pain experiences in hospital or anticipation of severe 
pain for another reason suggest that extra effort will be 
required to control the pain. 
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– Older patients tend to require lower doses of 
analgesics as a result of changes in drug distribution, 
metabolism, excretion and coexisting disease. 
Prescribing should take these factors into account 
rather than using them as an excuse for inadequate analgesia. 
There is no difference between the pains suffered by the 
different sexes having the same operation. 
– Upper abdominal and thoracic surgery cause the 
most severe pain of the longest duration, control of which is 
important because of the detrimental effects on ventilation. 
Pain following surgery on the body wall or periphery of limbs 
is less severe and for a shorter duration. 
Management of postoperative pain 
This can be divided into a number of steps: 
– assessment of pain; 
– analgesic drugs used; 
– techniques of administration; 
– difficult pain problems. 
Assessment of acute pain 
Regular measurement of pain means that it is more 
difficult to ignore and the efficacy of interventions can be 
assessed. There are a variety of methods of assessing pain; 
Table 3.3 shows a simple, practical system that is easily 
administered and understood by patients. The numeric score is 
to facilitate recording and allows trends to be identified. Pain 
must be assessed with appropriate activity for the stage of 
recovery; for example, 5 days after a hip joint replacement a 
patient would not be expected to have pain while lying in bed, 
but adequate Any patient who complains of pain that 
unexpectedly increases in severity, changes in nature or site, 
or is of new onset should be examined to identify the cause 
rather than simply be prescribed analgesia. 
Factors affecting the experience of pain 
Pain and the patient’s response to it are very variable 
and should be understood against the background of the 
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individual’s previous personal experiences and expectations 
rather than compared with the norm. 
– Anxiety heightens the experience of pain. The 
preoperative visit by the anaesthetist plays a significant role in 
allaying anxiety by explaining analgesia should allow 
mobilization with only mild to insignificant pain. 
The most commonly used drugs are opioids and 
NSAIDs. 
Opioids 
Morphine is most commonly used to control severe 
postoperative pain on surgical units, and diamorphine (heroin) 
on medical wards, for example coronary care units, mainly for 
historical reasons. There are few pharmacological differences 
between these two drugs. Morphine can be given by several 
routes. One of the principal metabolites, morphine–6–
glucuronide (M6G), has potent opioid effects and may 
accumulate and cause toxicity in patients with renal failure, 
particularly the elderly. Fentanyl and oxycodone have less 
active metabolites than morphine and so may be more suitable 
for these patients. 
For most painful clinical conditions there will be a 
blood level of opioid that provides useful analgesia, that is, a 
reduction in pain level. The dose required to achieve this may 
vary enormously between patients as a result of differences in: 
– pharmacodynamics: the effect of the drug on the 
body (via the receptors);  pharmacokinetics: how the body 
distributes, metabolizes and eliminates the drug; 
– the nature of the stimulus; 
– the psychological reaction to the situation. 
The biggest step forward in the treatment of acute pain 
with opioids has been the recognition that individual 
requirements are very variable and the dose needs to be 
titrated for each patient: 
– There is no minimum or maximum dose. 
–Even with best practice some pain will remain. 
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–Minimum levels of monitoring and intervention are 
necessary for safe, effective use. 
–Additional methods of analgesia should be 
considered if opioid requirements are high. 
Overdose 
Profound respiratory depression and coma due to 
opioids must be treated using the ABC principles described 
elsewhere (page 99). Having created a patent airway and 
supported ventilation using a bag–valve–mask with 
supplementary oxygen, the effects of the opioid can be 
pharmacologically reversed (antagonized) using naloxone. 
0.4mg is diluted to 5 mL with 0.9% saline and given in 
incremental doses of 1 mL IV (adult dosing). Analgesia will 
also be reversed, and careful thought must be given to 
continuing analgesia. HDU care is usually advisable in this 
situation. 
Long–term complications of opioids 
Adequate treatment of acute pain with opioids is not 
associated with dependency. 
Less potent opioid agonists 
– Codeine (3–methyl morphine) Well absorbed orally, 
dose 30–60 mg 6 hourly (can be given intramuscularly but 
never intravenously). Available in a range of tablets, often 
combined with paracetamol, for example co–codamol (8mg 
codeine, 500 mg paracetamol). Exerts its effect by a small 
amount (10%) being metabolized to morphine in the liver. 
Some patients lack the necessary enzyme and therefore get no 
effect from codeine. 
– Tramadol Similar potency to codeine and used for 
mild to moderate pain. 
Neither is a controlled drug and so are more easily 
accessible. 
Non–steroidal anti–inflammatory drugs (NSAIDs) 
– Paracetamol An analgesic and antipyretic with little 
anti–inflammatory action, but usually classified with 
NSAIDs. Inhibits prostaglandin synthesis, mainly in the CNS. 
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It is used to treat mild to moderate pain. Well absorbed orally, 
causing little irritation of the gastrointestinal tract. Widely 
used orally in a dose of 1g 4–6 hourly, maximum 4g/day. 
Often incorporated into compound preparations with aspirin 
or codeine. An intravenous preparation is available containing 
10 mg/mL, in 100 mL vials (1 g). This can be infused over 
15mins and is effective in 5–10 mins. The dose is the same as 
for the oral preparation. It is the safest of all analgesics but 
patients may need reassurance that regular dosing of 1 g every 
6 h is not associated with hepatic toxicity. 
Analgesic techniques used postoperatively 
Patient–controlled analgesia (PCA) 
– A microprocessor–controlled syringe pump capable 
of being programmed is used to deliver a predetermined dose 
of a drug intravenously. 
– Activation is by the patient depressing a switch that 
is designed to prevent accidental triggering (hence ‘patient–
controlled’). 
– There may be a background, low–dose, 
continuousinfusion. 
To prevent the administration of an overdose: 
– The dose and any background infusion is preset 
(usually by a doctor). 
– After successful administration of a dose, a 
subsequent dose cannot be administered for a preset period, 
the ‘lockout period’. 
– The total quantity of drug given over a 
predetermined period can be limited.  Typical settings for an 
adult using morphine delivered by a PCA device might be: 
– bolus dose: 1mg; 
– lockout interval: 5mins. 
Effective PCA requires: 
– That the patient be briefed by the anaesthetist and/or 
nursing staff preoperatively and, if possible, be shown the 
device to be used. 
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–A loading dose of analgesic, usually intravenously 
before starting. Failure to do this will result in the patient 
being unable to get sufficient analgesia from the PCA device 
and the system will fail. 
– A dedicated IV cannula or non–return valve on an 
IV infusion to prevent accumulation of the drug and failure of 
analgesia. Observation and recording of the patient’s pain 
score, sedation score and respiratory rate to ensure success.  
Advantages of PCA 
– Greater flexibility; analgesia matched to the patient’s 
perception of the pain. 
– Reduced workload for the nursing staff. 
– Elimination of painful IM injections. 
 
Management of overdose with patientcontrolled 
analgesia (PCA) 
– Stop the PCA. 
– Give oxygen via a mask. 
– Call for assistance. 
– Consider giving naloxone. 
– If the patient is apnoeic, commence ventilation using 
a self–inflating bag–valve–mask device. 
– Intravenous administration with greater certainty of 
adequate plasma levels. 
Disadvantages 
– Equipment is expensive to purchase andmaintain. 
– Requires patient comprehension of the system. 
– Patient must be physically able to trigger the device. 
– The elderly are often reluctant to use a PCA device. 
– The potential for overdose if the device is incorrectly 
programmed. 
As pain subsides the PCA can be discontinued, and 
oral analgesics can be used. The first dose should be given 1h 
prior to discontinuing PCA, to ensure continuity of analgesia. 
Regional analgesic techniques  
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• Peripheral nerve blocks Used mainly for pain relief 
after upper or lower limb surgery. A single injection of local 
anaesthetic, usually bupivacaine, results in 6–12 h of pain 
relief. An infusion of local anaesthetic via a catheter inserted 
close to the nerve may enable the block to be continued for 
several days. An alternative effective form of analgesia must 
be prescribed for when the local anaesthetic is discontinued to 
prevent the patient being in severe pain. 
– Epidural analgesia. Infusions of a local anaesthetic 
into the epidural space, either alone or in combination with 
opioids, act on the transiting nerve roots and the dorsal horn 
of the spinal cord, respectively, to provide dramatic relief of 
postoperative pain. It is essential that patients who are offered 
an epidural receive an explanation by the anaesthetist at the 
preoperative visit of what to expect postoperatively, in 
particular altered sensation, weakness of the lower limbs and 
the potential need for a urinary catheter. The epidural is often 
sited preoperatively and used as part of the anaesthetic 
technique. For upper abdominal surgery an epidural in the 
mid–thoracic region (T6/7) is used, while a hip operation 
would need a lumbar epidural (L1/2). 
Different combinations of local anaesthetic and opioid 
infusion have been used successfully. 
Ideally, the concentration of local anaesthetic should 
block sensory nerves, leaving motor nerves relatively spared. 
The choice and dose of opioid should be such that the drug 
passes through the dura into the CSF in sufficient quantities to 
block the opioid receptors in the spinal cord but not spread 
cranially to cause respiratory depression. For example: 
– bupivacaine 0.167% plus diamorphine 0.1 mg/mL; 
– bupivacaine 0.125% plus fentanyl 4 mg/mL. 
Epidural infusions can be used to maintain analgesia 
for several days. Opioid side–effects are less common and 
less severe than when given systemically as the dose is much 
less. 
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Points to note 
–The infusion rate and the site of the catheter 
determine the spread of the solution. In the thoracic epidural 
space a starting infusion rate might be 4 mL/h; in the lumbar 
space commence at 8 mL/h. 
–The efficacy of the infusion must be monitored in a 
similar manner as for PCA. 
– If analgesia is inadequate, a ‘top–up’ of 3–4 mL of 
solution may be necessary. 
– Observations of the patient’s vital signs should then 
be made on a regular basis according to local protocol. 
• In patients over the age of 60 years, the concentration 
of opioid is often halved. 
Difficult pain problems 
Patients in whom there is evidence of regular opioid 
use preoperatively, for example drug addicts, cancer and 
chronic pain patients and those patients with a previous bad 
pain experience, will pose a particular problem 
postoperatively. They are best managed using a team 
approach that will include: 
– Liaison with the Acute Pain Team to inform it of the 
patient’s admission. 
– Discussion with the anaesthetist, and surgical and 
nursing staff to plan perioperative care, to: 
– ensure any current opioid medication is continued on 
admission to prevent withdrawal; 
– understand that much larger doses of opioids than 
normal may be required; 
– explain that toxicity from high doses of opioid is 
very unlikely; 
– reassure that addiction is not a concern. 
– Discussion with the patient to explain: 
– types and effectiveness of analgesic regimes 
available postoperatively; 
– that analgesia may not be 100% effective; 
– that long–term continuation may be necessary; 
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– potential side–effects, especially if regional 
analgesia planned. 
– Plan regular reviews during postoperative period. 
– Coordination of care. 
 
Discharge of the patient 
The anaesthetist’s responsibility to the patient does not 
end with termination of the anaesthetic. Although care is 
handed over to the recovery staff (nurse or equivalent), the 
ultimate responsibility remains with the anaesthetist until 
discharge from the recovery area. If there are inadequate 
numbers of recovery staff to care for a newly admitted patient, 
the anaesthetist should adopt this role. 
Minimum criteria for discharge from recovery area 
– Fully conscious and able to maintain own airway 
(although patient may still be ‘sleepy’) 
– Adequate breathing 
–Stable cardiovascular system, with minimal bleeding 
from the surgical site 
–Adequate pain relief 
–Warm 
 
Examples  of tascs for determination of knowledge  lewel 
1.   After carrying out anesthesia in the patient with the 
use of arduan as a myorelaxant, a respiratory depression has  
occurred as a result of residual curarization. What preparation 
should be applied? 
a)  Adrenalin. 
b)  Euphylline. 
c)  Proserin. 
d)  Unithiolum. 
 
2.   In the immediate postanesthetic period the patient 
developed a complication, named as "Mendelson's 
syndrome". What is the essence of this complication? 
a)  Reflex cardiac arrest. 
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b)  Ventricular  fibrillation.  
c)  Sharp depression of respiration. 
d)  Acute exudative pneumonitis. 
 
3. Signs of threatening disturbance of vital functions are: 
a)  Systolic AP 60 mm Hg. 
b)  Temperature 39° C. 
c)  Dyspnea at rest. 
d)  Coma. 
 
4. The following substances are anticonvulsants: 
a) midazolam; 
b) suksametonium; 
a) nifedipine; 
g) atracurium; 
d) trifluoperazine. 
 
5. Malignant hyperthermia: 
a) develops intraoperatively in operations for more 
than 3 hours; 
b) triggered by succinylcholine; 
c) requires the monitoring of body temperature for the 
diagnosis; 
d) more frequent in patients with renal impairment. 
 
6. Acute heart failure at high central venous pressure is 
not typical for one of the following states: 
Possible answers: 
a) tension pneumothorax; 
b) venous air embolism; 
c) heart failure; 
d) bleeding. 
 
7.   For the state of hypovolemia is not typical: 
a) A decrease in blood volume (CBV); 
b) reduction of blood pressure, tachycardia; 
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c) a decrease in stroke volume and cardiac output (SV 
and CO); 
d) increasing the CVP; 
 
8.  Insulin resistance in the postoperative period in 
patients with diabetes may develop under the influence: 
a) inadequate local anesthesia; 
b) metabolic acidosis; 
c) use of glucocorticoids; 
d) all of the above. 
 
9. Mechanical hyperventilation in the normal patient 
during anesthesia will lead to: 
a) marked decrease in postoperative analgesia 
requirements; 
b) shifting oxyhemoglobin dissociation curve to the 
right; 
c) reduction of PaO2; 
d) postoperative hypoventilation. 
 
10. At early postoperative period hypotension may be 
more related to: 
a) hemorrhage, hypovolemia, or ongoing bleeding; 
b) with pain; 
c) with an overdose of anesthetic; 
d) endocrine insufficiency. 
 
Correct answers: 
1.–c;    2.–d);    3.–a),c),d);   4.–a);   5.–b);   6.–d)   ;7.–
d);   8.–d);   9.–d);   10.–a). 
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